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ABSTRACT 
The main aim of this work was to characterize the molecular mechanisms that underlie the 
physiopathology of LCA12 and RP10, that are inherited retinal dystrophies caused by alterations in 
guanine nucleotide metabolism.  
First, LCA12 is caused by loss-of-function mutations in the retinal degeneration 3 (RD3) gene, that 
impair rod and cone function and cause a fast retinal degeneration in patients. This disease is 
reproduced in the natural strain of rd3 mice. The underlying physiopathology mechanisms of LCA12 
are not well understood. We previously proposed that Guanylate Cyclase Activating Proteins 
(GCAPs) might be key Ca2+-sensors mediating the physiopathology of this disorder, based on the 
demonstrated toxicity of GCAP2 when blocked in its Ca2+-free form at photoreceptor inner segments. 
We here show that the retinal degeneration in rd3 mice is substantially delayed by GCAPs ablation. 
While the number of retinal photoreceptor cells is halved in six weeks in rd3 mice, it takes eight months 
to halve in rd3/rd3 GCAPs-/- mice. Although this substantial morphological rescue does not correlate 
with recovery of visual function due to very diminished guanylate cyclase activity in rd3 mice, it is very 
informative of the mechanisms underlying photoreceptor cell death. By showing that GCAP2 is 
mostly in its Ca2+-free phosphorylated state in rd3 mice, we infer that the [Ca2+]i at rod inner segments 
is permanently low. GCAPs are therefore retained at the inner segments in their Ca2+-free, guanylate-
cyclase-activator state. We show that in this conformational state GCAPs induce endoplasmic 
reticulum stress, mitochondrial swelling and cell death. ER stress and mitochondrial swelling are early 
hallmarks of rd3 retinas preceding photoreceptor cell death, that are substantially rescued by GCAPs 
ablation. By revealing the involvement of GCAPs-induced ER stress in the physiopathology of LCA12 
this work will aid to guide novel therapies to preserve retinal integrity in LCA12 patients to expand 
the window for gene therapy intervention to restore vision.  
Second, RP10 is caused by gain-of-function mutations in IMPDH1 gene. Inosine-5´-monophosphate 
dehydrogenase 1 (IMPDH1) catalyzes the rate-limiting step in the de novo synthesis of guanine 
nucleotides, impacting the cellular pools of GMP, GDP and GTP. Guanine nucleotide homeostasis 
is central to photoreceptor cells of the retina, where cGMP is the signal transducing molecule in the 
light response. Mutations in IMPDH1 lead to inherited blindness, but the physiological relevance of 
IMPDH1 in the retina or its in vivo regulation remain largely unknown.  We here investigate the in vivo 
regulation and physiological relevance of IMPDH1 in the retina, to gain insight into how IMPDH1 
mutations lead to retinal dystrophies. We here report that retinal IMPDH1 in vivo is regulated by light-
dependent phosphorylation at Thr159/Ser160 in the Bateman domain by protein kinase C, that 
desensitizes the enzyme to allosteric inhibition by GDP/GTP. The projected enhancement in guanine 
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nucleotide synthesis would contribute to sustain the GTP levels during illumination. Accordingly, we 
show that living mice accumulate IMPDH1 aggregates at rod outer segments upon prolonged bright 
light exposure; and that inhibiting IMPDH1 activity in living mice by intravitreal injection of IMPDH1 
inhibitors delays rod mass response recovery. Based on these results we propose a novel mechanism 
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INTRODUCTION 
1.1 The first steps in visual transduction. 
The sense of sight permits to extract information about the natural world, like color, shape, distance, 
texture and movement of objects in the visual field and thus, allows organisms an efficient interaction 
with its environment. Almost 30% of the human cerebral cortex is largely or exclusively dedicated to 
visual processing, evidencing the importance of vision in high mammals (Van Essen 1997).  
At the visual system, light enters the eye through the cornea (refracts the light), pupil (controls the 
amount of light that enters) and lens (focuses the light) and is projected to the retina at the back of 
the eye (Fig 1).  
 
Figure 1. Structure of the eye. From Bionic Vision Australia, accessed 10 December 2019  
<http://bionicvision.org.au/eye/healthy_vision> 
At the retina, rod and cone photoreceptors absorb photons and convert them into electrochemical 
signals that are relayed along a subset of retinal cells to ganglion cells. This pathway from  
photoreceptor cells to ganglion cells is a highly convergent pathway that incorporates lateral inhibition, 
ultimately emphasizing luminance contrast. Photoreceptor cells measure the light intensity at the 
different points of the visual field, but ganglion cells ultimately inform the brain about those points 
in the visual field that present spatial or temporal changes in luminosity.  In this way the retina initiates 
the coding of the shape and movement of objects in any luminosity environment of the natural world.  
The axons of ganglion cells converge into the optic nerve, that sends the electrical signals to a thalamus 




1.1.1 The retina: organization and function 
 
The retina presents a laminar structure and is made up of five classes of neurons arranged in three 
nuclear layers: the outermost layer (outer nuclear layer, ONL) accommodates photoreceptors, a 
middle layer (inner nuclear layer, INL) contains bipolar, amacrine and horizontal cells and the 
innermost layer (ganglion cell layer, GCL) contains the ganglion cells (Fig 2). These neurons are 
interconnected at two synaptic levels: the outer and inner plexiform layers (OPL, IPL) (Wässle 2004).  
The architecture of the retina is sustained by non-neural cells: the retinal pigmented epithelial (RPE) 
cells and Müller cells, that provide trophic support and contribute to prevent oxidative stress in 
photoreceptors.  
 
Visual processing begins with light entering through the pupil, traversing the transparent interior of 
the eye and reaching the retina, where it passes through the different retinal layers until reaching the 
photoreceptor cells. Beyond the photoreceptor cells, the adjacent retinal pigmented epithelium 
captures the excess of photons, thus preventing light reflection that would otherwise blur the image. 
The outer segment of the photoreceptor cells contains photopigments named opsins that are 
specialized in the capture of photons. When photopigments are photoexcited they trigger a complex 
enzymatic amplification cascade that ultimately changes the membrane potential and the rate of 
neurotransmitter release, in a process known as phototransduction (the conversion of photons into a 
















Figure 2. Retinal layer organization. In response 
to light, photoreceptors (PhRs) hyperpolarize and 
reduce the rate of glutamate release at their synapses.  
PhRs synapse with horizontal cells (HCs) and bipolar 
cells (BCs) at the OPL.  BCs in turn synapse with 
retinal ganglion cells (RGCs). The PhR-BC-RGC 
connection constitutes the direct pathway of 
information flow in the retina, while HCs and 
amacrine cells (ACs) are inhibitory interneurons that 
provide lateral connections to emphasize contrast. 
HCs mediate lateral interactions between PhRs and 
BCs providing feedback inhibition as a function of 
background illumination (Boycott 1988). PhRs-HCs-
BPs synapses set the basis for the coding of 
brightness and color contrast. BCs release glutamate 
onto ACs and RGCs. ACs are interneurons mainly 
inhibitory that interconnect neurons both laterally 
and vertically within the IPL. BCs-ACs-RGCs 
synapses set the basis for movement detection. 
Finally, RGCs integrate information typically across 
many BCs and ACs, and generate action potentials 
along well-defined axons that converge forming the 
optic nerve, transmitting the information to the 
brain. Illustration from (Odgen 1989).  
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Photoreceptor cells (PhR) use glutamate as a neurotransmitter and synapse onto second order 
glutamatergic bipolar cells (BCs) at the OPL level. Synaptic transmissions in the convergent 
connections between PhR and BCs in the direct pathway are modulated by horizontal cells (HCs) that 
confer lateral inhibition. BCs stablish synapses with retinal ganglion cells (RGCs) at the IPL level, that 
are modulated by amacrine cells (ACs). Finally, the axons of RGCs converge across the optic nerve 
and transmit visual information to the brain.  
1.1.2 Photoreceptor cells: structure and function 
 
Photoreceptor cells are the most abundant cell type in the retina, constituting approximately 70% of 
total cells (Curcio et al. 1990). There are two types of photoreceptor cells in the vertebrate retina: rods 
and cones. Rods are much more abundant than cones, and rod/cone distribution and relative 
proportion varies among species. In the human retina there are 120 million rods and 6 million cones. 
Rods localize all along the peripheral retina with rod cell density increasing in the central retina and 
fovea surrounding regions, but are absent from the fovea. Cones, on the other hand, are sparsed in 
the peripheral retina and their concentration increases in a linear gradient towards the macula lutea 
and fovea, where their density is maximal.   
 
Rods are extremely sensitive to light.  They are so sensitive that they can detect even a single photon 
(Rieke, 2000; Sampath and Rieke, 2004). As a result of their extreme sensitivity rods reach electrical 
saturation at relatively low background illumination. Rods are thus responsible for dim-light vision.  
 
Cones are 100 times less sensitive than rods, but they exhibit much faster responses to variations in 
light intensity and never reach electrical saturation, being able to operate at the brightest light 
intensities in the natural world. Furthermore, in humans there are three types of cones: S, M and L – 
sensitive to Short (blue), Medium (green) and Long (red) light wavelengths, respectively. Thus, cones 
are responsible for bright-light, high acuity and color-coding vision. 
 
Rods and cones are extremely specialized neurons, and are highly compartmentalized (Fig 3). They 
consist of an outer segment (OS), separated by a connecting cilium (CC) from an inner segment (IS) 
and cell nucleus (cell soma); and an axonic terminal.  
 
The OS derives from a primary non-motile cilium and constitutes the “sensory antenna” of the cell, 
that captures light and converts it into electrochemical signals in the phototransduction process. Rods 
and cones can be easily distinguished by their OS architecture. Rod OS are large (25 µm in mice) 
(Mustafi, Engel, and Palczewski 2009) and contain a stack of membranous discs, physically separated 
from the plasma membrane. Cone outer segments are shorter (13 µm in mice) and consist of folds of 
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the plasma membrane, which are in direct contact with the extracellular plasma. These membranous 
structures at the OS compartment are where the phototransduction proteins are organized. 
Physiologically, cones and rods differ in their photopigments or opsins. Rods only express one 





The OS is separated from the cell soma by a thin connecting cilium, reminiscent of a primary cilium 
(Fig 4E). At the cell soma, the IS contains the metabolic and biosynthetic machinery of the cell. 
Photoreceptor cells present a high energetic demand, as they must sustain the electrochemical 
gradients that keep these cells partially depolarized in darkness and a huge rate of neurotransmitter 
release and vesicle recycling at the axonic terminal; and the phototransduction cascade and opsin 
chromophore recycling under light conditions.  Furthermore, photoreceptor OS compartments are 
constantly renewed.  Their tips are constantly phagocytosed by the adjacent RPE cells, so new discs 
have to be incorporated at the OS base on a daily basis (Fig 4A). This OS renewal requires a massive 
protein and lipid synthesis, as well as a massive vectorial vesicular trafficking from the IS to the OS 
across the connecting cilium. The IS contains the biosynthetic machinery to sustain this energetic and 
anabolic demands. The distal zone of the IS accommodates the ellipsoid region (Fig 4C) which is rich 
in mitochondria for aerobic respiration. At the proximal zone of the IS, adjacent to the nucleus, the 
myoid region contains the endoplasmatic reticulum and golgi apparatus, where protein synthesis and 
maturation takes place. Contiguous to the inner segment there is the nucleus of the cell.  Collectively, 
the nucleus of rods and cones constitute the outer nuclear layer of the retina (Fig 4D).  
 
Figure 3. Rod and cone cellular 
structure. A) Vertical section of a 
murine retina stained with 
Richardson´s stain showing the 
photoreceptor cell layer.  B) 
Scheme of vertebrate rod and 
cone photoreceptors. The light-
sensitive outer segment (OS) is 
connected through a thin 
connecting cilium (CC) to the cell 
soma that comprises the inner 
segment (IS) and the nucleus. 
Morphological section from the 
lab.  Rod and cone illustration 
from (O’Brien 1982).  
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Finally, the axonic terminals of rods and cones (rod spherules, cone pedicles) contain one (rods) or 
various (cones) synaptic ribbons that organize the synaptic vesicles for their massive tonic release in 
darkness, and tight regulation as a function of light intensity (Fig 4F). 
 
Figure 4. Photoreceptor cell compartments observed by transmission electron microscopy. A. 
Photoreceptor outer segment (OS) in contact with adjacent retinal pigmented epithelium cells (RPE). Note 
microvilli (M) from RPE cells intercalating with photoreceptor OS. B. Stacks of membrane discs at OS 
compartments, in contact with the ellipsoid region of the IS. C. Magnified inner segment/outer segment region 
of a bovine rod. Ellip., ellipsoid. D. Photoreceptor nuclei at the ONL and adjacent axonic terminals showing  
a “gigantic” mitochondria each, in the proximity of the synaptic ribbon at synaptic contacts with BCs and HCs. 
E. Connecting cilium (CC) and its basal body (BB) from a bovine rod. F. Magnified rod synaptic ribbon at a 
characteristic triad (two HCs and a BC). TEM images from our lab.  
1.2 The light response: roles of cGMP and Ca2+ 
Phototransduction is initiated by photoexcitation of the visual pigments at the OS disc membranes.  
This triggers a series of enzymatic steps that ultimately convey a change in the cell transmembrane 
potential. Communication between the membrane discs -where photopigment locates- and the plasma 
membrane -where conductance is altered- is facilitated by a second messenger, a small soluble 




Free levels of cGMP set the opening probability of the cGMP-gated channels (CNG-channels) at the 
plasma membrane. That is, the free levels of cGMP set the transmembrane potential at any 
illumination condition. The balance between cGMP synthesis by retinal guanylate cyclase (RetGC) 
and cGMP consumption by cGMP phosphodiesterase (cG-PDE) determines the response to light at 
any illumination condition (see below).  
Calcium (Ca2+) is another key molecule as it plays a critical role in light adaptation, a regulatory process 
required to maintain responsiveness of the visual system to light over a wide range of illumination 
conditions. 
1.2.1 The dark current  
 
In contrast to a typical neuron at rest, that has a membrane potential of about -65mV close to the 
equilibrium potential for K+, the membrane potential of the rod outer segment in complete darkness 
is about -40mV.  That is, photoreceptor cells are partially depolarized in the dark. This depolarization 
is caused by the steady influx of Na+ through special channels in the outer segment membrane (the 
cGMP-gated channels, CNG-channels), that are gated by cGMP. The levels of cGMP are high in the 
dark, keeping the channels open. The movement of inward positive charge across the outer segment 
membrane in the dark is called the dark current (Fig 5) (Hagins, Penn, and Yoshikami 1970). Light 
reduces cGMP, causing the CNG-channels to close, and the membrane potential to become more 




Figure 5. Dark current. In dark 
adapted conditions the CNG-
channels at the outer segments are 
open because cGMP levels are high. 
Hence, positively charged ions 
(mainly Na+) enter the 
photoreceptor, keeping these cells 
depolarized at about -40mV. This 
depolarizing current is known as the 
dark current. From  University of 
Minnesota Medical School Duluth, 
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1.2.2 The dark-steady state 
 
In the dark, the visual pigment and other signaling proteins involved in the light response are in their 
inactive or basal states (Fig 6). Opsins (rhodopsin and cone opsins) are composed of the apoprotein 
opsin and a chromophore molecule derived from vitamin A: 11-cis-retinal. Opsins are seven 
transmembrane GTP-binding protein-coupled receptors (GPCRs). In the dark steady-state, the 
covalently bound 11-cis-retinal blocks the receptors in their inactive state (R, in the case of rhodopsin). 
Because cGMP levels are high in the dark equilibrium, CNG-channels are kept open, allowing a 
constant influx of Na+ into the outer segments. This current results in a relatively depolarized state of 
photoreceptor cells, characterized by the continuous release of glutamate neurotransmitter at the 
axonic terminals of rods and cones.  
 
Figure 6. Illustration showing a rod disc in dark-adapted conditions.  Rhodopsin (R) is bound to 11-cis- 
retinal and blocked in its inactive state. The heterotrimeric complex transducin (GTa,b,g) is assembled and 
inactive. The enzyme responsible for cGMP hydrolysis, cGMP-phosphodiesterase (cG-PDE), is kept at its 
basal state with the catalytic activity of the a/b subunits inhibited by the  g-subunits. CNG-channels at the 
plasma membrane are kept open, sustaining the dark current. Image modified from (Burns and Arshavsky 
2005). 
   
1.2.3 Activation phase of the light response 
 
The absorption of a photon initiates the phototransduction enzymatic cascade by causing the cis to 
trans-isomerization of the chromophore, which induces a rapid conformational change in rhodopsin.  
Photoisomerization of the chromophore confers rhodopsin its active state, metarhodopsin II or R* 






















R* activates the heterotrimeric G-protein transducin (Gta, b and g) by promoting the GDP/GTP 
exchange on transducin a subunit, Gta, that dissociates it from Gtbg (Fig 7) (Arshavsky, Lamb, and 
Pugh 2002). Gta-GTP activation constitutes the first amplification step in the phototransduction 
cascade. Activated Gta molecules bind to the g-subunit of its effector, cGMP-phosphodiesterase (cG-
PDE), relieving PDEg inhibition of PDEab catalytic subunits (Hurley and Stryer 1982). This reaction 
results in activated PDEab molecules that hydrolyze hundreds of cGMP molecules per second, 
constituting the second amplification step in the phototransduction cascade. 
 
The drop in cytoplasmic cGMP leads to the closure of the CNG-channels preventing the influx of 
Na+ and Ca2+ into the outer segment, while Na+/Ca2+/K+ exchanger (NCKX) continues extruding 
Ca2+. In this way, the light response causes a drop in the intracellular levels of cGMP and Ca2+. 
This is a graded effect. A slight lowering of the cGMP levels leads to the closure of some channels, 
whereas a large decrease in the cGMP levels will eventually lead to a complete closure of the channels 
(photoreceptor electrical saturation). Hyperpolarized photoreceptors reduce the rate of glutamate 
release at the ribbon synapse, transmitting visual information to second-order neurons.  
  
Figure 7. Phototransduction cascade. Photoisomerized rhodopsin (R*) causes transducin a (Gta) 
dissociation from Gtbg. Gta.GTP activates cGMP phosphodiesterase (cG-PDE) which dramatically increases 
the rate of cGMP hydrolysis, reducing the intracellular concentration of free cGMP. CNG-channels close while 
the Na+/Ca2+/K+ exchanger (NCKX) continues extruding Ca2+ ions from the outer segment cytosol, causing 
a drop in the intracellular Ca2+ levels. The reduction in the dark current causes a transient hyperpolarization. 
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1.2.4 Inactivation phase and light adaptation 
 
Once the photoreceptor has responded to light, when the light ceases the phototransduction cascade 
is inactivated to restore the darkness equilibrium. If the light persists (e.g. under exposure to a steady 
light), the photoreceptor cell adapts to the light condition in order to avoid saturation. Photoreceptor 
cells employ many mechanisms to avoid saturation by bright light and to adjust the amplitude and 
time course of their photoresponses to changing ambient illumination in a process known as light 
adaptation. The [Ca2+]i drop that accompanies the light response plays a key role both in termination 
of the light response and in light adaptation. 
 
Termination of the light response involves: i) that all components of the phototransduction cascade 
that have been activated are deactivated to cease signaling; and ii) that cGMP levels are restored to 
the dark-state levels by new synthesis. Deactivation of R* involves rhodopsin phosphorylation by 
rhodopsin kinase (GRK1) and arrestin binding, that effectively uncouples rhodopsin from transducin 
(Fig 8). Deactivation of the effector Gta.PDEab involves the protein complex responsible for 
catalyzing the GTPase activity in Gta: comprising RGS9-1, Gb5-L and R9AP proteins. By promoting 
GTP/GDP exchange in Gta, this protein complex sequesters Gta from PDE to promote its eventual 
re-assembly to Gtbg to re-establish the heterotrimetic inactive complex, Fig 8.   
 
Figure 8. Termination of the light response/light-adaptation. The steps involved in termination of the 
light response or light-adaptation consist on 1) R* inactivation to R by rhodopsin kinase (GRK1) 
phosphorylation and arrestin (Arr) binding, an step that is promoted by the drop in [Ca2+]i; 2) effector 
inactivation by RGS9-1.Gb5.R9AP catalysis of transducin alpha intrinsic GTPase activity; 3) RetGC activation 
by GCAP proteins promoted by the drop in [Ca2+]i and 4) the gain of CNG-channels affinity for cGMP due 









































The drop in [Ca2+]i exerts a negative feedback signal to the enzymatic cascade with the overall effect 
of counteracting the effect of light and restoring dark current. Ca2+ acts at three different levels in the 
light response, by acting on different molecular targets. First, the drop in [Ca2+]i is sensed by the 
calcium sensor protein recoverin (Rec), which stops recruiting rhodopsin kinase (GRK1) (Kawamura 
1993; C. K. Chen et al. 1995). Increased free GRK1 phosphorylates rhodopsin at multiple C-terminal 
sites, allowing arrestin binding that caps rhodopsin to prevent further activation of transducin 
(Gurevich and Benovic 1993). Rhodopsin phosphorylation and arrestin binding results in  fewer Gta-
GTP and consequently in less PDE activated molecules. As a consequence the rate of cGMP 
hydrolysis is reduced.   
 
Second, the drop in [Ca2+]i acts at activating guanylate cyclase activating proteins (GCAPs) and 
promoting cGMP synthesis. GCAPs are calcium sensor proteins that regulate retinal guanylate cyclase 
(RetGC) activity (depicted in Fig 8 at the inferior part of rod’s disc). As the Ca2+ drops in the light 
response,  Ca2+ dissociates from GCAPs and in their Ca2+-free state GCAPs stimulate RetGC activity, 
promoting cGMP synthesis. Synthesis of cGMP restores sensitivity (Dizhoor, Olshevskaya, and 
Peshenko 2010; Peshenko, Olshevskaya, Savchenko, et al. 2011a; Makino et al. 2012; A Mendez et al. 
2001; Burns et al. 2002a).  
 
A third Ca2+ dependent adaptation mechanism is the regulation of the affinity of CNG-channels for 
its ligand cGMP by the calcium sensor protein calmodulin (T. Y. Chen et al. 1994). Under dark-
adapted conditions calmodulin or calmodulin-like proteins are bound to CNG-channels reducing their 
affinity for cGMP. As the [Ca2+]i falls during the light response, calmodulin dissociates from the 
channel, increasing CNG-channel affinity for cGMP. This allows the channel in a light-adapted cell 
to operate at a lower range of cGMP concentrations than in a dark-adapted photoreceptor.  
1.3 Retinal inherited diseases 
Blindness and visual impairment has a direct impact on individual’s quality of life and has also public 
health consequences. In a twenty year’s retrospective study, the Global Burden of Disease (GBD) 
alerted that 285 million people are visually impaired worldwide with 39 million classified as blind 
(Bourne et al. 2013). Huge efforts are currently made in research to fight the most prevalent visual 
diseases such as age-related macular degeneration, glaucoma, diabetic retinopathy and cataracts. 
However, there are retinal inherited diseases that for its minoritary-nature have been more poorly 
studied and are less understood.  
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Retinal inherited diseases are a group of clinically and genetically heterogenous disorders that account 
for the main cause of vision loss in persons between 14 and 45 years of age, with 1:2000 individuals 
affected (Rattner, Sun, and Nathans 1999). They are linked to mutations in genes encoding proteins 
that are critical for photoreceptor development, function or survival. Nowadays more than 200 genes 
have been linked to inherited retinal diseases. The currently known genes are related to vital processes 
for photoreceptor cells, such as phototransduction, outer segment structure and morphogenesis, 
protein trafficking, protein folding, post-translational modifications, nucleotide homeostasis, 
carbohydrate and lipid metabolism, RNA splicing and transcription, ion transport, synaptic 
neurotransmission, extracellular matrix structure, development, etc.  
 
The principal types of inherited retinal degenerative disease are progressive: retinitis pigmentosa (RP) 
and macular degeneration (MD). Retinitis pigmentosa (RP) affects rods primarily, causing night 
blindness. In advanced phases of RP, as a consequence of the loss of rods, cones start to die as well. 
This results in a loss of cone-mediated central vision that often leads to total blindness. RP affects 
approximately 1:3500 people, with mutations in the RHO gene (encoding rhodopsin) being the most 
prevalent by accounting for 20-30% of all cases (Parmeggiani et al. 2011). Macular degeneration affects 
the macular region of the retina where most cones are concentrated, causing a loss in central vision 
and visual acuity. Although some mutations have been linked to early MD, more frequently it is life-
style and genetic predisposition that result in age-related macular degeneration (AMD).  
 
Other progressive retinal disorders are cone dystrophies (CD) characterized by compromised cone 
function; and cone-rod dystrophies (CORD) in which both rod and cone function are affected.  
 
Leber congenital amaurosis (LCA) is an early-onset retinal inherited disease affecting both cones and 
rods and is characterized by a severe loss of vision at birth or within the first years of life (den 
Hollander et al. 2008). The extent of vision loss varies from patient to patient, but can be quite severe 
with little or no light perception. LCA is one of the most common causes of blindness in children. 
The prevalence of LCA is 2 to 3 per 100000 newborns; and it accounts for 5% of total retinal 
dystrophies (Weleber et al. 1993). The most prevalent LCA mutations map at CEP290, CRB1, 
GUCY2D and RPE65 genes, and are inherited in an autosomal recessive pattern. However, LCA has 
also been associated with autosomal dominant inheritance caused by mutations in CRX and IMPDH1 
genes. Table 1 shows the frequency of LCA-associated genes (in blue, genes under study in the 





Table 1: Frequency of LCA-associated mutations  
 
From (Kumaran et al. 2017).  
 
There are also non-progressive disorders such as congenital stationary night blindness (CSNB) which 
affect rods and are characterized by impaired night vision but preservation of retinal morphology 
(therefore “stationary”, that does not involve retinal degeneration); and achromatopsia (ACHM) is a 
stationary cone disorder associated with loss of color vision. 
 
 
Gene Protein Frequency References 




<5% (Aboshiha et al. 2015) 
CABP4 Calcium binding protein 4 ? (Aldahmesh et al. 2010) 
CEP290 Centrosomal protein 290 15%-20%  
CLUAP1 Clusterin-associated protein 1 ? (Soens et al. 2016) 
CRB1 Crumbs homolog 1 10%  
CRX Cone rod homebox 1% (S G Jacobson et al. 1998)  
DTHD1 Death domain containing 1 ? (Abu-Safieh et al. 2013)  
GDF6 Growth differentiation factor 6 ?  
GUCY2D Retinal guanylate cyclase 1 10%-20% (Samuel G. Jacobson et al. 2013)  
IFT140 Intraflagellar transport 140 ? (M. Xu et al. 2015)  
IMPDH1 Inosine monophosphate dehydrogenase 1 5%  
IQCB1 IQ-Motif containing protein ? (Estrada-Cuzcano et al. 2011)  
KCNJ13 Inward rectifier potassium channel 13 ?  
LCA5 Lebercilin 1%-2%  
LRAT Lecithin retinol acyltransferase <1%  
NMNAT1 
Nicotinamide/nicotinic acid 
mononuclease adenylyltransferase 1 
? (Kumaran, Robson, and Michaelides 2018)  
OTX2 Homebox 2 protein ? (Henderson et al. 2009)  
RD3 Retinal degeneration 3 <1%  
RDH12 Retinal dehydrogenase 12 10% (Mackay et al. 2011)  
RPE65 
Retinal pigmented epithelium- 
specific 65 kDa 
5%-10%  (Kumaran et al. 2018)  
RPGRIP1 
X-linked retinitis pigmentosa GTPase 
regulator-interacting protein 1 
5%  
PRPH2 Peripherin-2 ?  
SPATA7 Spermatogenesis-associated protein 7 3%  
TULP1 Tubby-related protein 1 <1%  
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1.4 The protein complex responsible for cGMP synthesis in rods and cones 
1.4.1 cGMP production by Retinal guanylate cyclase 
In photoreceptor cells, RetGCs (retinal guanylate cyclases) are the enzymes responsible for cGMP 
synthesis. These enzymes belong to the membrane-bound GC (guanylate cyclase) family. Membrane-
bound GCs display similar topologies and are type I transmembrane proteins that have an extracellular 
domain linked by a single transmembrane domain to an intracellular catalytic domain (Fig 9). Most 
of particulate GCs are stimulated by the binding of a ligand to its extracellular domain. In contrast, 
RetGCs are stimulated intracellularly by guanylate cyclase-activating proteins (GCAPs). 
 
In the human retina there are two RetGC isoforms: RetGC1 (encoded by GUCY2D gene) that is 
present in both rods and cones and RetGC2 (encoded by GUCY2F gene) that is exclusive of rods.  
RetGC1 is the isoform that has been linked to human blindness, and therefore is the most relevant 
isoform.  
 
1.4.2 RetGCs regulation by GCAP calcium sensors 
 
Guanylyl cyclase-activating proteins (GCAPs) are EF-hand Ca2+-binding proteins that regulate RetGC 
activity. They present four EF-hand domains, of which EF2, EF3 and EF4 are functional to bind Ca2+ 
and EF1 is not. Apparently EF1 has evolved in GCAP proteins to  be a critical region in the contact 
surface with RetGC (Peshenko, Olshevskaya, and Dizhoor 2008).   
 
GCAPs are thought to form stable complexes with RetGCs at photoreceptor outer segments, where 
they exert their function. At RetGC/GCAP complexes, GCAPs bind or dissociate Ca2+ according to 
the [Ca2+]i set by illumination.   
 
In the dark, Ca2+-bound GCAPs are in an “inhibitory conformational state” in which they inhibit 
guanylate cyclase activity.  Upon Ca2+ dissociation upon light exposure GCAPs acquire an “activator 
state” and stimulate RetGC activity, causing a boost of cGMP synthesis that serves to reopen CNG-
channels and restore sensitivity (A Mendez et al. 2001; Burns et al. 2002a; Dizhoor, Olshevskaya, and 
Peshenko 2010; Peshenko, Olshevskaya, Savchenko, et al. 2011b).  
 
It has been recently specified that GCAPs are Ca2+/Mg2+ sensors (Peshenko and Dizhoor 2004), that 
bind Mg2+ in their Ca2+-free state. Because [Ca2+]i levels drop drastically in response to light, while the 
[Mg2+]i remains unchanged (C. Chen, Nakatani, and Koutalos 2003), it is the [Ca2+]i that determines 




In humans there are two different isoforms of GCAPs: GCAP1 (encoded by GUCA1A gene) and 
GCAP2 (encoded by GUCA1B gene). While RetGC1 is regulated by both GCAP1 and GCAP2 in 
both rods and cones; RetGC2 is only regulated by GCAP2 almost exclusively in rods (Peshenko, 
Olshevskaya, and Dizhoor 2015).  
 
The mechanisms by which GCAPs regulate RetGCs have been extensively characterized by 
biochemical, structural, genetic and electrophysiological studies.  Based on the in vitro determined 
individual Ca2+ sensitivities of GCAP1 and GCAP2, and the electrophysiological phenotype of double 
and individual knockout mice, a model was proposed of GCAPs sequential action in the light 
response. GCAP1, that has a slightly lower sensitivity for Ca2+, acquires its active state first as the 
[Ca2+]i drops during the light response. GCAP2, with a slightly higher sensitivity for Ca2+, would only 
acquire its active state later in the light response, as the [Ca2+]i approaches its lower limit (Makino et 
al. 2012).  This so-called “Ca2+-relay model” would secure a fine tune of RetGC activity to subtle 
changes in [Ca2+]i across the wide range of physiological calcium concentrations.  
 
Figure 9. Model of RetGCs regulation by GCAPs. RetGCs are transmembrane polypeptides that consist of 
an extracellular domain (ECD); a transmembrane domain (TMD) that anchors the enzyme at the disc 
membrane; a juxtamembrane domain (JMD); a kinase homology domain (KHD); a dimerization domain (DD) 
that mediates cyclase activation; and a catalytic domain (CD) that converts GTP to cGMP.  RetGC polypeptides 
are active as dimers. They are thought to be permanently bound to the GCAP proteins, that confer Ca2+ 
sensitivity to their catalytic activity. In the dark, the [Ca2+]i is high and GCAPs are in their “inhibitory” Ca2+-
bound state, maintaining the catalytic domain of RetGC dimers at a distance and therefore inactive. In response 
to light, as the [Ca2+]i drops, GCAPs switch to their Mg2+-bound conformation that prompts the dimerization 
of the cyclase catalytic domains, stimulating cGMP synthesis. GCAP1 and GCAP2 activate RetGC sequentially, 
according to the [Ca2+]i set by illumination. GCAP1 and GCAP2 bind to RetGC at overlapping residues situated 
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1.4.3 Trafficking of RetGCs to the outer segment: the role of RD3 
 
While the mechanisms of RetGC modulation by GCAPs have been extensively studied and are 
becoming clear, the mechanisms underlying RetGC/GCAPs complex assembly and transport to the 
outer segment in living rods and cones have been less explored. As integral membrane polypeptides, 
RetGCs are synthesized at the endoplasmic reticulum and subjected to posttranslational maturation 
at the Golgi.  
 
RetGCs therefore rely on the secretory pathway (vectorial vesicular trafficking) for their distribution 
to the cilium. Whether RetGCs contain an intrinsic ciliary targeting sequence that confer them ciliary 
destination has remained elusive. Deletion and mutational analysis in transgenic Xenopus laevis have 
failed to identify a RetGC ciliary targeting sequence (Karan et al. 2011).  
 
More recently RetGCs were found to depend on the 23 kDa blindness-associated protein RD3 (from 
the natural strain of blind mice “retinal degeneration 3” with the rd3 locus mutated) for their 
extraction from the endoplasmic reticulum, protein stability and ciliary trafficking (Seifollah Azadi, 
Molday, and Molday 2010). The rd3 mice, lacking functional RD3, have dramatically reduced levels of 
RetGCs and are characterized by fast retinal degeneration. This phenotype is reverted by heterologous 
expression of RD3 (L. L. Molday et al. 2013).  The 23 kDa RD3 was therefore established as a protein 
required for RetGCs stability and ciliary trafficking. However, the mechanism by which RD3 confers 
stability to RetGCs and facilitate their distribution to the cilium are not yet known. 
 
On the other hand, GCAP1 and GCAP2 are known to depend on RetGCs for their own stability and 
transport to the outer segment.  In the absence of RetGC1 and RetGC2 (RetGC1/RetGC2 double 
knock out) GCAPs fail to distribute to the outer segment compartment of rods and cones, and their 
stability is compromised (Baehr et al. 2007). The same is observed in the rd3 mice due to the 
dramatically decreased levels of RetGCs (Seifollah Azadi, Molday, and Molday 2010). Actually, direct 
binding of GCAP1 to the cyclase is required for GCAP1 distribution to rod outer segments, which 
suggests that RetGC and GCAP assemble at the inner segment and are transported as a complex 
(López-Begines et al. 2018).  
 
Interestingly, while investigating the effect of RD3 on in vitro RetGC catalytic activity, Peshenko et al. 
found that RD3 was a high-affinity inhibitor of RetGC.  In addition to inhibiting RetGC basal activity, 
RD3 also competed with GCAP1, precluding GCAP1 activation of the cyclase. Based on this in vitro 
data Peshenko et al. proposed that one physiological role of RD3 could be preventing cGMP synthesis 
at the cell soma while RetGC was being transported to the cilium (Peshenko, Olshevskaya, Azadi, et 
al. 2011).  
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This predicted function of RD3 required that RD3 was localized at the inner segment and was 
excluded from the outer segment. This model appeared to be at odds with RD3 immunolocalization 
results reported in the original study, that localized RD3 at the outer segment (Seifollah Azadi, Molday, 
and Molday 2010). This discrepancy created the urge to determine the in vivo localization of RD3 in 
photoreceptor cells by rigorous, unbiased methods.  
 
Furthermore, the mutually exclusive binding of RD3 and GCAPs to the cyclase raised key questions 
about the trafficking of this protein complex, by implying the need of a series of sequential regulated 
steps that account for the facts that RetGCs depended on RD3 for their trafficking to the cilium; at 
the same time that GCAPs depend on RetGCs for their outer segment distribution.   
 
1.4.4 GUCY2D blindness associated mutations.  Mouse models to study 
RetGC function. 
 
GUCY2D (encoding RetGC1) was the first gene associated with Leber congenital amaurosis (LCA) 
and was thus assigned to the LCA1 locus (I. Perrault et al. 1996). Since then, over 100 mutations have 
been identified in the GUCY2D gene causing different forms of retinal dystrophies (Wimberg et al. 
2018). Autosomal recessive mutations in GUCY2D result in loss-of-function of RetGC1 by 
compromising protein stability, impairing catalytic activity or  dimerization capacity. Mutations 
ultimately reduce the cGMP content at the outer segment, causing the permanent closure of CNG-
channels.  Closure of the channels precludes rod and cone visual function and presumably results in 
a permanent hyperpolarization state that is deleterious for the cell.  
 
Heterozygous mutations in GUCY2D have been associated to autosomal dominant cone dystrophies 
(adCD) and cone-rod dystrophies (adCORD, namely CORD6) (Gregory-Evans et al. 2000). These 
are gain-of-function mutations that lead to constitutive activity of the cyclase in vitro (S E Wilkie et al. 
2000).  Based on the in vitro phenotype of the mutations, the underlying mechanism of the pathology 
in adCD and adCORD is thought to be the unabated synthesis of cGMP in vivo, which would lead to 
abnormally high levels of cGMP. Abnormally high cGMP would keep a higher-than-normal fraction 
of CNG-channels open, increasing the influx of calcium. Elevated intracellular cGMP and calcium 
are both established as causes of toxicity in photoreceptor cells (Power et al. 2019; Krizaj and 
Copenhagen 2002).  
 
Several loss-of-function models of RetGC have been generated and characterized. The individual 
targeted depletion of the Gucy2d and Gucy2f genes allowed the characterization of RetGC1 and 
RetGC2 roles in murine retinas (Yang et al. 1999; Baehr et al. 2007b). Subsequently the 
RetGC1/RetGC2 double KO was also generated (RetGC1/RetGC2 dKO) (Baehr et al. 2007).   
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The mouse system differs from the human system in that both RetGC1 and RetGC2 play a 
physiological role in the light response. RetGC1 KO showed cone degeneration but largely retained 
rod function; while RetGC2 KO retained largely normal retinas, which pointed to some 
RetGC1/RetGC2 functional redundancy. The RetGC1/RetGC2 dKO, though, presented a rapid 
retinal degeneration that reduced the number of photoreceptor cells to 50% in six months, resembling 
the human LCA1 phenotype. This loss-of-function model of RetGC activity lacked rod and cone 
visual function and showed reduced levels of GCAP1 and GCAP2 that were abnormally retained at 
the inner segment compartment (Baehr et al. 2007).  
 
1.4.5 GUCA1A and GUCA1B blindness-associated mutations. Mouse models 
to study GCAP1 and GCAP2 function.  
 
To date, fourteen mutations have been identified in the GUCA1A gene encoding GCAP1 that lead 
to inherited retinal dystrophies (Listed in Table 2).  
 
Mutations in GUCA1A mainly affect cones and cause autosomal dominant cone-dysthrophies 
(adCD), cone-rod dystrophies (adCORD) and macular degeneration (Kamenarova et al. 2013). Most 
of the mutations in GUCA1A map at one of the functional EF-hands, with the effect of diminishing 
Ca2+ binding affinity.  This decrease in Ca2+ binding affinity of GCAP1 alters the calcium sensitivity 
of RetGC activity in in vitro assays, displacing the sensitivity curve to higher values of [Ca2+]i (Susan E. 
Wilkie et al. 2001; Nishiguchi et al. 2004; Bowne et al. 2002; Peshenko et al. 2019). The in vivo effect 
of a displacement of RetGC activity towards higher [Ca2+]i would be the constitutive activity of the 
cyclase in the physiological range of [Ca2+]i, independently on the light conditions. That GCAP1 
mutations that decrease Ca2+ binding affinity lead to unabated cGMP synthesis in photoreceptors in 
vivo has by now been demonstrated (Olshevskaya et al. 2004; Woodruff et al. 2007). 
 
One mutation in the GUCA1B gene (encoding GCAP2) that impairs Ca2+ binding has been linked to 












Table 2: Mutations in GUCA1A and GUCA1B genes leading to retinal dystrophies 
 
Compiled from (Jiang et al. 2014, Kamenarova et al. 2013, Dell’orco et al. 2014, Palczewski et al. 2004, 
Nishiguchi et al. 2004; Sato et al. 2005; Peshenko et al. 2019). 
  
Loss-of-function models of the GCAP proteins were also generated and characterized. The analysis 
of the GCAP1/GCAP2 dKO preceded the analysis of the individual KOs, given that GUCA1A and 
GUCA1B are contiguous in the genome (A Mendez et al. 2001). GCAP1/GCAP2 dKO (GCAPs-/- 
mice) presented largely normal retinas with unaltered basal RetGC activity (A Mendez et al. 2001).  
 
However, the ablation of GCAPs eliminated the Ca2+-feedback loop to RetGC activity during dark-
adapted light responses and during light adaptation. These mice elicited abnormally large responses 
and reached saturation at lower background light intensities. The analysis of GCAPs-/- revealed the 
important individual contribution of the Ca2+ feedback loop to RetGC to single photon response 
sensitivity and kinetics. In terms of photoreceptor viability, GCAPs depletion did not have a 










    Activity GC 
 
         References 
GCAP1 P50L  
AdCD, 
AdCORD 
Like WT (Sokal et al. 2000) 
GCAP1 G86R  AdCORD Constitutive activation (Peshenko et al. 2019) 




Constitutive activation      (Marino et al. 2015) 
GCAP1 E89K EF3 AdCD Constitutive activation (Kitiratschky et al. 2009) 
GCAP1 Y99C EF3 
AdC, AdCORD, 
Macular 
Constitutive activation (Michaelides et al. 2005) 
GCAP1 D100E EF3 AdCD Constitutive activation (Kitiratschky et al. 2009) 
GCAP1 N104K EF3 AdCD Constitutive activation (Jiang et al. 2008) 




Constitutive activation (Marino et al. 2015) 
GCAP1 E111V EF3 AdCORD Constitutive activation (Marino et al. 2018) 
GCAP1 T114I EF3   atypical RP   
GCAP1 I143NT EF4 AdCD Constitutive activation (Nishiguchi et al. 2004) 
GCAP1 L151F EF4 AdCORD Constitutive activation (Jiang et al. 2005) 
GCAP1 E155GD EF4 AdCD Constitutive activation (Susan E. Wilkie et al. 2001) 
GCAP1 G159V EF4 AdCD Constitutive activation (Kitiratschky et al. 2009) 
GCAP2 G157R EF4 AdRP  (Sato et al. 2005) 
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year of age (A Mendez et al. 2001); consistent with blindness-associated GCAP mutations being 
autosomal dominant, of gain-of-function nature.   
 
Transgenic mice expressing GCAP1 mutants linked to adCORD, such as Y99C-GCAP1 with a 
Tyr99Cys substitution at EF-hand 3, and E155G-GCAP1 with a Glu155Gly substitution at EF-hand 
4 (Woodruff et al. 2007), were developed to demonstrate how the lowered GCAP1 affinity for Ca2+ 
shifted the Ca2+ sensitivity of RetGC in vivo.  The enhanced activity of the cyclase in vivo at any light 
condition increased CNG-channel activity, causing an elevation of [Ca2+]i which in turn caused cell 
death (Olshevskaya et al. 2004).  
 
To study the in vivo effect of impaired Ca2+ binding to GCAP2 (as a generic approach to GCAP2 
mutations associated to RP), a transgenic mouse model was established that expressed a form of 
GCAP2 impaired to bind calcium at the three functional EF-hand domains (EF-GCAP2 mice). EF-
GCAP2 mice showed a rapid retinal degeneration by a mechanism independent of cGMP at the OS 
(Hoyo et al. 2014). The mechanism underlying GCAP2 toxicity in this context was GCAP2 retention 
at rod inner segments (Hoyo et al. 2014). Based on these results it was proposed that GCAPs 
could act as damage mediators in the genetic contexts expected to result in GCAPs retention 
at the cell soma in a context of chronic low [Ca2+]i, such as in LCA1 or LCA12.  
 
1.4.6 RD3 blindness mutations. The rd3 mice. 
 
In 1969 four wild-type mice captured in Valle di Poschiavo, Switzerland, were imported to the Jakson 
Laboratories because they were known to have Robertsonian chromosomes. These mice were crossed 
with Swiss mice to obtain the RBF/DnJ strain (Festing 1979) and subsequently inbred in different 
black and albino mouse strains. These animals were characterized for retinopathies (Heckenlively et 
al. 1993) and were found to show a rapid retinal degeneration whose progression varied among the 
genetic backgrounds. Black strains developed nearly normal retinas that retained electroretinogram 
(ERG) responses up to p32, showing initial signs of degeneration at three weeks; while albino strains 
degenerated much faster showing extinguished ERG responses earlier. These animals were renamed 
as rd3 (retinal degeneration 3) mice.  
 
Later, Friedman et al. characterized the rd3 mice more deeply (Friedman et al. 2006), and identified a  
c.319àt transition in the third exon of the C1orf36 gene. This mutation caused a premature truncation 
in the C1orf36 gene product, a protein of 195 aa, that led to a 106 aa unstable protein that was rapidly 
degraded. Thus C1orf36 gene was renamed as Rd3. It was predicted that similar mutations in the RD3 




A screening for mutations in the RD3 locus in patients with different retinal dystrophies including 
LCA revealed that two siblings affected by LCA presented a homozygous GàA transition 
(c.296+1GàA) in a donor splice site in the RD3 gene. This mutation was predicted to result in the 
premature truncation of the RD3 protein; and LCA patients affected by loss-of-function mutations 
in the RD3 gene were assigned the LCA12 form of this disease (Friedman et al. 2006).    
 
To date four extra mutations in RD3 have been linked to human LCA12 (Listed in Table 3). These 
mutations lead to premature truncation of the protein, or to deletion of the intracellular coiled-coil 
domain. Intriguingly, a lysine to glutamic acid substitution in residue 87 has been identified in a family 
affected by retinitis pigmentosa (RP) rather than LCA (De Castro-Miró et al. 2014).  
 
Table 3: Mutations identified in RD3 leading to retinal dystrophies 
 
 
Compilled from (Friedman et al. 2006; Perrault et al. 2013; De Castro-Miró et al. 2014). 
1.5 Photoreceptor cell death mediated by alterations in cGMP levels 
Mutations in many apparently unrelated genes linked to different forms of inherited retinal 
dystrophies converge at altering cGMP levels in rods and/or cones as the insult that ultimately causes 
photoreceptor cell death.  
 
Free cGMP levels determine the transmembrane potential of photoreceptor cells at any illumination 
condition. cGMP turn-over rates are very high in rods and cones so that even small changes in 
illumination are reproducibly transduced to changes in membrane potential with fast kinetics. The 
cGMP turn-over rate is determined by the rate of cGMP synthesis by RetGCs and the rate of cGMP 
hydrolysis by cG-PDE. These enzymatic activities change with the illumination levels, but a balance 
between synthesis and hydrolysis must be established for each steady-state, so that cGMP levels are 
always kept within a physiological range of concentrations.  
 
Mutation        Dystrophy             Effect on protein                 References 
R38X LCA12 Lacking residues 38-99 (Perrault et al. 2013) 
c.296+1GàA LCA12 Truncated protein (Friedman et al. 2006) 
E46X LCA12 Lacking residues 46-99 (Perrault et al. 2013) 
E46A2bp 
deletion 83X LCA12 Truncated protein (Perrault et al. 2013) 
Y60X LCA12 Truncated protein (Preising et al. 2012) 
K87E RP Unknown (De Castro-Miró et al. 2014) 
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The cGMP turn-over rate in photoreceptor cells is at least 10-fold higher than in any other cell type 
(Pugh and Lamb 1990; Granovsky and Artemyev 2001), with  the rate of cGMP synthesis estimated 
at 100-600 µM cGMP/s  in the recovery phase that follows photoexcitation (Burns et al. 2002a). This 
high cGMP turn-over helps to explain why mutations in any of the genes that affect cGMP synthesis 
or cGMP hydrolysis create an unbalance of forces that produces large alterations in cGMP levels. 
Disruption of cGMP homeostasis has profound effects on cell physiology and compromise viability, 
causing photoreceptor cell death (Power et al. 2019).  
 
Several mutations have been shown to disrupt cGMP homeostasis in photoreceptor cells. Loss-of-
function mutations in the different subunits of rod and cone cGMP-phosphodiesterases (cG-PDEs) 
responsible for cGMP hydrolysis, lead to abnormally high cGMP levels that are associated to 
different forms of blindness, both in humans (Dryja et al. 1999; McLaughlin et al. 1993; Tsang et al. 
1996; Grau et al. 2011; Kohl et al. 2012) and in naturally occurring animal models (Bowes et al. 1990; 
D B Farber, Danciger, and Aguirre 1992; McLaughlin et al. 1993). In these models the cGMP levels 
rise dramatically as soon as the animals open their eyes and lack cGMP hydrolysis, due to light-
activated RetGC activity. The resulting abnormally high cGMP levels cause the opening of an 
abnormally high fraction of CNG-channels, increasing the influx of Na+ and Ca2+. It is presumably 
the increase in [Ca2+]i that leads to apoptosis (Olshevskaya et al. 2004; Woodruff et al. 2007; Paquet-
Durand et al. 2009; Trifunović et al. 2010; Sothilingam et al. 2015).  
 
Loss-of-function mutations in transducin subunits that prevent cG-PDE activation are also associated 
with abnormally high cGMP levels  (Dryja et al. 1996; Kohl et al. 2002); and null mutations in the 
CNG-channel subunits, CNGA3 and CNGB3, lead to a cGMP accumulation in cones that underlies 
the physiopathology of achromatopsia (Ma et al. 2015b). As mentioned above, gain-of-function 
mutations in GUCY2D or in GUCA1A associated to cone or cone/rod dystrophies are also 
detrimental for photoreceptor cells by affecting the Ca2+ sensitivity of RetGC activity and causing an 
excessive production of cGMP (Kelsell et al. 1998; Sato et al. 2005; Kamenarova et al. 2013; Wimberg 
et al. 2018). 
 
On the other hand there are mutations on several genes that lead to the opposite situation: 
abnormally low cGMP.  Representative mutations leading to abnormally low cGMP levels are the 
already mentioned null mutations in GUCY2D encoding RetGC1 and the RD3 gene, linked to LCA1 
and LCA12 respectively (Seifollah Azadi, Molday, and Molday 2010; Agrawal et al. 2017). Loss-of-
function mutations in genes that encode proteins involved in termination of the light response such 
as rhodopsin kinase and arrestin (Fuchs et al. 1995; Nahazawa, Wada, and Tamai 1998; Cideciyan et 
al. 1998), or gain-of-function mutations in transducin alpha (Szabo et al. 2007) that lead to unabated 
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signaling in response to light, also result in an abnormal decrease of cGMP. These contexts are 
generally referred to as “light equivalent” genetic contexts, in the sense that prolonged bright light 
exposure that results in prolonged low cGMP can also result in photoreceptor cell death and retinal 
degeneration (Fain 2006).  In this scenario, which is the opposite to the one leading to abnormally 
high cGMP, chronic hyperpolarization would lead to chronic low Ca2+, that could be the basis of the 
pathology. 
Examples of mutations in genes expected to alter cGMP regulation are listed in Table 4 (in blue genes 
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Table 4.  
Genes that when mutated may cause inherited retinal dystrophies by altering cGMP levels 
in photoreceptor cells  
 
Modified from (Power et al. 2019). Gene nomenclature is found in gene list section. 
 
 
Gene Mutation effect cGMP Phenotype References 
AIPL1       Blocks the functional assembly of PDE High LCA (Ramamurthy et al. 2004) 
CNGA1 Disrupts the cGMP-Ca2+ negative feedback loop High RP (Dryja et al. 1995) 
CNGB1 Disrupts the cGMP-Ca2+ negative feedback loop High RP 
(Hartong, Berson,  
and Dryja 2006) 
CNGA3 Disrupts the cGMP-Ca2+ negative feedback loop High ACHM (Johnson et al. 2004) 
CNGB3 Disrupts the cGMP-Ca2+ negative feedback loop High ACHM (Kohl et al. 2005) 
REEP6 Decreases the RetGC1/2 isozymes Low RP (Agrawal et al. 2017) 
GNAT1 
Loss-of-function prevents PDE activation 




             (Dryja et al. 1996) 
             (Szabo et al. 2007)  
            (Carrigan et al. 2016) 
GNAT2 Prevents PDE activation High ACHM (Rosenberg et al. 2004) 
GRK1 Fails to inactivate Rhodopsin Low CSNB (Cideciyan et al. 1998) 




(Kamenarova et al. 2013) 
GUCA1B Disrupts the cGMP-Ca2+ negative feedback loop High RP (Sato et al. 2005) 
GUCY2D 
 
Gain-of-function leads to constitutive cGMP 
production 







(Wimberg et al. 2018) 
IMPDH1? 
Autosomal dominant mutations predicted to  
be gain-of-function mutations that would  
elevate GTP pool, that would in turn  




(Kennan et al. 2002) 
(den Hollander et al. 2008) 
 
PDE6A Impairs cGMP consumption High 
RP, 
CSNB 
(Dryja et al. 1999) 
PDE6B Impairs cGMP consumption High RP (McLaughlin et al. 1993) 
PDE6C Impairs cGMP consumption High ACHM (Grau et al. 2011) 
PDE6G Impairs cGMP consumption High RP (Tsang et al. 1996) 
PDE6H Impairs cGMP consumption High ACHM (Kohl et al. 2012) 
RHO 
Inactivates the phototransduction cascade 
 Impairs cGMP consumption 
      High RP 
(Hartong,  
Berson, and Dryja 2006) 
RD3 Decreases the RetGC1/2 isozymes Low LCA (Friedman et al. 2006) 
SAG Fail to inactivate Rhodopsin Low 
CSNB 
RP 
(Fuchs et al. 1995) 









Besides gating CNG-channels and therefore controlling ionic flux at the outer segment, cGMP has 
other effects in photoreceptor cells. An effect of cGMP that has more recently been revealed is its 
activation of protein kinase G (PKG). Excessive activation of PKG was found to be the cause of cell 
death in mouse models of achromatopsia caused by mutations in the alpha and beta subunits of cone 
CNG-channels (Ma et al. 2015).  
 
1.5.1 Cell death mediated by ER stress 
 
The endoplasmic reticulum (ER) is a complex, dynamic organelle whose functions include protein 
folding, Ca2+ storage, and lipid and carbohydrate metabolism (Senft and Ronai 2015). Various cellular 
stresses such as protein folding defects, perturbations in Ca2+ homeostasis, altered protein 
glycosylation or redox imbalance disrupt ER functions and lead to unfolded or misfolded proteins to 
accumulate in the ER lumen in a process known as ER stress (Hetz and Mollereau 2014). To alleviate 
ER stress, cells respond with an integrated signaling system by activating the unfolded protein 
response (UPR), ER-associated degradation (ERAD), autophagy, hypoxic signaling and mitochondrial 
biogenesis (Walter and Ron 2011). The combined activity of these mechanisms determines the 
magnitude of ER stress and thus governs whether cells will recover homeostasis or activate cell death 
programs (Ferri and Kroemer 2001).   
 
ER-stress and the UPR are intricately connected and are transduced by three ER resident proteins: 1) 
the inositol-requiring enzyme 1 (IRE1); 2) the activating transcription factor-6 (ATF6) and 3) the 
protein kinase R-like ER protein kinase (PERK) (Hetz 2012). The three ER stress branches act at 
different levels to reestablish cell homeostasis: 1) by regulating the expression of chaperones such as 
glucose regulated protein-78 or binding-immunoglobulin-protein (GRP78/BIP); 2) by reducing 
protein synthesis through phosphorylation of eukaryotic initiation factor-2a (eIF2a); or 3) ultimately 
by activating apoptotic responses by expression of several genes such as CHOP/GADD153 encoding  
a transcription factor that negatively regulates the anti-apoptotic factor BCL-2 (Fig 10).  
 
The BCL-2 family (from “B cell lymphoma”) is essential to mediate the crosstalk between the ER and 
mitochondria to trigger apoptosis under conditions of chronic ER stress by controlling the release of 
cytochrome C and apoptosome assembly (Rodriguez, Rojas-Rivera, and Hetz 2011). 
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In photoreceptor cells, abnormally high cGMP levels have shown to result in ER stress either by 
causing an elevation of Ca2+ influx by increasing the fraction of CNG-channels open (Butler et al. 
2017); or through PKG activation (Ma et al. 2015); whereas abnormally low cGMP levels, that 










Figure 10. The unfolded protein 
response. Image obtained from (Iurlaro 




1.6 IMPDH1 in the retina 
Mutations in the housekeeping gene IMPDH1 have been associated to severe forms of blindness: 
autosomal dominant retinitis pigmentosa 10 (adRP10) and Leber’s Congenital Amaurosis 11 (LCA11). 
Inosine monophosphate dehydrogenase 1 (IMPDH1) is the enzyme responsible for the first 
committed step in the de novo synthesis of GTP. Despite the ubiquitous nature of this enzyme, 
mutations in IMPDH1 are restricted to the retina for reasons that are not yet understood. The levels 
of IMPDH1 in photoreceptors cells are higher than in any other cell type, and there are retinal specific 
spliced-forms of the enzyme. Despite its relevance in human blindness little is known about the 
physiological role of this enzyme in photoreceptor cells of the retina, or its in vivo regulation.  
 
1.6.1 Purine nucleotide control in photoreceptors 
 
Cells use different pathways to synthesize purine nucleotides and balance the guanine and adenine 
pools (Fig 11). In the salvage pathways, nucleotides are produced from recycled purine bases (blue 
arrows in Fig 11). In de novo biosynthesis, a purine ring is assembled over ribose 5´-phosphate by 
sequential enzymatic steps that use precursors of the carbohydrate and amino acid metabolism (Zhao 
et al. 2013; Pedley and Benkovic 2017) (black arrows in Fig 11). In this pathway, inosine 
monophosphate (IMP) is the first molecule with a complete purine ring and is the common precursor 
for GTP and ATP synthesis. Inosine monophosphate dehydrogenase 1 (IMPDH1) is the enzyme 
catalyzing the rate limiting step in the de novo synthesis of GTP (red in Fig 11).    
 
In the phototransduction cascade, guanine nucleotides play a central role, as cGMP is a key signaling 
molecule in the light response. The balance between cGMP consumption by PDE and re-synthesis 
by RetGC dictates the polarized/depolarized state of the cell, and its synaptic communication with 
second-order neurons. It is not clear how RetGC obtains its substrate GTP to replenish cGMP. It has 
been proposed that after phosphodiesterase consumption of cGMP, the resulting 5’-GMP diffuses to 
the inner segments for its recycling to GTP (Ridge et al. 2003). Guanylate kinase (GK) and nucleoside 
diphosphokinases (NDK) at the inner segment would sequentially convert GMP to GDP and GTP. 
Both GK and NDK have been immunolocalized to inner segments, perinuclear regions and synaptic 
terminals of photoreceptor cells (Wimberg, Janssen-Bienhold, and Koch 2018b) and (Rueda et al. 
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Figure 11.  De novo and salvage pathways of purine synthesis in eukaryotic cells. Modified from (Zhao et al. 
2013).  
 
The contribution of the de novo pathway to GTP supply in photoreceptor cells has not been thoroughly 
addressed, despite the fact that  mutations in IMPDH1 have been associated with severe forms of 
blindness (see below), and that hypoxanthine phosphoribosyl transferase (HRPT), the key enzyme in 
the salvage pathway, presents a very low expression in photoreceptor cells (Kennan et al. 2003). This 
apparent oblivion of IMPDH1 role in photoreceptor cells is probably due in part to the observation 
that a mouse model of IMPDH1 deficiency presents only a mild retinopathy (Aherne et al. 2004). 
1.6.2 IMPDH structure and catalytic cycle 
 
Inosine monophosphate dehydrogenase (IMPDH) is the enzyme catalyzing the rate-limiting step in 
the de novo synthesis of GTP. Eukaryotic IMPDH monomers consist of two domains: a catalytic 
domain consisting in a (b/a)8 barrel, and a regulatory domain containing two nucleotide-binding CBS 
domains (named after their homology to “cystathionine beta synthase” domains), also known as 
Bateman domain (Fig 12). IMPDH is a tetrameric enzyme that adopts a square planar geometry with 
CBS domains protruding from the corners of the tetramer.  
IMPDH catalyzes the conversion of inosine monophosphate (IMP) to xanthosine monophosphate 
(XMP) in two different chemical transformations: the first being a dehydrogenase reaction that results 
in NADH and the E-XMP* intermediate; and the second a hydrolysis step that converts E-XMP* to 
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XMP (Hedstrom 2009). Both reactions take place in the active site of the enzyme and involve a 
profound rearrangement of the enzyme. 
 
Three mobile structural elements allow these two distinct reactions to occur at the same active site: a 
mobile flap [residues 412-432], a catalytic loop [residues 313-328] and the C-terminal segment 
[residues 481-503]. The rearrangement of these mobile structures allows an open conformation for 
the enzyme during the initial redox reaction and a closed conformation during the E-XMP* hydrolysis. 
The Bateman domain is not required for enzymatic activity since its deletion does not affect catalytic 
activity in vitro (Nimmesgern et al. 1999; Gan, Petsko, and Hedstrom 2002). However, this domain 
acts as an ATP and GTP sensor for allosteric modulation of the enzyme (Anthony et al., 2017; Buey 
et al., 2015; Fernández-Justel et al., 2019; Labesse et al., 2013). 
1.6.3 IMPDH1 in photoreceptor cells 
 
There are two IMPDH isozymes, IMPDH1 and IMPDH2, that are 84% identical in humans. While 
most human tissues show only basal IMPDH1 and high IMPDH2 expression, the retina is one of a 
few exceptions where IMPDH1 predominates (Hedstrom 2009). In the retina, IMPDH1 shows very 
high levels of expression specifically in photoreceptor cells, as demonstrated with specific antibodies 
against unique IMPDH1 regions (Bowne, Liu, et al. 2006).  
In the retina, major unique IMPDH1 spliced forms outweigh the canonical 514 aa protein (Bowne, 
Liu, et al. 2006). The number of splicing isoforms and their relative abundance differ in the different 





Figure 12. Human type-I ionosine 5’-
monophosphate dehydrogenase crystal structure 
(514 aa). Each monomer appears in a different color. 
Each monomer consists of two CBS domains, in the 
extremes of the tetramer; and in a catalytic domain 
with a TIM barrel structure. Image obtained from 
PDB: 1jcn.  
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while seven isoforms have been characterized in the murine system, in which isoforms g and d 
predominate (Fig 13). 
Figure 13. Gene structure and predicted retinal transcripts of IMPDH1 in human and mouse. Four 
different retinal transcripts have been identified for the human IMPDH1. Human  b corresponds to the 514 
aa canonical transcript. The major isoform a presents 32 extra aa from exon 13b. Minor isoforms g and d are 
from AF to 3’UTR R (49 extra amino acids from AF and 32 extra amino acids from intron 13b) but d lacks 
exon 4. In mouse seven different retinal transcripts have been identified. Murine b corresponds to the canonical 
transcript. Major isoforms g and d are from AF to 3’UTR R and use exon 13b, with the only difference between 
these transcripts being the inclusion of 3bp at the 5’-end of exon 1 in transcript g resulting in one additional 
amino acid. Minor isoforms present extra amino acids from exon AF or exon 13b. From (Bowne, Liu, et al. 
2006).  
Mutations in IMPDH1 are associated to severe forms of inherited blindness. At least nine mutations 
have been associated to the RP10 form of autosomal dominant retinitis pigmentosa, that primarily 
manifests as night blindness and gradually progresses to loss of central vision (Table 5). Together 
they account for about 1% of adRP cases (Sullivan et al. 2013).  IMPDH1 mutations have also been 
associated to rare autosomal dominant Leber Congenital Amaurosis, LCA11. Despite the ubiquitous 
nature of guanine nucleotide synthesis, clinical manifestations of IMPDH1 mutations are limited to 
the retina, for reasons that are not yet understood.   
RP10 mutations are “gain-of-function” mutations, given that IMPDH1 knock-out mice present only 
a mild retinopathy (Aherne et al. 2004).  Mutations do not directly affect IMPDH1 catalytic activity in 
vitro (Mortimer and Hedstrom 2005; D. Xu et al. 2008; Aherne et al. 2004). IMPDH1 capacity to bind 
 
 48 
single-stranded nucleic acids (Mortimer et al. 2008; Hedstrom 2008) as well as IMPDH1 tendency to 
aggregate (Tam et al. 2008; Aherne et al. 2004) have been suggested to contribute to the 
pathophysiology based on results in vitro; but have not been demonstrated in vivo.  
Table 5: Mutations in IMPDH1 gene leading to retinal dystrophies 
Mutation Mapping Phenotype Reference 
R105W  adLCA (Bowne, Sullivan, et al. 2006) 
T116M CBS domain adRP10 (Bowne, Sullivan, et al. 2006) 
N198K CBS domain adLCA (Bowne, Sullivan, et al. 2006) 
R224P CBS domain adRP10 (Kennan et al. 2002b) 
D226N CBS domain adRP10 (Bowne et al. 2002) 
R231P CBS domain adRP10 (Grover, Fishman, and Stone 2004) 
K238E  adRP10 (Wada et al. 2005) 
K238R  adRP10 (Wada et al. 2005) 
V268I  adRP10 (Bowne, Sullivan, et al. 2006) 
G324D Catalytic domain adRP10 (Bowne, Sullivan, et al. 2006) 
H372P Catalytic domain adRP10 (Bowne, Sullivan, et al. 2006) 
 
Compiled from (Kennan et al. 2002, Bowne et al. 2006) 
 
1.6.4 IMPDH negative allosteric regulation by nucleotides 
 
Cells use different strategies to regulate the nucleotide levels. On the de novo biosynthesis pathway of 
purines three major feedback mechanisms cooperate to regulate the overall rate of purine synthesis 
and the relative rates of formation of AMP and GMP (Fig 14). The first control mechanism is 
exerted on the first reaction in purine synthesis: the transfer of an amino group to PRPP to form 5-
phosphoribosylamine. This reaction is catalyzed by the allosteric enzyme glutamine-PRPP 
amidotransferase (GPA), which is inhibited by the end products IMP, AMP, and GMP. These same 
nucleotides act synergistically to inhibit the synthesis of PRPP from ribose phosphate by ribose 
phosphate pyrophosphokinase (PRS). In the second control mechanism, an excess of GMP in the 
cell inhibits IMPDH, diminishing the conversion of IMP to XMP in the first committed step of 
guanine synthesis. Conversely, an accumulation of adenylate results in inhibition of formation of 
adenylosuccinate (SAMP) by adenylosuccinate synthetase (ADSS), in the first committed step of 
adenine synthesis. In the third mechanism, GTP is required in the conversion of IMP to AMP, 
whereas ATP is required to form GMP from IMP, a reciprocal arrangement that tends to balance 
synthesis of the two nucleotides. 
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In this way, the enzymes responsible for the first committed step toward guanine nucleotide synthesis 
(IMPDH) or adenine nucleotide synthesis (ADSS) are competitively inhibited by product.  
Recently, a breakthrough structural study has revealed that eukaryotic IMPDHs are not only regulated 
competitively by GMP, but are also regulated allosterically by the binding of GDP and GTP to their 
Bateman domains (Buey et al. 2015). Nucleotide binding at the Bateman domains regulates the activity 
of a variety of proteins such as voltage-gated chloride channels (ClC), AMP-activated protein kinase 
(AMPK) and CBS (Scott et al. 2004). In these proteins the Bateman domain acts as an ATP sensor, 
and mutations in the adenyl binding sites in this domain have been linked to homocystinuria (CBS); 
familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome (AMPK); and myotonia 
congenital (ClC-1) (Scott et al. 2004).  
The milestone of recent structural studies on IMPDH proteins was the discovery that eukaryotic 
IMPDHs responded to GDP/GTP in addition to ADP/ATP; and that while ADP/ATP binding 
promoted activation of the enzyme, GDP/GTP binding allosterically inhibited catalytic activity. Buey 
et al. identified three allosteric nucleotide binding sites in the Bateman domain of eukaryotic IMPDHs: 
sites 1, 2 and 3. Sites 1 and 2 are canonical nucleotide binding sites that bind either ADP/ATP or 
GDP/GTP (Scott et al. 2004). Site 3 is a non-canonical site located at the interface between CBS 





















Figure 14. Negative regulation 
excreted by nucleotides in the de 
novo synthesis of purines. 






The basis for nucleotide allosteric regulation of IMPDH enzymes reside on the reversible dimerization 
of tetramers.  Nucleotide binding makes IMPDH tetramers assemble into octamers, by inducing the 
dimerization of Bateman domains  (Fig 15). ADP/ATP binding promotes the formation of octamers 
with an extended conformation, that are catalytically active. In contrast, GDP/GTP binding induces 
the formation of compressed octamers which are inactive. The conformation and activity of the 
octamers is set specifically by the occupancy of sites 2 and 3, which resides on the binding competition 
of ADP/ATP and GDP/GTP.  Because non-canonical site 3 is GDP/GTP specific (can be either 
empty or GDP/GTP-bound), GDP/GTP can inhibit IMPDHs even in the presence of ATP.  
 
Interestingly, several of the residues mutated in adRP10 map at the GDP/GTP binding sites at the 
Bateman domain, and in vitro studies have determined that these mutations disrupt GDP/GTP-
mediated allosteric regulation of the enzyme (Buey et al. 2017).  It has therefore been proposed 
that the physiopathology of adRP10 resides on the disruption of the GDP/GTP negative allosteric 
feedback to de novo GTP synthesis.   
1.6.5 IMPDH capacity to reversibly polymerize into filaments  
 
Many enzymes involved in cell metabolism can form reversible filamentous structures in vitro and in 
vivo in response to cellular stress or under conditions that require a boost of enzymatic capacity to 
cope with specific cellular requirements (Liu 2010). Various filamentous structures have been 
characterized in vitro by biophysical methods, including electron microscopy (Park and Horton 2019). 
Cytoophidia, for instance, are large-scale self-assembled structures that are observed by 
superresolution techniques as foci, rods, and rings. Some of the enzymes described to form 
Figure 15. Model of eukaryotic IMPDH 
allosteric regulation by nucleotides. Eukaryotic 
IMPDHs Bateman domains present three 
nucleotide binding sites: sites 1, 2 and 3. Sites 1 
and 2 can bind either ADP/ATP or GDP/GTP.  
Site 3 can only bind GDP/GTP. When adenine 
nucleotides are bound to sites 1 and 2, and site 3 
is empty, IMPDH forms extended octamers with 
normal catalytic activity. The binding of guanine 
nucleotides in Sites 2 and 3; or in all sites results in 
the formation of compressed octamers with 
compromised catalytic activity. Image from 
(Johnson and Kollman 2020).  
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cytoophidia include: glutamate dehydrogenase (Olson and Anfinsen 1952), acetyl CoA carboxylase 
(Kleinschmidt, Moss, and Lane 1969), nitrilase (Harper 1977), b-glucosidase (Kim et al. 2000), 
cytosine triphosphate synthase (Noree et al. 2010), glutaminase (Ferreira et al. 2013), glutamine 
synthase (O’Connell et al. 2014), phosphofructokinase (Webb et al. 2017), glucokinase (Stoddard et 
al. 2019) and ribonucleotide reductase (Thomas et al. 2019).  
IMPDH can form macromolecular filamentous structures in mammalian cells under metabolic 
deficiency. IMPDH forms macromolecular assemblies under conditions that require higher IMPDH 
activity to keep with GTP demand (Liu 2010;  Chang et al. 2015; Aughey and Liu 2016; Keppeke et 
al. 2018), like high rates of proliferation, or Gln/Ser/folate-metabolite deficiency (Calise et al. 2016; 
Chang et al. 2015; Keppeke et al. 2018).  Formation of these reversible fiber-like subcellular structures 
is believed to transiently boost IMPDH activity (Chang et al. 2015; Keppeke et al. 2018). IMPDH 
cytoophidia can also be induced in cells by the addition of inhibitors that block de novo GTP 
biosynthesis, such as mycophenolic acid (Ji et al. 2006) and ribavirin (Carcamo et al. 2014). 
Disassembly of cytoophidia can be induced by the addition of the downstream product guanosine or 
GTP (Calise et al. 2014); or by disrupting the cell cycle through the PI3K-AKT-mTOR pathway using 
PI3K inhibitors (Chang et al. 2015).  
More recently, structural studies in IMPDH2 have revealed that increases in IMP stabilize IMPDH2 
filaments, even in the presence of high GTP levels (Johnson and Kollman 2020).  
IMPDH1 filaments could be induced in vitro (Fernández-Justel et al. 2019). It was shown that high 
ATP levels promoted the assembly of IMPDH into filaments, whereas addition of GTP led to 
filament disassembly into free octamers. Blindness-associated mutations in IMPDH1 resulted in 
proteins that had the capacity to form filaments, but were not able of reverting the filaments 
to free octamers (Fernández-Justel et al. 2019), due to the inability of these mutants to bind 
GTP. 
Although structural-functional in vitro analysis are paving the way to dissect key aspects on IMPDH 
regulation, the relevance of these mechanisms of regulation of the enzyme in vivo have not yet been 
addressed. Addressing these questions in vivo and particularly in the retina is of the outmost importance 
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2.1 AIMS OF THE STUDY 
 
The MAIN AIM of this work is to deepen the knowledge of guanine metabolism and cGMP synthesis 
in photoreceptor cells of the retina, and how genetic defects at this level lead to different forms of 
retinal dystrophies. We focus this work on the study of GCAPs and IMPDH1 proteins and their 
relationship to Leber´s Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP). 
 
2.1.1 SPECIFIC AIMS 
 
1. Explore the putative role of Guanylate Cyclase Activating Proteins (GCAPs) as calcium 
sensor proteins that mediate the physiopathology in Leber´s Congenital Amaurosis 12 
(LCA12): i) establish whether GCAPs are involved in the physiopathology of LCA12, by assessing 
the effect of GCAPs ablation in the rd3 mice;  ii) study how GCAPs may mediate photoreceptor cell 
death in this scenario.  
 
2. Characterize the role and in vivo modulation of inosine monophosphate dehydrogenase 1 
(IMPDH1) in photoreceptor cells of the retina, to get insight into how IMPDH1 mutations 
lead to retinitis pigmentosa:  i) IMPDH1 localization in the retina; ii) IMPDH1 in vivo regulation 




























Chapter 1: Antibody generation against the proteins of study: RetGC1, RD3 and 
IMPDH1 
Chapter 2: Exploring the putative role of GCAPs as damage mediators in the rd3 
mouse model of LCA12 
Chapter 3: Characterizing the in vivo modulation of IMPDH1 in dark/light and its 









































3.1 RESULTS CHAPTER 1. ANTIBODY GENERATION AGAINST THE 
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3.1.1 Contributions 
We are in debt with Dr. Álvaro Gimeno and Lidia Gómez at the Vivarium facility for performing the 
immunization protocol in rabbits. We aknowledge Dra. Dunja Lukovic from the Slaven Erceg 
Laboratory [University of Valencia] for providing us with human retinal eyecup sections derived from 
iPSCs for testing anti-RetGC1 antibodies. We are in debt with Dr. Jordi Andilla [ICFO] and Dr. 
Benjamin Torrejón [CCiT-UB] for their assistance with image acquisitions at the confocal microscope.  
My contribution to this chapter was the preparation of antigens for  immunization of rabbits: either 
by crosslinking the peptides of interest to KLH (RetGC, RD3); or by purification of recombinant 
IMPDH1 expressed in bacteria. I prepared the columns (by –SH or –NH4 covalent binding of  the 
antigen) for affinity purification of the antibodies from rabbit serum, and performed the affinity  
purification. I rigorously characterized the specificity of the antibodies in western blots, and 
immunofluorescence and immunoprecipitation assays. I acquired the images by confocal microscopy 
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ANTIBODY GENERATION AGAINST THE PROTEINS OF STUDY: RETGC1, 
RD3 AND IMPDH1 
3.1.2 Antibody against murine RetGC1 
 
An antibody anti-RetGC1 was generated by immunizing rabbits with the last 21 COOH-terminal 
amino acids of murine RetGC1. Since there are two RetGC isoforms in murine retinas (RetGC1 and 
RetGC2, with RetGC1 present in rods and cones, and RetGC2 restricted to rods), a region specific to 
RetGC1 was chosen. The last COOH-terminal peptide presents less than 20% homology with the 
RetGC2 amino acidic sequence. Therefore, an in vitro synthetized 21 aa peptide corresponding to the 
last twenty-one amino acids of RetGC1 followed by a Cys: H2N-IPPERRKKLEKARPGQFTGKC-
OH was conjugated to Keyhole Limpet Hemocyanin (KLH) by using the Imject Maleimide-activated 
mcKLH Spin kit (Thermo Scientific), see Methods.  KLH is an extremely immunogenic and effective 
carrier protein for immunogen preparation, given that each KLH protein molecule contains several 
hundred of lysines that provide primary amines as targets for covalent attachment of haptens.  Once 
prepared, the antigen was used to immunize New Zealand rabbits following a standard 3-boost 
protocol (detailed in Methods).  
 
Rabbit serum was subjected to an affinity purification protocol, by using the immunizing peptide 
covalently attached to agarose by –SH chemistry, using a SulfoLink Immobilization kit for peptides 
(Thermo Scientific), see Methods.  After extensive dialysis of the antibody against phosphate saline 
buffer pH 7.2, the concentration of different antibody batches was determined, preservatives were 
added (either 40% glycerol or 0.4% BSA in 0.025% sodium azide), and antibodies were aliquoted and 
kept at -80oC.  
 
Anti-RetGC affinity purified antibodies were first tested by Western blot analysis on whole murine 
retinal extracts. Fig 16A shows a 12% SDS-PAGE with 40 µg of murine retinal extract (corresponding 
to 1/10 of a retina).  
 
The antibody recognized a prominent band between 100-150 kDa, with the expected molecular weight 
for RetGC1 being 120 kDa (Fig 16A). This result shows that anti-mRetGC1 Ab works efficiently and 
specifically in Western blots. 
 
Antibodies were then tested in immunolocalization assays, by performing indirect 
immunofluorescence of murine retinal cryosections. The Ab yielded a strong signal at the 




Note that cone outer segments are shorter than rod’s and are typically discerned at the inner segment 
(IS) layer (white arrows). Note that cones in the image are stained in red, with an Alexa647-conjugated 
cone-marker: peanut agglutinin (PNA) lectin, that binds to specific-cone surface oligosaccharides 
(Blanks and Johnson 1984). The green anti-mRetGC1 signal overlaps with the red PNA signal, 
yielding the yellow staining of cone outer segment compartments (white arrows).  
 
The antibody was also tested in bovine retinal sections, giving a strong cone outer segment signal.  See 
green signal at magnified cone from bovine retina, Fig 16C.  Anti-mRetGC1 Ab also recognized the 
human isoform of the protein in immunolocalization assays.  In human retinal eyecups derived from 
induced pluripotent stem cells iPSCs [a kind gift from the Slaven Erceg Lab, Principe Felipe Institute, 
Valencia] the antibody specifically recognized the incipient outer segment structures that are 
characteristic of these organoids (Fig 16D).  
 
Figure 16. RetGC1 antibody specifically recognizes RetGC1 of various species in Western blot and 
immunolocalization assays. A. Anti-mRetGC1 Ab recognizes only one band at 120 kDa in a 12% SDS-
PAGE gel loaded with whole murine retinal extract (40 µg protein). B. Immunolocalization of RetGC1 in 
murine retinal fixed tissue. Both cone outer segments (white arrows at the IS compartment) and rod outer 
segments (OS layer) were stained with the anti-mRetGC1 antibody (green signal). RetGC1 colocalizes with 
lectin PNA (red), a cone specific marker. C. Detail of a bovine cone stained with RetGC1 (green) and Creatine 
Kinase B (CKB) (red) obtained by super-sensitivity [ICFO]. D.  Section from a human eyecup derived from 
iPSCs labeled with RetGC1, showing staining of incipient photoreceptor outer segments (green). Phalloidin 
stains actin filaments, labelling the outer limiting membrane (red) whereas PNA lectin stains cones (blue). OS 
(Outer segment), IS (Inner segment), OLM (Outer limiting membrane) and ONL (Outer nuclear layer). 
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3.1.3 Antibody against murine RD3  
 
The anti-RD3 antibody was generated against the last COOH-terminal 16 amino acids of murine 
RD3. The peptide Cys: H2N-PPRTWSMPEFRAPQAD -OH was conjugated to KLH, and a rabbit 
immunizing protocol was followed as indicated above. Antibody affinity purification was performed 
as indicated for anti-mRetGC1 pAb.  
 
The affinity purified antibody was first tested by western blot in murine retinal extracts from wild-
type and rd3/rd3 retinas. The rd3 mice present a point mutation [c.319CàT] at exon 3 of the Rd3 
gene, that results in a truncated protein lacking the last 89 aa of the protein (Friedman et al. 2006). 
The truncated RD3 protein is rapidly degraded in these mice; but even if traces of RD3 protein were 
present they would not be detected with this Ab generated against the C-terminal. The antibody 
detected a band between 20-25 kDa; which corresponds to RD3, a protein of 23 kDa (Fig 17A). This 
band is not detected in rd3/rd3 retinal extracts. 
 
Then the anti-mRD3 pAb was tested in immunolocalization assays. RD3 localization has been 
controversial since it was reported by Robert Molday´s Lab. They first identified RD3 in bovine rod 
outer segments in a proteome-based study (Kwok et al. 2008). Then the authors studied the 
localization of RD3 by producing a policlonal antibody against the last 15 aa murine amino acids of 
the protein and determined that RD3 localizes at the rod outer segment layer of the retina (S. Azadi, 
Molday, and Molday 2010). However, other studies have pointed to a different localization of RD3. 
A polyclonal antibody against a human peptide encompassing the RD3 171-183 amino acid region 
was tested in human retinal sections, resulting in a strong inner segment staining (Aravindan et al. 
2017). At Karl Wilhelm Koch´s Lab, RD3 has been immunolocalized to both photoreceptor inner 
and outer segments using a commercial monoclonal antibody against RD3 (Wimberg, Janssen-
Bienhold, and Koch 2018). Recently, Dizhoor´s Lab has determined that RD3 localizes at the inner 
segment of photoreceptors by developing a RD3-GFP engineered mouse (Dizhoor, Olshevskaya, and 
Peshenko 2019).  
 
When we tested our antibody by immunofluorescence on wild-type retinas we observed a rather clear 
staining of photoreceptor outer segments (outer segment layer shown in green, Fig 17B). However, 
the antibody gave an identical signal on rd3/rd3 retinal sections (Fig 17C). This result indicated that 
the antibody generated against the last 16 aa of the protein, even though it recognizes RD3 epitopes 
very specifically under protein denaturing conditions on SDS-PAGE, is not recognizing RD3 
specifically in retinal sections of fixed tissue. The antibody may be recognizing conformational 
epitopes from other proteins on retinal sections. 
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Antibodies against RD3 have proved to be problematic for immunolocalization in several different 
laboratories, and this issue has been attributed to the inaccessibility of the epitopes and/or low levels 
of RD3 expression (Aravindan et al. 2017). We made three attempts at generating antibodies against 
RD3 in the lab: against two different peptides of RD3; and against the full-length protein solubilized 
in urea. They all worked to different extents in Western blot. None of them worked in 
immunolocalization assays, despite different antigen retrieval protocols were tried.  For determination 
of RD3 subcellular localization we ultimately relied on the transient transgenic expression of RD3.V5 
in rods by in vivo DNA electroporation after subretinal injection (see Fig 23, Chapter 2). 
 
Figure 17. Anti-mRD3 antibody testing on murine retinal extracts and retinal sections of wt and 
rd3/rd3 retinas. A. Western blot showing RD3 antibody specificity. RD3 protein is detected between 20-25 
kDa on wild-type retinal extracts, but not in rd3/rd3 retinal extracts. Tubulin levels in the extracts are shown as 
a loading control. B. Immunolocalization of RD3 on a retinal section from wild-type fixed eyecup. The anti-
mRD3 antibody strongly stained the photoreceptor outer segment layer, and colocalized with the PNA lectin 
cone-marker. The same signal was detected with the same extent in rd3/rd3 mice (C). Anti-mRD3 antibody 
was tested in three independent rd3/rd3 animals that were confirmed to be deficient in RD3 by genotyping. OS 
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3.1.4 Antibody against bovine IMPDH1 
 
For antibody generation against IMPDH1, we purified the bovine canonical isoform of IMPDH1-
(514 aa). bIMPDH1-514 aa was expressed in E.coli and purified from inclusion bodies (Krishnaiah 
1975) by solubilization in guanidinium hydrochloride, purification in its denatured form by metal 
chelation with a HiTrap column, and subsequent dialysis in a gradient of urea (see methods).  
 
Purified bIMPDH1 in <1M urea was used to immunize two New Zeland rabbits following a standard 
3-boost protocol as described above. Rabbit serum was purified against recombinant bIMPDH1-
crosslinked to Aminolink coupling resin (see methods).  
 
IMPDH1 is a highly conserved protein (Hedstrom 2009). Five human retinal isoforms were identified 
(Bowne, Liu, et al. 2006), with the 546 aa (presenting an extra C-terminus) and 595 aa (extra N-
terminus and extra C-terminus) being the more abundant. In the mouse system, the major isoforms 
are the 603/604 aa and 546 aa isoforms, that predominate among the seven isoforms identified. By 
the use of an antibody against the whole recombinant protein we expected to detect the different 
IMPDH1 splicing isoforms in murine and bovine retinal extracts.   
 
The anti-bIMPDH1 antibody was tested by western blot in murine and bovine retinal homogenates 
(Fig 18A). In murine extracts the predominant isoforms of 603/604 aa and 546 aa were clearly 
detected. In the bovine system the different IMPDH1 splicing isoforms have not been annotated.  In 
bovine retinal extracts we detected two major isoforms between 50-75 kDa. The antibody also 
recognized the tetrameric form of IMPDH1 on bovine homogenates, despite the presence of SDS in 
the loading buffer. These results show that the anti-bIMPDH1 antibody was highly specific. 
 
On murine retinal sections, anti-bIMPDH1 strongly stained the inner segment layer and the outer 
plexiform layer. The signal was also present in the perinuclear region of the ONL (Fig 18B). Note 
that despite IMPDH1 abundance, IMPDH1 signal did not colocalize with the cone-marker PNA at 
synaptic terminals. IMPDH1 immunolocalization results are consistent with previous studies (Bowne, 




Figure 18. Specificity of anti-bIMPDH1 antibody in Western, immunolocalization and 
immunoprecipitation assays. A. Western blot showing IMPDH1 antibody specificity. The two major bands 
observed (50-75 kDa) correspond to the two predominant retinal splicing isoforms in the murine and bovine 
systems, with predicted masses of 55 and 60 kDa. In bovine retinal extracts (more material loaded), the 
tetrameric form of the protein is also detected, at ~220 kDa. B. Immunolocalization assay on a wild-type 
murine fixed retina. IMPDH1 stains rod inner segments, the perinuclear region and synaptic terminals. OS 
(Outer segment), IS (Inner segment), ONL (Outer nuclear layer) and OPL (outer plexiform layer). C. 
Immunoprecipitation assay with anti-IMPDH1 antibody. A fixed input (IN) corresponding to one-tenth of a 
retinal bovine homogenate was used as starting material.  Increasing concentrations of antibody (0.5; 1 and 3 
µg) were used with a fixed amount of Protein G magnetic beads. FT: Flow Through (Unbound fraction) and 
ELU: Elution (Bound fraction). CL: crosslinked antibody (10 µg). IMPDH1 increases in the elution fractions 
an decreases in the FT fractions with increasing amounts of Ab. 
Because the anti-bIMPDH1 antibody was generated against the whole recombinant protein, it is 
expected to detect many IMPDH1 epitopes, putatively valid for immunoprecipitation purposes. We 
performed an immunoprecipitation assay to titrate the antibody required to immunodeplete IMPDH1 
from a given retinal extract. For that, we incubated a fixed amount of bovine retinal extract, and 
increasing amounts of Ab (0.5, 1 and 3 µg), with a fixed amount of protein-G dynabeads. We 
determined that 3 µg of the anti-IMPDH1 antibody completely immunodepleted the IMPDH1 from 
one-tenth of a bovine retina (corresponding to 0.5 mg total protein) (Fig 18C). Unfortunately, this 
antibody could not be cross-linked to protein G-dynabeads for immunoprecipitation assays at a larger 
scale for proteomic purposes, because the Ab lost immunogenicity when crosslinked (CL in panel 
3C). 
 












3.2 RESULTS CHAPTER 2. EXPLORING THE PUTATIVE ROLE OF GCAPS AS 














































   
 




Dr. Pedro de la Villa from the University of Alcalá, Madrid, recorded the dark-adapted ERG responses 
from the different mouse lines here shown (C57BL/6; GCAPs-/-; rd3/rd3 and rd3/rd3 GCAPs-/-) in 
a visit to the lab. Dr. Santiago López-Begines, a former PhD student in the lab, performed the pull-
down assays with GCAP2-P and GCAP2 from bovine retinal homogenates and created the volcano 
plot presented. Dr. Josep M. Estanyol and Dr. M. José Fidalgo, from the CCiT-UB Technical Platform 
performed the  LC-MS/MS experiments. We aknowledge the help of Alex Rovira (TFG student) in 
the cloning of  pRho_mRd3V5_dsRed expression vector, and of Nerea Ugartondo (Master student) 
in the in vivo DNA electroporation of the plasmid in rd3 mice. I am in debt with Dr.Jordi Andilla and 
Dr. Benjamin Torrejon for their help at image acquisition and analysis at the confocal microscope.   
  
My contribution to this chapter was the establishment and analysis of the rd3/rd3 GCAPs-/- line; that 
involved developing a method to detect the SNP present in the rd3 line; and the genotyping of F1, F2 
and F3 generations. I analyzed the extended eye collection from wt; wt/rd3; rd3/rd3; rd3/rd3 
GCAPs+/- and rd3/rd3 GCAPs-/- at different time points in order to assess the rate of retinal 
degeneration, both by light and electron microscopy, performing the morphometric measurement 
statistical analysis.  I determined the expression levels and subcellular localization of our proteins of 
interest in these mice.  I established that GCAP2 is mainly in its phosphorylated form in rd3 mice by 
running isoelectrofocusing gels of murine retinal extracts. I assessed ER stress and apoptosis markers 
in the different lines. I significantly contributed to experimental design, data analysis, and 
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3.2.2 Rationale  
 
Mutations in a number of genes that impair or alter cGMP synthesis in rods and cones have been 
associated to different forms of blindness (Isabella Perrault et al. 1996; Payne et al. 1998; Kelsell et al. 
1998).  Loss-of-function mutations in the RD3 gene (name coming from the natural strain of blind 
mice called “retinal degeneration 3”, Rd3 locus mutated) cause Leber’s Congenital Amaurosis 12 
(LCA12) (B. Chang et al. 1993; Friedman et al. 2006).  LCA12 is characterized by severe vision loss at 
an early age and rapid retinal degeneration, due to rod and cone impaired function. 
 
It is known that the 23 kDa RD3 protein is required for the stability and ciliary trafficking of the 
guanylate cyclases RetGC1 and RetGC2 (S. Azadi, Molday, and Molday 2010).  RetGCs are regulated 
by the guanylate cyclase activating proteins GCAP1 and GCAP2, that confer Ca2+ regulation to cGMP 
synthesis. In rd3 mice the levels of RetGC1 and RetGC2 are dramatically decreased, and retained at 
the cell soma (S. Azadi, Molday, and Molday 2010).  GCAPs, that depend on RetGCs for their stability 
and distribution to the outer segment, are also diminished and retained (Baehr et al. 2007; López-
Begines, et al. 2018; S. Azadi, Molday, and Molday 2010).  This is expected to result in reduced cGMP 
synthesis, closure of CNG-channels and severely impaired vision.  This phenotype mimics that of 
LCA1 caused by null mutations in GUCY2D (RetGC1) in humans (Samuel G. Jacobson et al. 2013), 
or by retinal guanylate cyclase deficiency in mice [RetGC1/RetGC2 double knockout mice, (Baehr et 
al. 2007)].  However, while mice deficient in RetGC1/RetGC2 show a progressive retinal 
degeneration, in rd3 mice the loss of rod and cone cells progresses fast (Linberg et al., 2005). 
 
Little is known about the molecular mechanisms that link the lack of RD3 with photoreceptor cell 
death in rd3 mice. We have previously proposed that the GCAP proteins could contribute to the 
pathophysiology of several retinal dystrophies characterized by rod/cone chronic hyperpolarization 
and low [Ca2+]i at the photoreceptor soma.  This hypothesis was based on the fact that when a form 
of GCAP2 impaired to bind Ca2+ (with all functional EF-hands mutated, EF-GCAP2) was expressed 
in living photoreceptors, it was retained at the cell soma by phosphorylation and 14-3-3 binding, 
resulting in severe toxicity and fast retinal degeneration (Hoyo et al. 2014).  GCAPs are retained at the 
cell soma in rd3 mice, in a context of chronic low [Ca2+]i.  Considering that GCAP2 has previously 
been identified as a modifier gene of the rd3 mouse phenotype (Danciger et al. 2008), we hypothesized 
that Ca2+-free GCAPs could be contributing to the pathophysiology of this disease. We here test this 
hypothesis.     
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EXPLORING THE PUTATIVE ROLE OF GCAPS AS DAMAGE MEDIATORS IN 
THE RD3 MOUSE MODEL OF LCA12 
 
3.2.3 Retinal degeneration due to RD3 deficiency is substantially rescued by 
GCAPs ablation. 
 
To test the hypothesis that the GCAP proteins contribute to the pathophysiology of LCA12 blinding 
disease associated to the lack of functional RD3, we bred rd3 mice to GCAP1/GCAP2 double 
knockout mice (GCAPs-/- mice), to compare the rate of retinal degeneration caused by RD3 
deficiency in the presence or absence of GCAP proteins.   
We first characterized the rate of retinal degeneration in the specific rd3 strain used in this study 
[B6.Cg-Rd3rd3/Boc], hereinafter referred to as rd3 mice, because rates of degeneration vary in the 
different strains carrying the Rd3 mutation (Linberg et al., 2005).  Our analysis showed that rd3 mice 
developed normal retinas up to two postnatal weeks, but showed signs of retinal degeneration as early 
as postnatal day 20 (p20).  While wt/rd3 heterozygous littermate controls showed a nearly normal 
outer nuclear layer (ONL) with 11-12 rows of photoreceptor nuclei and a width of 40-42 µm at p20, 
rd3/rd3 homozygous mice showed a slightly shorter ONL (8-10 rows of nuclei, 32-36 µm-thickness) 
at this age (Fig 19A). At p26, the ONL of rd3/rd3 mice was reduced to 6-8 rows of nuclei (28-30 µm), 
and at p44 to about 5 rows of nuclei (20 µm) (Fig 19A).  An statistical analysis of ONL thickness was 
performed on morphometric measurements from 2 p20 and 2 p26 retinas of each genotype (p20-p26 
traces, n=4), and 4 retinas at p44 of rd3/rd3 mice (Fig 19B).  We conclude that the retinal degeneration 
in rd3 mice manifests as early as at p20 and halves the number of photoreceptor cells in about 6 weeks, 
which is consistent with the reported rate of degeneration of pigmented strains with the rd3 mutation 
(Linberg et al., 2005). 
We confirmed that RetGC expression was severely reduced in this rd3 strain at p20 (S. Azadi, Molday, 
and Molday 2010), with RetGC1 levels reduced to ~12% the expression in control mice (Fig 19C).  
The expression levels of GCAP1 and GCAP2 were reduced to 37% and 42% the levels in control 
mice (Fig 19C).  A novel observation is that RetGC1 was detected by immunofluorescence analysis 
on retinal sections of rd3 mice at the inner segment layer and perinuclear region of photoreceptors, 
showing a characteristic punctated staining (Fig 19D). GCAP1 and GCAP2 were largely retained to 
proximal photoreceptor compartments in rd3 mice, as previously described (S. Azadi, Molday, and 






Figure 19.  Time course and molecular alterations that characterize the retinal degeneration in rd3 
mice strain B6.Cg-Rd3rd3/Boc. (see figure legend in next page) 
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Figure 19.  Time course and molecular alterations that characterize the retinal degeneration in rd3 
mice strain B6.Cg-Rd3rd3/Boc. A. Retinal micrographs of wt/rd3 and rd3/rd3 mice at p20, p26 and p44 
show the progressive retinal degeneration in rd3/rd3 mice, that halves the number of photoreceptor cells at 
p44.  Scale bar 20 µm. B. Retinal morphometric analysis of wt/rd3 and rd3/rd3 mice at the indicated ages, 
showing outer nuclear layer (ONL) length (µm) at 200 µm-intervals from the optic nerve in the vertical meridian 
of the eye, superior retina to the right. Each trace represents the average measurements of four mice analyzed, 
with error bars indicating the standard error of the mean (SEM) [n= 2 biological replicates at p20, and n= 2 
biological replicates at  p26 for wt/rd3 and rd3/rd3; n= 4 biological replicates at p44 for rd3/rd3].  C.  Expression 
levels of RetGC1, GCAP1 and GCAP2 in rd3/rd3 mice compared to wt/rd3 mice at p30. Histograms indicate 
the percentage of expression of each protein in rd3/rd3 mice versus wt/rd3 mice, after normalization with a-
tubulin. No RD3 protein is detected in rd3/rd3 mice with an antibody generated against RD3 C-terminus.  For 
the determination of protein levels, three independent experiments were performed. Unpaired t-test for 
RetGC1 (wt/rd3 versus rd3/rd3; P<0.0001***); GCAP1 (wt/rd3 versus rd3/rd3; P=0.032*); GCAP2 (wt/rd3 
versus rd3/rd3; P=0.0017**). D.  Immunofluorescence localization of RetGC1, GCAP1 and GCAP2 in wt/rd3 
and rd3/rd3 mice at p24.  RetGC1, GCAP1 and GCAP2 signals are greatly reduced in rd3/rd3 mice, and mostly 
restricted to the photoreceptor inner layer.  Cones are labeled with peanut agglutinin (PNA) in red; the rod 
outer segment layer with anti-Rhodopsin mAb 1D4 (1 cm overlay) in cyan; and nuclei are labeled with DAPI 
(blue). Scale bar 20 µm. OS, outer segment; IS, inner segment; ONL, outer nuclear layer; ST, synaptic terminals. 
 
To assess whether ablation of GCAPs affected the time course of retinal degeneration in the rd3 mice, 
we bred rd3 mice to GCAPs-/- mice. To minimize strain variation effects, the breeding was established 
between rd3/rd3 GCAPs+/- mice, so that homozygous rd3/rd3 mice that were either GCAPs+/- or 
GCAPs-/- littermates could be directly compared (Fig 20). The ONL width of rd3/rd3 mice at p44 
from (Fig 19B) is plotted as a reference.  Compared to rd3/rd3 mice at p44 [ONL thickness of 20 µm, 
5 nuclei]; rd3/rd3 GCAPs+/- showed a very minor improvement at this age [22-24 µm, 5-6 nuclei, 
n=4]; but rd3/rd3 GCAPs-/- mice showed a striking improvement [30-32 µm, 7-8 nuclei, n=4], (Fig 
20A-B).  This rescue effect of GCAPs ablation was preserved at p60 (Fig 20C-D), when 4 biological 
replicates per genotype were analyzed (rd3/rd3 GCAPs+/- and rd3/rd3 GCAPs-/- littermates).  
Rd3/rd3 GCAPs-/- mice preserve 75% of their photoreceptors at p60; when rd3/rd3 mice have lost 
more than 50%.  
This substantial preservation of photoreceptors in the absence of GCAPs correlated with an increase 
in RetGC levels in rd3/rd3 GCAPs-/- retinas (Fig 20E-F).  Quite surprisingly, RetGC1 in rd3/rd3 
mice was distributed to rod outer segments to a higher extent in the absence of GCAPs (Fig 20I). 
At eight months rd3/rd3 mice have completely lost the photoreceptor cell layer, and rd3/rd3 GCAPs-
/- mice still preserved 5 rows of photoreceptors with visible outer segments (Fig 21A-B). We 
conclude that GCAPs ablation markedly slows down photoreceptor cell death in the rd3 mice, 
substantially delaying retinal degeneration in this mouse model of LCA12.  Consequently, the GCAP 




Figure 20.  Retinal degeneration in rd3 mice is substantially prevented by GCAPs ablation.                     
(see figure legend in next page) 
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Figure 20.  Retinal degeneration in rd3 mice is substantially prevented by GCAPs ablation. A. Retinal 
morphology of rd3/rd3; rd3/rd3 GCAPs+/- and rd3/rd3 GCAPs-/- mice at p44.  Photoreceptor cell loss is 
substantially prevented in the GCAPs-/- background.  Scale bar 20 µm.  B.  Retinal morphometry analysis of 
the indicated genotypes at p44 showing ONL length (µm) along the vertical meridian of the eye.  Each trace 
shows the average from measurements taken from four mice, with error bars showing the standard error of 
the mean (SEM).  GCAPs removal resulted in preservation of 25% more photoreceptors at p44. C. 
Morphology of the retina in rd3/rd3 GCAPs+/- and rd3/rd3 GCAPs-/- at p60.  The protective effect of 
GCAPs ablation persisted at this age. Scale bar 20 µm.  D.  Statistical analysis of ONL length in rd3/rd3 
GCAPs+/- and rd3/rd3 GCAPs-/- retinas at p60.  Results are Mean + SEM of four biological replicates.  E.  
Level of expression of RetGC1 in rd3/rd3 GCAPs+/- and rd3/rd3 GCAPs-/- retinas at p30, p40 and p60. 
RetGC1 expression levels correlated with the fraction of photoreceptors preserved.  F. Statistical analysis of 
RetGC1 expression levels, Mean + SEM of three biological replicates per genotype.  RetGC1 levels were not 
altered by the presence or absence of GCAPs at p30, consistent with rd3/rd3 and rd3/rd3 GCAPs-/- mice 
having a similar ONL thickness at this age.  RetGC1 levels were significantly higher in the GCAPs-/- 
background at p40 and p60 compared to rd3/rd3, reflecting the extent to which photoreceptor cells were 
preserved at this ages. Unpaired t-test (rd3/rd3 versus rd3/rd3 GCAPs-/- at p40, P=0.0023**);  (rd3/rd3 versus 
rd3/rd3 GCAPs-/- at p60, P=0.0043**)  G-I. In the absence of GCAPs, more RetGC1 distributed to the rod 
outer segment layer in rd3 mice (I), than in the presence of GCAPs (H).  Scale bar 20 µm.  OS, outer segment; 










Figure 21.  Protective effect of GCAPs ablation 
persists at eight months.  A.  Retinal section of 
rd3/rd3 mice at eight months of age, with nuclei 
stained with DAPI (blue) and rod outer segment 
layer stained with anti-rhodopsin antibody 1D4 (in 
red, note the absence of rhodopsin in rd3/rd3 mice 
at 8 months).  Retinas from rd3/rd3 mice show a 
complete loss of the photoreceptor cell layer at 8 
months.  Insets of frontal, middle and nasal regions 
of the retina are shown to evidence the loss in 
photoreceptor cell nuclei. B. Retinal morphology of 
rd3/rd3 GCAPs-/- mice at the same age, showing an 
outer nuclear layer with five rows of nuclei.  Note 
the rod outer segment layer (ROS) stained with anti-
rhodopsin mAb 1D4 (red). Retinal sections are 
representative of three mice per genotype. Scale bar 
20 µm. ONL, outer nuclear layer; INL, inner nuclear 




3.2.4 Morphological rescue of rd3 retinas by GCAPs ablation does not 
correlate with an amelioration of visual function 
 
To test whether the substantial morphological rescue of rd3 mice that resulted from GCAPs ablation 
correlated with an amelioration of visual function, light-elicited electroretinogram (ERG) responses 
were recorded from wildtype, rd3/rd3, GCAPs-/- and rd3/rd3 GCAPs-/- mice at p40. 
 
Rd3 mice showed substantially reduced scotopic and photopic responses (Fig 22), as expected based 
on the drastically reduced RetGC levels in this mice, as previously reported (L. L. Molday et al. 2013).   
Although the rd3 mice had substantially reduced sensitivity to light, rd3 mice at p40 elicited diminished 
but reliable responses to flashes in the scotopic and photopic range (Fig 22), indicating that rd3 mice 
at this age retained some rod and cone visual function. 
GCAPs-/- mice presented reduced visual responses in the scotopic and photopic range due to the 
lack of GCAPs stimulation of guanylate cyclase activity, but they largely retained visual function (Fig 
22).  
Strikingly, rd3/rd3 GCAPs-/- mice at p40 yielded barely noticeable responses to flashes at either the 
scotopic or photopic range (Fig 22), despite maintaining 25% more photoreceptor cells than rd3/rd3 
mice and higher levels of RetGC at the retina. A possible explanation for these results is that rd3/rd3 
GCAPs-/- responses reflect the lack of stimulation of RetGC activity by the GCAP proteins; whereas 
rd3/rd3 mice retain GCAP stimulation of the remaining RetGC proteins. 
Taken together our results show that GCAPs ablation in the rd3 mice substantially prevented retinal 
degeneration but at the cost of impairing rather than ameliorating visual function. 
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Figure 22. Light responses are drastically reduced in rd3/rd3 GCAPs-/- mice.  Electroretinographic 
recordings from 40 days-old wild type, rd3/rd3, GCAPs-/- and rd3/rd3 GCAPs-/- mice in response to light 
stimuli of increasing intensity at scotopic or photopic conditions.  Representative recordings are shown from 
one mouse of each genotype, evoked by light pulses of increasing intensity (indicated in cd.s.m-2).   Scotopic a-
wave and b-wave amplitudes (mean + SD) and photopic b-wave amplitudes are plotted at different light 
intensities from a total of four wild type mice; seven rd3/rd3 mice; five GCAPs-/- and five rd3/rd3 GCAPs-/- 
mice.  Both GCAPs-/- and rd3/rd3 mice showed substantially reduced responses when compared to wild type 
responses.  GCAPs ablation in rd3/rd3 mice resulted in nearly abolished responses at the scotopic or photopic 
range. 
 
3.2.5 Subcellular localization of RD3 in retinal sections 
 
There have been some inconsistencies in recent reports regarding RD3 subcellular localization.  RD3 
was immunolocalized to the outer segment layer of the retina in wildtype mice by specific antibodies 
against the COOH-terminus of the protein (S. Azadi, Molday, and Molday 2010).  Subsequently RD3 
was described as a potent inhibitor of RetGC activity in vitro, and was predicted to localize to the inner 
segment layer where it could silence the cyclase during its transport to the cilium (Peshenko, 
Olshevskaya, Azadi, et al. 2011).   
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To determine RD3 subcellular localization by avoiding the use of anti-RD3 antibodies, we here 
generated transient transgenic mice that expressed RD3 fused to a short tag (RD3.V5) in rod 
photoreceptors. To express RD3.V5 in rods we made use of in vivo DNA electroporation after 
subretinal injection to transfect newborn rd3/rd3 mice with the construct pRho_mRD3.V5_dsRed.  
RD3 was then immunolocalized at p20 in retinal sections using well-established anti-V5 antibodies 
(see methods). 
RD3.V5 showed the mosaic pattern of expression that characterizes in vivo DNA electroporation 
transgenesis, in which only transfected cells express the transgene. The expression of RD3.V5 in 
rd3/rd3 transfected rods restored RetGC expression and its localization to the outer segment, which 
indicates that the RD3.V5 protein was active (Fig 23).  RD3.V5 localized to the inner and outer 
segments of transfected cells, giving a stronger signal at the inner segments. Particularly, there appears 
to be a membrane region, probably at the connecting cilium, where the RetGC1 and RD3.V5 signals 
strongly colocalize (see the white signal that results at the merged green and magenta channels with 
the shape of  “staples”). 
 
Figure 23. Subcellular localization of RD3 protein in murine retinas. Immunolocalization of RD3.V5 
protein in retinal sections from rd3/rd3 mice electroporated with pRho_mRD3.V5_dsRed.  RD3.V5 distributes 
between the inner and outer segment compartments of transfected photoreceptor cells, with a stronger signal 
at inner segments.  Note that the signal particularly marks a structure that could be an apical membrane domain 
of the inner segment, co-localizing with RetGC1. Note that the expression of RD3.V5 in transfected cells 
restores RetGC1 expression levels and its transport to the outer segment.  The red channel shows the dsRed 
signal from pRho_dsRed, a plasmid co-electroporated with pRho_mRD3.V5_dsRed to serve as a reporter in 
the identification of the eye injected area (see methods). 
 
Therefore our results are in line with the results obtained by (Dizhoor, Olshevskaya, and Peshenko 
2019) that localize RD3 mainly at the inner segment, but we do observe some signal at the outer 
segments as well.  The mosaic expression excludes that this signal is unspecific, as electroporated cells 
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are surrounded by negative-control cells. Anti-V5 antibodies unspecifically stain synaptic ribbons.  
This signal is clearly unspecific because it is detected in transfected and untransfected cells. 
 
3.2.6 GCAP2 in rd3 mice is mostly in its phosphorylated Ca2+-free form, a 
target for 14-3-3 binding 
 
We have previously reported that an accumulation of Ca2+-free GCAP2 at the inner segment and 
proximal cell compartments is highly deleterious for rod cells (Hoyo et al. 2014).  In rd3 mice GCAP2 
is retained at the inner segment and proximal cell compartments (Fig 19D).   
To test whether GCAP2 is in its Ca2+-free “deleterious” conformation in rd3 mice we analyzed 
GCAP2 levels of phosphorylation. In vitro and in vivo studies have shown that GCAP2 is 
phosphorylated at Ser201 preferentially in its Ca2+-free form (Peshenko, Olshevskaya, and Dizhoor 
2004; Hoyo et al. 2014). In wild type mice, about 50% of GCAP2 is phosphorylated when mice are 
reared under standard cyclic light, independently of their sacrifice in the dark or light period (Hoyo et 
al. 2014).  
However, a GCAP2 mutant locked in its Ca2+-free form (EF-GCAP2) transgenically expressed in rods 
showed a much higher extent of GCAP2 phosphorylation. This indicates that the extent of GCAP2 
phosphorylation in vivo reflects the fraction of GCAP2 molecules in the Ca2+-free conformation (Hoyo 
et al. 2014).  
The extent of GCAP2 phosphorylation in rd3/rd3 versus wild type mice was analyzed by resolving 
retinal homogenates at p21 in isoelectrofocusing gel strips that covered a linear pH gradient of 3-10 
(Fig 24A). Three-fold more rd3/rd3 protein sample (75 µg) than wild type sample (25 µg) was loaded 
in order to equilibrate the GCAP2 signal. Unphosphorylated GCAP2 presented an isoelectric point 
(IP) of 4.92, whereas phosphorylated GCAP2 an IP of 4.85. In wild type mice, GCAP2 and GCAP2-
P were present at a 1:1 ratio as originally reported. In contrast, GCAP2 and GCAP2-P were observed 
at a 1:3 ratio in rd3 mice (Figure 24B). This ratio of GCAP2 to GCAP2-P was very similar to the 
ratio reported for EF-GCAP2 mice (Hoyo et al. 2014), and indicates that GCAP2 in rd3 mice is mostly 
in its phosphorylated Ca2+-free state.   
To gain insight into the mechanism by which Ca2+-free GCAP2 could contribute to the 
physiopathology of rd3 mice, we searched for molecular targets of Ca2+-free GCAP2 in the retina. We 
performed pull-down assays with purified myristoylated recombinant bGCAP2 that was in vitro 
phosphorylated -or with its mock control- on Triton-X100 solubilized bovine retinas, under EGTA 
conditions (see Methods).  
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Experiments were performed in triplicate. Bound proteins were identified by liquid chromatography 
and mass spectrometry (LC-MS/MS) and subjected to label-free quantitative statistical analysis. For 
each identified protein (776 total proteins, data not shown), the equation detailed in Methods was 
used to determine its normalized spectral abundance factor (NSAF) in the GCAP2-P and the GCAP2 
sample. The scatter plot in Fig 24C presents the Log2 (Mean NSAFGCAP2-P/Mean NSAFGCAP2) 
on the X axis, versus the -10Log(P value) in the Y axis, considering threshold values of 1.35 and 5 for 
the X and Y axis, respectively. Proteins that showed an statistically significant preference for GCAP2-
P are shown as red dots, while those with preference for unphosphorylated GCAP2 as blue dots (Fig 
24C).  
 
The 14-3-3 proteins, known to interact with GCAP2-P (Hoyo et al. 2014), were identified with robust 
statistics as GCAP2-P binding proteins; as were proteins NDUFS5 (NADH 
dehydrogenase[ubiquinone] iron-sulfur protein 5), Ndel1 (nuclear distribution protein nude-like1) and 
RPL31 (60S ribosomal protein L31). On the other side, among the proteins with preference for 
unphosphorylated Ca2+-free GCAP2, were HSP90(a, b) and HspB8, chaperones that may be required 
to stabilize this unstable form of the protein, and superoxide dismutase 1 (SOD1) and peroxiredoxin-
6 (PRDX6), involved in maintaining the redox state of the cell.  
RetGC1 was only identified in two out of three experiments, with < 6 spectral counts, and showed a 
slight preference for the unphosphorylated form of GCAP2. However, it is well established that the 
RetGC-GCAPs interaction is very sensitive to detergents, and virtually impossible to detect in pull-
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Figure 24.  GCAP2 in rd3/rd3 retinas is largely in its Ca2+-free phosphorylated state, which is a target 
for 14-3-3 binding.  A.  Isoelectric focusing (IEF) separation of retinal homogenates from wt and rd3/rd3 mice 
at p30 in linear pH 3-10 gradient gel strips.  Following isoelectric focusing, proteins were transferred to a 
nitrocellulose membrane and immunoblotted with anti-GCAP2 pAb.  B. The GCAP2-P to GCAP2 ratio was 
determined by densitometric analysis (Mean+ SEM) of three independent isoelectrofocusing experiments.  
Unpaired t-test (GCAP2 versus GCAP2-P in the wildtype, P=0.72) and (GCAP2 versus GCAP2-P in rd3/rd3 
mice, P=0.0082**).  C.  Label-free quantitative proteomic analysis to identify putative protein interactions of 
Ca2+-free GCAP2-P and GCAP2. Pull-down assays were performed on bovine retinal homogenates with 
purified myristoylated GCAP2 that was phosphorylated in vitro or with a MOCK-phosphorylation control, 
under EGTA conditions.  The Volcano plot represents the statistical analysis of three independent pull-down 
assays.  Log2 (P/NP) refers to Log2 (Mean NSAFGCAP2-P/Mean NSAFGCAP2), with NSAF being the normalized 
spectral abundance factor, see Methods.  The already reported 14-3-3 phosphobinding proteins (different 
isoforms of YWHA) were clearly revealed as Ca2+-free GCAP2-P interactors, validating the assay.  Other 
putative interactors identified with statistical significance are marked in red (GCAP2-P) and blue (GCAP2-NP). 
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3.2.7 Endoplasmic reticulum stress and mitochondrial swelling are 
prominent early signs of retinal degeneration in the rd3 mice that are 
substantially rescued by GCAPs ablation 
 
One early alteration that we observed in the retinas of rd3 mice at p20 was rhodopsin mislocalization.  
Although rhodopsin transport is not affected by the lack of RD3 and rhodopsin antibodies largely 
stain the outer segment layer in rd3 mice (e.g., Fig 19), a number of photoreceptor cells showed 
rhodopsin perinuclear staining in any taken frame of the rd3 outer retina at p20 (Fig 25A). This was 
not observed in age-matching wild type or rd3/rd3 GCAPs-/- mice (Fig 25A). The number of cells 
per unit area that showed mislocalized rhodopsin in rd3 mice was highest at p20 and diminished with 
age (Fig 25B-C).  
 
Because this signal could be reflecting rhodopsin retention at the endoplasmic reticulum (ER) due ER 
dysfunction, we assessed ER stress by comparing the levels of ER stress marker C/EBP homologous 
protein (CHOP) in wild type, rd3/rd3 and rd3/rd3 GCAPs-/- mice. CHOP is a transcription factor 
that links severe ER impairment with the induction of apoptosis (Thapa et al. 2012). We observed a 
clear induction of CHOP expression in rd3 mice at p20 (Fig 25D-E), that was substantially prevented 
by GCAPs ablation (Fig 25D-E). Apoptotic cell death was assessed by evaluating caspase 3 activation 
(detection of the p17 large fragment from caspase 3 cleavage) and the cleavage of poly (ADP-ribose) 
polymerase PARP, a main target of caspases. Fig 25D-E shows activated p17 fragment of caspase 3 
at a much higher level in rd3 mice than in wt or rd3/rd3 GCAPs-/- mice, with statistical significance 
(experiment performed in triplicate). The extent of PARP1 cleavage in rd3 mice versus wt 
and rd3/rd3 GCAPs-/- mice confirms the induction of apoptotic cell death in rd3 mice at p20, that is 
partially rescued by GCAPs ablation. 
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Figure 25.  Rhodopsin mislocalization and endoplasmic reticulum stress are early signs of retinal 







Figure 25.  Rhodopsin mislocalization and endoplasmic reticulum stress are early signs of retinal 
degeneration in rd3 mice that are palliated by GCAPs ablation. A. Retinal sections from wt, rd3/rd3 and 
rd3/rd3 GCAPs-/- mice at p20 stained with anti-rhodopsin antibody (green) and DAPI (blue). Rhodopsin 
mislocalization at the perinuclear region and proximal compartments is observed in a number of photoreceptor 
cells at any given frame of the outer retina in rd3/rd3 mice at p20, but not in wildtype or rd3/rd3 GCAPs-/- 
mice at this age. Scale bar 20 µm. B-C.  Representative images and quantification of cells that present rhodopsin 
mislocalization at p20 versus p60 in rd3/rd3 mice, expressed per unit area [n=5 rd3/rd3 mice at p20; n=4 rd3/rd3 
mice at p60. Unpaired t-test p20 versus p60, P=0.0058**]. D. Levels of CHOP; full-length and p17 kDa 
fragment of cleaved caspase 3; and full length and 89 kDa fragment of cleaved PARP1 proteins in retinal 
extracts from wt, rd3/rd3 and rd3/rd3 GCAPs-/- at p20.  Note that the full length casp3 and c-casp3 signals 
were obtained from different exposure conditions of the same membrane, given that c-casp3 represents a small 
percentage of full length casp3. No RD3 protein was observed in rd3/rd3 or rd3/rd3 GCAPs-/- extracts. E. Six 
independent experiments were performed to determine CHOP expression levels (wild type versus rd3/rd3, 
P=0.0012**; and rd3/rd3 versus rd3/rd3 GCAPs-/- P=0.0001***). Three independent experiments were 
performed to determine PARP1 and c-PARP1 levels [PARP1: wt versus rd3, P=0.001***; and rd3/rd3 versus 
rd3/rd3 GCAPs-/-, P=0.0018**)]; [c-PARP1: wt versus rd3, P=0.026*; and rd3/rd3 versus rd3/rd3 GCAPs-/-, 
P=0.37 ns)].  Three independent experiments were performed to determine casp3 and c-casp3 levels [Casp3: 
wt versus rd3, P=0.035*; and rd3/rd3 versus rd3/rd3 GCAPs-/-, P=0.05*)]; [c-Casp3: wt versus rd3, P=0.026*; 
and rd3/rd3 versus rd3/rd3 GCAPs-/-, P=0.031*)].   
 
Actually, one of the most prominent alterations in rd3 mice at p20-p26 revealed by ultrastructural 
analysis was mitochondrial swelling, indicative of apoptosis. Fig 26 shows representative electron 
micrographs of rd3/rd3 mice at p20-p26 (Fig 26B, D), opposed to wt/rd3 heterozygous littermate 
controls (Fig 26A, C).  
Retinas from rd3/rd3 mice showed distinctive features like emerging vertical outer segment membrane 
discs (black arrows in panels B and D, and enlarged area at panel E); as well as disc structures that 
have been internalized at the inner segment (black arrowheads in panels F, G, H and K). Prominent 
morphological alteration in rd3/rd3 mice was mitochondrial swelling at the inner segment, noticeable 
at p20 at a fraction of cells (panel F, magnified at G), and at p26 at the majority of cells (panels I 
and J). This mitochondrial swelling preceded cell death. 
Interestingly, the striking mitochondrial swelling in rd3 photoreceptor cells (Fig 27A) was greatly 
diminished in rd3/rd3 GCAPs-/- mice (Fig 27B) when four animals of each genotype were compared 
(Fig 27C).  
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Figure 26.  Mitochondrial swelling is an early sign of retinal degeneration in rd3/rd3 mice.  A to E.  
Comparison of rd3/rd3 retinas at p20 (B, D) versus wt/rd3 littermate controls (A, C). Retinas from rd3/rd3 
mice present distinctive features like emerging vertical outer segment membrane discs (black arrows in panels 
B and D, and in the enlarged area in panel E); as well as swelling mitochondria (arrowheads, panels B and E). 
F, G, I, J.  Mitochondrial swelling is a hallmark ultrastructural alteration in rd3/rd3 mice at early stages of retinal 
degeneration, as observed at p20 at the ellipsoid region of several photoreceptor cells (panels  B, D), and more 
dramatically at a higher number of photoreceptor cells at p26 (panels F, G, I, J). Other striking alterations are 
the internalization at the inner segment of what appears to be stacks of outer segment disc membranes (black 
arrowheads in panels F, G, H and K); and the occasional infiltration of cells of the immune system at the 





Figure 27. Mitochondrial swelling is substantially prevented by GCAPs ablation in the rd3 mice. A. 
Representative electron micrographs of retinal sections from rd3/rd3 and rd3/rd3 GCAPs-/- (B) mice at p26.  
Images are the result of fusing four transmission electron microscopy fields obtained at 10 000x magnification. 
Scale bar 2 µm. C. The number of photoreceptor cells that present mitochondrial swelling is substantially 
reduced in rd3/rd3 GCAPs-/- mice versus the rd3/rd3 mice. Four independent regions were analyzed per retina; 
and retinas were obtained from four mice of each genotype. Histograms represent the percentage of cells with 
presence of vacuoles, from the total number of cells.  Unpaired t-test (rd3/rd3 versus rd3/rd3 GCAPs-/-, 
P=0.019*). 
 
Taken together, our results show that GCAPs induce the ER stress response in rd3 mice, inducing 
CHOP expression and triggering apoptosis at a very early stage of the disease, and that GCAPs 







   
 




We here show that the GCAP proteins play a central role in the physiopathology of blinding diseases 
associated to loss of functional RD3 (LCA12), by showing that GCAPs ablation substantially delays 
retinal degeneration in the rd3 mouse model. While preservation of the retinal morphology is not 
accompanied by restoration of visual function, it is very revealing of the molecular mechanisms that 
link the lack of functional RD3 with photoreceptor cell death, and may assist at designing therapies 
to expand the window for gene therapy intervention in LCA12 patients. 
 
We first confirmed all the previously reported manifestations of the phenotype of the rd3 mice (S. 
Azadi, Molday, and Molday 2010), with further attention to meaningful details. RetGC1 levels are 
drastically reduced in rd3 retinas as reported, but can still be detected, and are estimated at ~12% of 
the wild-type levels in rd3 mice at p20 (Fig 19C). RetGC1 is retained at proximal cell compartments, 
mostly at the inner segment and perinuclear regions (Fig 19D and Fig 23). GCAP1 and GCAP2 
levels are reduced in rd3 mice to ~37 and ~42% of wild-type levels. Although mostly retained at the 
inner segment as previously reported (S. Azadi, Molday, and Molday 2010), traces of RetGC1, GCAP1, 
and GCAP2 are also observed at the outer segment layer (Fig 19D), explaining why rd3 mice elicit 
bigger ERG responses than rd3/rd3 GCAPs-/- mice (Fig 22). 
 
The rd3 strain of mice showed a fast rate of retinal degeneration, going from approximately ten rows 
of photoreceptor nuclei at p20 to approximately five rows at p44. GCAPs ablation substantially 
slowed down retinal degeneration, so that at 8 months of age rd3/rd3 GCAPs-/- mice still retained 
five rows of photoreceptor nuclei. Therefore, the loss of RD3 still caused cell death in the absence of 
GCAPs, but at a substantially slower rate. We infer that: (i) the loss of RD3 causes an initial insult, 
with its origin in the closure of CNG-channels and the ensuing chronic decrease in [Ca2+]i; and (ii) the 
GCAP proteins mediate/amplify the response to this initial insult.  
 
At a molecular level we show that >75% of GCAP2 in rd3 mice is phosphorylated and therefore in 
its Ca2+-free state (Fig 24A-B), which is indicative of low [Ca2+]i at rd3 photoreceptor cell somas. Both 
GCAPs would therefore be in their Ca2+-free, guanylate cyclase activator state at photoreceptor cell 
somas of rd3 mice, where they result in cellular damage. How would GCAPs induce damage in this 
context? We envision two possible pathways, sketched in our proposed model in Fig 28 (see below). 
  
First, as proposed by Dizhoor et al. (Dizhoor, Olshevskaya, and Peshenko 2019) Ca2+-free GCAPs 
could, in the absence of RD3, stimulate RetGCs and promote constitutive cGMP synthesis at the 
inner segment, where it would result in toxicity. Dizhoor’s demonstration that RD3.GFP expressed 
as a transgene in rods localizes to the inner segment compartment (Dizhoor, Olshevskaya, and 
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Peshenko 2019) supports RD3 proposed role of silencing RetGCs while at the inner segment 
(Peshenko, Olshevskaya, Azadi, et al. 2011). Dizhoor et al. also bred the rd3 mice to GCAPs−/− mice 
and reported the retinal morphological rescue, interpreting the outcome as a demonstration of the 
importance of cyclase silencing at the inner segment for photoreceptor viability.  
 
While we believe that other scenarios cannot be discarded at this point, we consider our data to be 
consistent with Dizhoor’s interpretation. We here show that the levels of RetGC in rd3 mice are ~12% 
of the wild-type levels, that are present at the inner segment layer. By showing that GCAP2 is mostly 
phosphorylated, we can infer that GCAPs are in their Ca2+-free form. Although 75% of the GCAP2 
present in rd3 mice (reduced to 42% of GCAP2 wild-type levels) is phosphorylated and bound to 14-
3-3 and therefore not free to bind the cyclase, there is still ~10% of GCAP2 (referred to wild-type 
GCAP2 levels) that could bind the cyclase and activate it in a constitutive manner. Constitutive 
synthesis of cGMP would therefore rely on ~12% of the wild type levels of RetGC and ~10% of 
GCAP2, which is apparently low. However, constitutive synthesis of cGMP at the inner segment 
compartment of cones has been shown to be very toxic and the basis of the physiopathology in mouse 
models of achromatopsia caused by null mutations in cone CNG-channel subunits CNGA3 and 
CNGB3. In these models, activation of cGMP-dependent protein kinase (PKG) alters ER ionic 
homeostasis causing ER stress (Ma et al. 2015a; Thapa et al. 2012; Butler et al. 2017).  
 
Actually, we here show that GCAPs mediate damage by activating ER stress-mediated apoptosis, by 
demonstrating CHOP induction as well as caspase 3 and PARP1 cleavage in rd3 mice that are 
prevented in rd3/rd3 GCAPs-/- mice (Fig 26). Nevertheless, evidence of cGMP synthesis specifically 
at the inner segment compartment and/or PKG involvement is still missing in the rd3 model and will 
require further investigation. An intriguing thought, assuming that preventing RetGC activity at the 
inner segment is critical for photoreceptor’s viability, is that GCAP2 phosphorylation and 14-3-3 
binding might serve as an additional mechanism to prevent cyclase activation in this compartment.  
 
Whether GCAP1 is phosphorylated is not known, and will require further investigation. However, it 
is Guca1b gene encoding GCAP2 that was identified as a modifier gene of the rd3 mouse phenotype 
(Danciger et al. 2008), and GCAP2 expression that was downregulated in rd3 mice (R. S. Molday and 
Cheng 2013). 
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A second putative pathway of damage involves the conformational instability of Ca2+-free GCAP2, 
manifested by its high tendency to aggregate when expressed in bacteria (Hoyo et al. 2014). We have 
previously shown that a form of GCAP2 locked in its Ca2+-free form expressed as a transgene in rods 
is retained at the inner segment compartment by phosphorylation and 14-3-3 chaperone binding, 
leading to a fast retinal degeneration (Hoyo et al. 2014). EF−GCAP2 toxicity occurs in the presence 
of RD3 silencing the cyclase. One possibility would be that the Ca2+-free form of GCAP2 formed 
toxic protein oligomers, with 14-3-3 binding serving as a protective role by preventing this formation. 
In this manner, GCAP2 could cause damage in a similar way as how α-synuclein contributes to 
Parkinson’s disease (Yacoubian et al. 2010; Plotegher et al. 2014). The instability of Ca2+-free GCAP2 
is also reflected in its high affinity for the HSP90 dimer observed in pull-down assays (Fig 24C), that 
raises the possibility that Ca2+-free GCAP2 under chronic low [Ca2+]i may trigger the heat shock 
response. 
 
Figure 28. Sketch summarizing 
the mechanisms that likely 
contribute to the physiopathology 
of rd3 mice and LCA12 patients. 
The lack of RD3 represents an 
immediate insult for photoreceptor 
cells by causing chronic 
hyperpolarization and chronic low 
[Ca2+]i due to the closure of CNG-
channels by the severe drop in cGMP 
synthesis. This chronic low 
[Ca2+]i likely represents the original 
insult causing damage to the cell. 
Chronic low Ca2+ cause the GCAP 
proteins to remain permanently in 
their Ca2+-free conformation. 
GCAPs in their Ca2+-free guanylate 
cyclase activator state in the absence 
of RD3 may stimulate cGMP 
synthesis at the inner segment, 
ultimately causing ER stress and ER 
stress-mediated apoptosis. Ca2+-free 
GCAP2 conformational instability 
may also ultimately induce ER stress. 
GCAP2 phosphorylation and 14-3-3 
binding might serve as a protective 




A few other proteins were selectively identified as putative interactors of GCAP2-P, like the 
cytoskeletal regulator Ndel1, nuclear-distribution gene E homolog like-1 protein, a modulator of 
dynein that has been involved in securing the selectivity of cargo delivered to axons (Kuijpers et al. 
2016), and at inhibiting primary cilia assembly in proliferating cells (Inaba et al. 2016). Ndel1 would 
be a putative candidate to mediate the morphological disc alterations observed in rd3 mice. Future 
experiments will test this hypothesis, and aim at confirming other putative interactions. 
 
Finally, by expressing RD3.V5 as a transgene in the rods of rd3 mice, we report that RD3 localizes 
mainly to photoreceptor inner segments, although it also distributes to some extent to the outer 
segments (Fig 23). The outer segment RD3 signal might not have been so apparent in the recent 
study of RD3.GFP localization in rods (Dizhoor, Olshevskaya, and Peshenko 2019) due to the protein 
modification by the much bigger tag. RD3 main localization to the inner segment provides some 
insight into the mechanisms underlying trafficking of the cyclase to the cilium. The cyclase is probably 
transported in two stages: a first stage, in which it is escorted and silenced by RD3 to the base of the 
connecting cilium; and a second, in which the GCAPs displace RD3 to bind the cyclase, previous to 
RetGC/GCAPs complex entry into the outer segment compartment. Future studies will be addressed 





















3.3 RESULTS CHAPTER 3. CHARACTERIZING THE IN VIVO MODULATION OF 






























   
 
   97 
 
3.3.1 Contributions 
The technical execution of the retinal phosphoproteome analysis was carried out by Eduard Sabidó 
and Guadalupe Espadas from the CRG/UPF Proteomics Unit.  Ruben Martínez-Buey from the 
University of Salamanca provided us with the bacterial expression vectors for the retinal spliced 
isoforms of hIMPDH1, and key technical advice on how to purify the enzymes for enzymatic assays.  
David Justel in Rubén Martínez-Buey´s laboratory performed the GDP/GTP inhibitory assay.  Isidre 
Casals and Esther Miralles at the Separation Techniques platform at the UB (CCiT-UB, Parc Cientific) 
were instrumental at helping us to set up a protocol for determination of nucleotides by High Pressure 
Liquid Chromatography (HPLC). I was able to run the retinal extracts and analyze the chromatograms 
in their facility under their supervision. Alexandra Junza and Oscar Yanes at the Institut d´Investigació 
Sanitària Pere Virgili (IISPV) at the Hospital Universitari Sant Joan de Reus performed the analysis of 
nucleotides by mass spectrometry, and I performed the quantitation.  The electroretinogram dark-
adapted responses were recorded in the laboratory of Pedro de la Villa, at the University of Alcalá de 
Henares, where I had the chance to stay for a week and learn how to analyze the recordings.  A former 
PhD student from our lab, Santiago López-Begines, contributed to the project at its early stages, by 
cloning and expressing the bovine isoforms of IMPDH1. I was very fortunate to count with the 
assistance of Jordi Andilla and Pablo Loza from the Institute of Photonic Sciences with image 
acquisition and analysis at the confocal microscope.  
My contribution to this chapter was: i) the obtention of the fresh and rigorously processed bovine 
retinal dark/light samples for the phosphoproteomic study; ii) the in vivo metabolic labeling analysis 
of IMPDH1 in mice; iii) the isoelectrofocusing analysis of IMPDH1 phosphorylation in dark/light-
adapted living mice; iv) the cloning, bacterial expression and purification of the bovine/human 
IMPDH1 isoforms and its mutants (disease mutant collection; and phosphomimic/phosphoKO 
collection) for enzymatic assays; v) most of the IMPDH1 enzymatic assays; vi) the in vitro 
phosphorylation assays; vii) the immunolocalization of IMPDH1 at different light conditions, and 
analysis of the spicula.  I significantly contributed to experiment design, conceptualization, statistical 
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3.3.2 Rationale  
 
Mutations in inosine monophosphate dehydrogenase 1 (IMPDH1), the enzyme responsible for the 
first and rate-limiting step in de novo GTP synthesis, are associated to severe forms of inherited 
blindness. At least nine mutations have been associated to the RP10 form of autosomal dominant 
retinitis pigmentosa, that primarily manifests as night blindness and gradually progresses to loss of 
central vision: R224P (Kennan et al. 2002a); D226N (Bowne et al. 2002); R231P (Grover, Fishman, 
and Stone 2004); T116M, V268I, G324D, H372P (Bowne, Sullivan, et al. 2006); K238E (Wada et al. 
2005) and K238R (Wada et al. 2005).  Together they account for about 1% of adRP cases (Sullivan et 
al. 2013). IMPDH1 mutations have also been associated to rare autosomal dominant Lebers 
Congenital Amaurosis (adLCA), characterized by nearly complete blindness from early age: R105W 
and N198K (Bowne, Sullivan, et al. 2006). Despite the ubiquitous nature of guanine nucleotide 
synthesis, clinical manifestations of IMPDH1 mutations are limited to the retina, for reasons that are 
not yet understood.   
RP10 mutations are allegedly “gain-of-function” mutations, given that IMPDH1 knock-out mice 
present only a mild retinopathy (Aherne et al. 2004). Mutations do not directly affect IMPDH1 
catalytic activity in vitro (Mortimer and Hedstrom 2005; D. Xu et al. 2008; Aherne et al. 2004). 
IMPDH1 capacity to bind single-stranded nucleic acids (Mortimer et al. 2008; Hedstrom 2008) and 
IMPDH1 tendency to aggregate (Tam et al. 2008; Aherne et al. 2004) have been suggested to 
contribute to the pathophysiology.  
More recently, a structural study has provided a new framework to interpret the effect of mutations, 
by revealing the allosteric inhibition of eukaryotic IMPDHs by GDP/GTP binding to the Bateman 
domain (Buey et al. 2015). GDP/GTP binding sites at the Bateman domain overlap with several of 
the residues mutated in adRP10 (Buey et al. 2015).  
The competition of adenine or guanine nucleotides at the nucleotide binding sites of the Bateman 
domain controls a conformational switch that modulates catalytic activity (Buey et al. 2015). ATP 
binding induces the formation of extended octamers that are fully active; while GTP binding induces 
the formation of compacted octamers with significantly reduced catalytic activity (Labesse et al. 2013; 
Buey et al. 2015).  Most of the residues in hIMPDH1 associated to blindness map at or in the proximity 
of GDP/GTP binding sites and diminish GDP/GTP negative allosteric control of human IMPDH1 
in vitro (Buey et al. 2015).  
IMPDH can form macromolecular filamentous structures in mammalian cells (spicules or 
cytoophidia) under conditions that require higher IMPDH activity to keep with GTP demand (Liu 
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2010; Chang et al. 2015; Aughey and Liu 2016; Keppeke et al. 2018), like at high rates of proliferation, 
or Gln/Ser/folate-metabolite deficiency (Calise et al. 2016; Chang et al. 2015; Keppeke et al. 2018). 
Formation of these reversible fiber-like subcellular structures is believed to transiently boost IMPDH 
activity (Chang et al. 2015; Keppeke et al. 2018).  Once the guanine levels are reestablished, GTP itself 
promotes disassembly of the “cytoophidia-like” structures (Calise et al. 2014).   
Reversible formation of IMPDH fibers could be recently induced in vitro from recombinant proteins, 
revealing that most adRP10 IMPDH1 mutants form filaments but fail to disassemble them due to 
their inability to sense GTP at the Bateman domain (Fernández-Justel et al. 2019).  
Importantly, structural and functional characterization of IMPDHs has largely been performed on 
recombinant proteins expressed in E Coli.  Little is known about the relevance of IMPDH1 catalytic 
activity in photoreceptor cells of the retina or its physiological regulation in vivo.  
This study aimed to study IMPDH1 role in photoreceptor cells and its regulation in vivo in dark/light 
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CHARACTERIZING THE IN VIVO MODULATION OF IMPDH1 IN DARK/LIGHT 
AND ITS EFFECT ON THE LIGHT RESPONSE 
 
3.3.3 Dark/light-dependent phosphorylation of retinal IMPDH1. 
 
Phosphoproteomic analysis of dark- and light-adapted bovine retinas (see methods) revealed three 
phosphorylation sites in IMPDH1: Thr159/Ser160, Ser416 and Ser477 (Fig 29A-B).  One phosphorylation 
event was detected at the Bateman domain, assigned to Thr159 or Ser160 with a 50:50 probability 
[numbering corresponding to canonical bovine IMPDH1 (b) of 514 aa]. The peak areas of the 
precursor ions for the monophosphorylated peptide 154-169 in 3 dark (1-3) and 3 light (4-6) biological 
replicates revealed a light preference of the observed phosphorylation event (light/dark log2 fold 
change =1.67;  p=0.03*). Residues Thr159 and Ser160 map within the CBS1 (cystathionine b-synthase) 
sequence of the Bateman domain, in close proximity to N198, R224 and D226 mutated in adLCA or 
adRP10 (Fig 29C-D).  
 
A second phosphorylation event was detected at residue Ser416, but was observed to a similar extent 
in dark and light conditions (light/dark log2 fold change = 0.33; p= 0.08).  This residue maps at the 
mobile flap in the catalytic domain (residues 412-432, shown in green in Fig 29E), required in the 
conformational rearrangement of IMPDH1 during the hydrolysis step (E-XMP* to XMP) (Hedstrom 
2009).   
 
The third phosphorylation event was detected at residue Ser477, which occurred preferentially in the 
dark-adapted state although statistical significance was not reached (light/dark log2 fold change= -
0.50; p= 0.19).  Ser477 maps to a region that has not been involved in the catalytic process.   
Remarkably, all the phosphorylated residues are conserved in mammalian IMPDHs (Fig 29F). 
 
The light/dark log2 fold change of phosphopeptides representative of well characterized light- or 
dark-dependent phosphorylation events in rhodopsin (Wilden 1995; K. A. Lee et al. 2002; A Mendez 
et al. 2000), phosducin (R. H. Lee, Brown, and Lolley 1990; B. Y. Lee, Thulin, and Willardson 2004) 
and GRK1 (R. H. Lee, Brown, and Lolley 1982; Palczewski et al. 1992) are shown (Fig 30) as a quality 




Figure 29. IMPDH1 phosphorylation sites identified in a phosphoproteomic study of dark/light-
adapted bovine retinas. (see figure legend in next page) 
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Figure 29. IMPDH1 phosphorylation sites identified in a phosphoproteomic study of dark/light-
adapted bovine retinas. A. Mass spectra of identified IMPDH1 phosphorylated peptides.  Residue numbers 
refer to the canonical bovine isoform b (514 aa) [Uniprot A0JNA3]. For peptide 154-169 only one 
phosphorylation was detected, that could not be unequivocally assigned to Thr159 or Ser160. Phosphorylation at 
peptides 413-422 and 475-480 were at Ser416 and Ser477, respectively. B. Peak areas of the precursor ions 
corresponding to the identified phosphopeptides of IMPDH1.  Samples 1-3 are dark-adapted retinas; 4-6 light-
exposed retinas (biological replicates).  Thr159/Ser160 are preferentially phosphorylated in light, Ser477 in dark, 
and Ser416 indistinctly. C. Ribbon diagram of IMPDH in its tetrameric conformation [pdb: 1jcn], showing the 
TIM barrel catalytic domain in coral, and the regulatory Bateman domain with two copies of cystathione beta-
synthase (CBS) sequence in slate blue (CBS1) and green (CBS2). D. Monomer conformation [pdb: 1jcn] 
showing Thr159 and Ser160 at CBS1 in the Bateman domain; and Ser477 at the COOH-terminus.  Disease 
associated mutations, depicted in red, are proximal to Thr159/Ser160 (Asn198; Arg224; Asp226) or to Ser477 
(His372). E. The catalytic domain of AgIMPDH [pdb:4xfi] in coral, the mobile flap where Ser416 maps in green 
and the COOH-terminus of an adjacent monomer in blue. F. Alignment of IMPDH from T. foetus 
(prokaryotic), A. gossypii (filamentous fungus), H. sapiens, M. musculus and B. taurus IMPDH1 canonical isoforms.  





Figure 30. Dark/light fold-change of peak areas from control phosphopeptides from phosducin, GRK1 
and rhodopsin shown as a quality control of the phosphoproteomic analysis.  Mass spectra of 
phosphorylated peptides of: phosducin 72-82 peptide MSVQEYELIHK [Uniprot P19632]; GRK1 480-491 
peptide NIQDVGAFSTVK [Uniprot P28327]; and rhodopsin 326-348 peptide NPLGDDEASTT-
VSKTETSQVAPA [Uniprot P02699]. For each peptide, the peak area of the precursor peptide ion was 
extracted and plotted for each sample.  Samples 1-3 are dark-adapted retinas; 4-6 light-exposed retinas 
(biological replicates). Light/dark log2 fold-change values were: phosducin Ser73 (-1.39; P=0.01); GRK1 
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3.3.4 IMPDH1 is phosphorylated in vivo at a high extent in both dark and 
light conditions 
 
To further characterize IMPDH1 phosphorylation in vivo we performed an in situ metabolic labeling 
assay. Retinas from dark-adapted mice were dissected and incubated in Locke´s buffer with 32P-
inorganic phosphate for 90 min in the dark, to allow for 32P incorporation in the ATP pool. Retinas 
were then kept in the dark or exposed to 2000 lux light for 5 min.   
 
IMPDH1 was immunoprecipitated from supernatant and membrane fractions with an anti-
bIMPDH1 pAb generated against the canonical bovine IMPDH1b of 514aa (see results Chapter 1).  
This antibody immunoprecipitated all IMPDH1 isoforms in the murine retina (immunoblots in Fig 
31A-B).  32P-incorporation was limited to the largest and most abundant isoform in murine retinas, 
the 603/604 aa retinal-specific spliced form (autoradiographs in Fig 31A-B). Phosphorylation of 
603/604 aa IMPDH1 occurred to a high extent in dark- and light-retinas, both in the soluble and 
membrane fractions. Phosphorylation of IMPDH1 in the soluble fraction was slightly skewed towards 
the light condition (P=0.18); while in the membrane fraction toward the dark condition (P=0.30), 
with no statistical significance, Fig 31C.   
 
To obtain insight into the predominant phosphorylated species in dark and light, immunoprecipitated 
IMPDH1 from 32P-labeled retinas was resolved by isoelectrofocusing (IEF), Fig 31D. Three abundant 
species were detected in dark and light conditions: unphosphorylated IMPDH1-603/604aa, 
monophosphorylated IMPDH1-603/604aa-1P, and diphosphorylated IMPDH1-603/604aa-2P.   
The same ratio of IMPDH1-0P, -1P and -2P was observed by IEF separation of retinal homogenates 
from living mice that were either dark-adapted or exposed to 2000lux light for 5, 20 and 60 min.  
Measured isoelectric points (IP) of IMPDH1-603/604aa-0P, -1P and -2P correlated well with IP 
predicted values, Fig 31E. 
 
Taken together our results show that the most abundant isoform of IMPDH1 in the retina, which is 
a retina-specific spliced form, is phosphorylated to a high extent in vivo. Nearly two thirds of the 
protein are phosphorylated in vivo, with mono- and di-phosphorylated forms being present but 
monophosphorylated species predominating under dark or physiological light conditions. Dark/light 





Figure 31.  The retinal spliced variant of IMPDH1 is phosphorylated to a high extent in intact retinas.  
A. Immunoblot of IMPDH1 immunoprecipitated from soluble fractions of 32P-labeled retinas, and 
corresponding autoradiograph. 32Pi incorporation was observed at mIMPDH1-603/604 aa isoform, in both 
dark and light conditions (autoradiograph), 3 biological replicates. B. Immunoblot and autoradiograph of 
IMPDH1 immunoprecipitated from membrane fractions. 32Pi incorporation was observed at IMPDH1-
603/604 aa, at dark and light conditions, 2 biological replicates. C. Average intensity of 32P-labeled 603/604 aa 
bands normalized by immunoblot signal, for dark and light samples. IMPDH1 is substantially phosphorylated 
under dark and light, both in soluble and membrane fractions. D. Isoelectrofocusing (IEF) of 
immunoprecipitated IMPDH1 samples from 32Pi-labeled retinas revealed the presence of mono- and di-
phosphorylated forms of IMPDH1-603/604 aa in dark and light. Observed bands were: mIMPDH1-603/604-
0P; mIMPDH1-603/604-1P and mIMPDH1-603/604-2P. Please note that the di-phosphorylated form 
incorporates 2 radiolabeled phosphates per protein molecule, so that the band intensity of the di-
phosphorylated form in the autoradiograph reflects twice its abundance. E. IEF of retinal homogenates 
(soluble fractions) from 16 hrs dark-adapted mice or mice that were exposed to 5, 20 or 60 min of 2000 lux 
light after pupil dilation. Measured isoelectric points (IP) of bands correlated well with theoretical IP for the 
mIMPDH1 isoforms indicated.  
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3.3.5 In vitro effects of phosphorylation on IMPDH1 catalytic activity  
 
While IMPDH1-603/604 aa is the prevalent isoform in murine retinas, two isoforms predominate in 
human retinas: IMPDH1a (546 aa) and IMPDH1g (595 aa) (Bowne, Liu, et al. 2006), with IMPDH1a 
(546aa) being the most abundant. In order to study the effect of phosphorylation on the catalytic 
activity of IMPDH1, recombinant human IMPDH1a (546 aa) and its individual phosphomimetic 
mutants (Thr (T) or Ser (S) substituted by Asp (D)) were expressed in bacteria and purified to 
homogeneity.  
 
The S160D-hIMPDH1a and S477D-hIMPDH1a  mutants showed very similar reaction kinetics and 
Michaelis-Menten parameters as the wildtype protein (Fig 32A-B), indicating that phosphorylation at 
these sites were unlikely to affect the Km or Vmax of the enzyme. However, the S416D-hIMPDH1a  
mutant showed a slower reaction. This result was not surprising, given that Ser416 maps at the mobile 
flap that determines the open or closed conformation of the enzyme during enzyme catalysis 
(Hedstrom 2009).  
 
Figure 32.  Effect of phosphomimetic substitutions on enzymatic activity.  A.  Reaction kinetics of 
wildtype; S160D; S416D and S477D mutants of hIMPDH1a (546 aa). Assays were performed with 2 µg of 
recombinant protein in assay buffer with 125 µM IMP and 0.5 mM NAD+. Absorbance at 340 nm was used 
to monitor NADH production at 6 min intervals. Results represent the mean and S.E.M of three independent 
experiments with three technical replicates each. S160D and S477D mutants showed wildtype kinetics; while 
S416D mutant showed delayed kinetics. B. Michaelis-Menten plots for the wildtype and phosphomimetic 
mutants.  NADH production plotted to concentration of IMP. Assays were performed at 0.5 mM NAD+ and 
varying concentrations of IMP, from 0 to 500 µM. NADH production (nmol/min/mg enzyme) was obtained 
from DAbs/Dt by applying Lambert- Beer’s law (eNADH340nm=6220 M-1cm-1, l=0.58 cm), and results were 
fitted to Michaelis-Menten curves with GraphPad Prism [Mean and S.E.M of three independent experiments, 




We further confirmed the effect of Ser416 phosphorylation by measuring the effect on kinetics and 
IMP dependence of the S416D substitution in main hIMPDH1 isoforms: hIMPDH1b (514 aa) and 




Figure 33. Effect of S416D phosphomimetic substitution on enzymatic activity.  A. Main splice variants 
of hIMPDH1:  hIMPDH1a (546 aa) and hIMPDH1g (595 aa) contain extended sequences at the COOH- 
terminal (546 aa) or both the NH2- and COOH-terminal (595 aa). B. S416D mutant recombinant proteins were 
rigorously normalized to their wildtype counterparts preceding enzymatic analysis. C. Effect of S416D 
substitution on the Michaelis-Menten kinetics of hIMPDH1b (514 aa); hIMPDH1a (546 aa); and hIMPDH1g 
(595 aa) isoforms. Kinetic parameters were:  hIMPDH1b (514 aa) [Vmax=0.099±0.004, Km=7.62±1.69]; 
S416D/hIMPDH1b (514 aa) [Vmax=0.084±0.002, Km=19.13±1.75]; hIMPDH1a (546 aa) [Vmax=0.152±0.002, 
Km=20.72±1.32]; S416D/hIMPDH1a (546 aa) [Vmax=0.046±0.002, Km=59.59±9.74]; hIMPDH1g (595 aa) 
[Vmax=0.093±0.003, Km=12.86±2.18]; S416D/hIMPDH1g (595 aa) [Vmax= 0.049±0.001, Km=13.95±1.71]. 
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Recombinant proteins were rigorously normalized by Bradford and SDS-PAGE prior to the 
enzymatic assays, to ensure that identical amounts of proteins were used (Fig 33B). Michaelis-Menten 
kinetics of S416D-hIMPDH1b (514 aa); S416D-hIMPDH1a (546 aa) and S416D-hIMPDH1g (595 
aa) showed that S416D substitution in the mobile flap had a significant effect at inhibiting the enzyme, 
that was higher for the retinal spliced forms of 546 and 595 aa than for the canonical form (Fig 33C).  
However, because phosphorylation at this residue was similar in dark and light conditions, we believe 
that the decrease in IMPDH1 catalytic activity associated to Ser416 phosphorylation might occur in 
response to other signals such as nutritional stress, but would have an effect unrelated to dark/light 
physiological conditions (see Discussion).  
 
3.3.6 T159 and S160 phosphorylation impairs GDP/GTP regulation of 
IMPDH1   
 
It has been recently established that GTP and GDP allosterically inhibit the catalytic activity of 
eukaryotic IMPDH enzymes in vitro (Anthony et al. 2017; Buey et al. 2015; Fernández-Justel et al. 
2019). Thereby, we then tested whether phosphorylation could affect allosteric inhibition in vitro. To 
do that we assayed IMPDH activity of wild-type and phosphomimetic proteins (Thr (T) or Ser (S) 
substituted by Asp (D) or Glu (E)) in the presence of GDP and GTP.  
 
Fig 34 plots the normalized Vmax values (Vmaxapp in the presence of 2 mM GTP or GDP divided by 
Vmax  in the absence of nucleotide) for all hIMPDH1b (514 aa) wild-type and phosphomimetic mutants.  
As expected, phosphorylation at Thr159/Ser160 had an obvious effect on the allosteric inhibition of 
IMPDH1 by GDP/GTP in vitro (Fig 34A). As Thr159 phosphomimetic mutants affected both GDP 
and GTP inhibition we then assayed the catalytic activity of the T159E/D at different concentrations 
of GDP (Fig 34B) and GTP (Fig 34C). K1/2 values for enzyme inhibition were around 5-fold higher 
in T159D than for the wild-type (Table 6).   
 
Enzyme kinetics data were fitted by non-linear regression to the Michaelis-Menten equation to derive 
Vmax and KM values. The Vmax values versus GTP/GDP concentration were then adjusted to a sigmoidal 






Figure 34.  Effect of phosphomimetic mutations on GDP and GTP allosteric regulation of IMPDH1 
activity. A. Vmaxapp/Vmax for the indicated phosphomimetics mutants. B. Vmaxapp/Vmax for the T159E and 
T159D mutants, as a function of GDP concentration.  C. Vmaxapp/Vmax for the T159E and T159D mutants, as 
a function of GTP concentration. Results shown are representative of two independent experiments.  
Table 6:  K1/2 values (mM) for GDP and GTP 
 GDP GTP 
HsIMPDH1 b (514aa)-WT 0.45 ± 0.03 0.97 ± 0.1 
HsIMPDH1 b (514aa)-T159D 2.19 ± 0.2 ≈ 6 
 
K1/2 values are given in mM units (Mean ± SD), and are representative of two independent 
experiments. 
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Taken together our results show that phosphorylation at Thr159/Ser160 desensitizes the enzyme to the 
allosteric inhibition exerted by GTP and GDP. Given the light-dependence of this phosphorylation 
event, these results predict an activation of IMPDH1 activity upon light exposure in vivo.  
3.3.7 Photoreceptor cells present roughly equimolar levels of GTP and ATP 
in the dark and light steady-states 
 
The structural studies that uncovered the allosteric regulation of eukaryotic IMPDHs by purines 
established that ATP/ADP and GTP/GDP compete for the nucleotide-binding sites at the Bateman 
domain.  ATP/ADP and GTP/GDP have opposite effects on catalytic activity.  ATP/ADP binding 
leads to the formation of extended octamers with full enzymatic activity, while GTP/GDP binding 
induces the formation of compacted octamers with compromised enzymatic activity (Buey et al. 2015). 
 
In most cell types the ratio of ATP:GTP is between 3:1 to 5:1 (Traut 1994), and even under these 
conditions it has been proposed that IMPDHs could be partially inhibited by GDP/GTP in their 
quiescent state (Johnson and Kollman 2020).  Photoreceptor cells present GDP and GTP levels that 
are much higher than normal.  Numerous studies since the 70s have shown that the GTP pool equals 
the ATP pool in whole retinas (Biernbaum and Bownds 1979; Berger et al. 1980) and in bovine rod 
outer segment preparations (Ostroy, Svoboda, and Wilson 1990).  
 
If the ratio of ATP:GTP was 1:1 in photoreceptor cells, it would favor the GDP/GTP allosteric 
inhibition of IMPDH1, because GDP/GTP would effectively compete with ADP/ATP at nucleotide 
binding sites 1, 2 and 3 at the Bateman domain.  We therefore assessed the GTP and ATP nucleotide 
levels in whole retinas, both in the dark- and bright light steady-states (Fig 35).  We also determined 
GMP and AMP levels. Nucleotide levels were determined by high pressure liquid chromatography 
(HPLC) as well as by mass spectrometry, given that each analytical method presents unique advantages 
and limitations. 
 
First, we determined the nucleotide levels by HPLC from in situ murine retinas obtained from dark-
adapted mice, that were either kept in darkness for 5 min or exposed to bright light (2000 lux light) 
for 5 min.  Whole retinas were used to obtain nucleotide extracts.  It must be noted that although our 
nucleotide determinations are done in whole retinas, guanine nucleotide levels largely reflect 
nucleotide content in photoreceptor cells, given that photoreceptor cells account for 70% of the 
retinal cells (Curcio et al. 1990) and that it has been demonstrated that cGMP and GTP levels are 
reduced to less than 20% their values in retinas that lack the photoreceptor cell layer (rd1 mouse model 
(Du et al. 2016)).   
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Our results show that ATP and GTP levels are at about a 1:1 molar ratio both in darkness and under 
light conditions, Fig 35 and (Table 7) as previously established.  
 
Figure 35: Nucleotide levels assessed by HPLC from in situ murine retinas in the dark-steady state 
and after 5 min of bright light exposure (2000 lux). A. GMP, AMP, GTP and ATP nucleotide levels 
(pmol/retina) determined by ion-pairing high performance liquid chromatography in dark- and 5 min light- 
exposed murine retinas. Values represent the Mean + SEM of at least 4 biological replicates. Unpaired t-test 
for dark versus 5 min light: GMP (P=0.0014**), GTP (P=0.4747), AMP (P=0.075) and ATP (P=0.8768).  






One major advantage of the HPLC method is that it allows a direct comparison of the relative levels 
of the mono-, di- and tri-phosphate nucleotides. Identification of each peak is based on its retention 
time and spectral sensitivity, by comparison with individual nucleotide standards. Nucleotide 
concentrations in the extract are inferred from integration of the peaks after using individual 
concentration standards, but a glimpse at the chromatogram already conveys the relative levels of the 







GMP 183.10 ± 19.3 335.75 ± 23.4 
GTP 1197.48 ± 66.1 1131.49 ± 55.9 
AMP 233.88 ± 24.2 301.64 ± 17.4 
ATP 967.58 ± 85.3 983.97 ± 54.7 
Ratio GTP/ATP 1.24 1.15 
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Figure 36.  Representative HPLC chromatogram from a retinal extract showing the separation of 
GMP, AMP, GDP, GTP and ATP. A. Chromatogram of a mix of nucleotide standards, showing each 
nucleotide retention time and typical spectral sensitivity.  B.  Representative chromatogram of a retinal extract 
from a dark-adapted retina showing the retention time and relative abundances of the different nucleotides. 
GTP levels are > 6-fold higher than GMP levels in the dark-adapted retina. GTP and ATP present very similar 









One limitation of the HPLC analytical method, though, is that the IMP levels could not be determined. 
IMP was masked by the GMP peak under the HPLC gradient required to unequivocally separate GTP 
from ATP ((Di Pierro et al. 1995) see methods). 
 
Mass spectrometry on the other side allows the unequivocal assignment of nucleotide identity to each 
peak, but nucleotide relative levels cannot be inferred unless specific mass standards are run for each 
nucleotide of interest, which is expensive. We have also determined the nucleotide levels by mass 
spectrometry (See Fig 41, in section below).  
 
From our nucleotide determinations by HPLC we conclude that ATP:GTP are at a 1:1 molar ratio in 
darkness, and that neither their absolute levels nor their relative levels change with light. 
3.3.8 Prolonged bright light exposure of living mice causes the accumulation 
of IMPDH1 aggregates at the rod outer segment layer of the retina 
 
It has been reported that mammalian IMPDHs can form mesoscale macromolecular assemblies in 
mammalian cells, denoted as cytoophidia, when an increase in IMPDH activity is required to keep 
with GTP demand (Aughey and Liu 2016; Keppeke et al. 2018; Y. S. Ji et al. 2006; Chang et al. 2015). 
Recently it has been proposed that IMPDH1 cytoophidia are more resistant to GTP/GDP-mediated 
allosteric inhibition, which indicates that they would allow a boost of GTP synthesis when required 
(Fernández-Justel et al. 2019; Keppeke et al. 2018). 
Because the light-dependent phosphorylation of IMPDH1 pointed to enzyme activation in light, we 
reasoned that an increase in the de novo synthesis of GTP might be required to sustain the light 
response particularly under prolonged bright light exposures. We hypothesized that IMPDH1 could 
form aggregates –cytoophidia-like- under these conditions, to keep with GTP demand.   
IMPDH1 cytoophidia are not observed in the retina in mice reared in standard 12h dark/12h light 
cycles, although they can be induced and clearly detected if retinas are treated with mycophenolic 
acid (MPA) (Fig 37A) as previously reported in cells (Y. Ji et al. 2006) 
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Figure 37.  Formation of IMPDH1 spicules in intact retinas in response to mycophenolic acid-
treatment.  A.  Murine retinal sections from dark-adapted mock- or 10 µM MPA-treated retinas for 1 or 2 hrs.  
MPA inhibition of IMPDH1 resulted in the formation and accumulation of IMPDH1 spicules with time, 
particularly noticeable at the perinuclear region of photoreceptor cells at the ONL. Spicules are clearly 
appreciated at bottom panels (8.5x zoom images). IMPDH1 shown in green; PNA staining of cones in cyan 
and rhodopsin in red.  Confocal images are the average z-projections of three optical slices acquired with a step 
size of 0.13 µm.  B.  Histogram showing the number of spicules/100 µm2. Unpaired t-test for mock vs 1h 
MPA, P=0.0001***; and mock vs 2h MPA P<0.0001***, with at least 6 planes from 2 animals analyzed per 
condition. OS: outer segment, IS: inner segment, ONL: outer nuclear layer, OPL: outer plexiform layer. Scale 
bar upper panels (20 µm) and bottom panels (5 µm).  
 
In dark and cyclic light conditions IMPDH1 signal is particularly intense at the inner segment, outer 
nuclear and outer plexiform layers, and stronger in rods than cones (Fig 37A mock panel and Fig 
38A dark panel), and no spicula or cytoophidia are particularly noticeable. Strikingly, exposure of 
living mice to 2000 lux bright light after pupil dilation led to the gradual accumulation of IMPDH1 
aggregates at the rod outer segment (ROS) layer, that increased in number and size with time (Fig 
38A and C).  IMPDH1 accumulation was even more evident when mice were reared for 15 days under 





Figure 38.  Accumulation of IMPDH1 aggregates at the outer segment layer in living mice exposed 
to constant bright light. A. Murine retinal sections from dark-adapted mice or mice exposed to 2000lux-light 
for 20 min, 2 hrs or 4 hrs were immunostained for IMPDH1 (green) and co-immunostained for rhodopsin 
(red). Confocal images are average z-projections of 5 optical slices with 0.13 µm-step size. Magnified frames 
from the outer segment layer show gradual accumulation of IMPDH1 aggregates with time of bright light 
exposure. Scale bar: 20 µm upper panels; 5 µm bottom panels. B.  Retinal sections from constant dark or 2000 
lux constant light-reared mice for 15 days, immunostained for IMPDH1 (green) and rhodopsin (red). Magnified 
inner/outer segment layers show a prominent accumulation of IMPDH1 signal at the outer segment layer, 
representing 30% of the total IMPDH1 signal in the retina. A basal IMPDH1 signal is already detected at the 
outer segment layer in dark-adapted mice. Scale bar: 20 µm upper panels; 5 µm bottom panels. C. Size and 
number of IMPDH1 aggregates with time. Unpaired t-test for dark vs 2 hrs light, P<0.0001***; and dark versus 
4 hrs light, P<0.0001***, with at least 6 planes from 2 animals analyzed per condition D. Quantification of 
IMPDH1 signal at the outer segment layer, expressed as a fraction of total IMPDH1 in the retina. Unpaired t-
test dark versus light, P=0.0017**, three independent experiments. 
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This light-dependent accumulation of IMPDH1 aggregates at the outer segment layer (evident at 72 
hours of bright light exposure) could be reverted by a subsequent dark-adaptation of 16 hours (Fig 
39A). The levels of expression of IMPDH1 did not change in this process, indicating that the protein 
that accumulated at ROS was translocated from the inner compartments but did not result from 
transcriptional upregulation (Fig 39B- C).    
 
Figure 39.  The light-dependent IMPDH1 accumulation and aggregation at ROS is reversible by 
subsequent dark-adaptation. A. IMPDH1 aggregate formation at the outer segment layer by 72 hrs of bright 
light exposure could be reverted by subsequent dark-adaptation (16 hrs). Shown is a representative result 
observed in three independent groups of mice. Scale bar 20 µm. B. The levels of murine IMPDH1 (603/604 
aa and 546 aa) were not altered during bright light exposure/ subsequent dark-adaptation. Cyclic light (12 hrs 
dark/12 hrs light standard cycles), 72h BL (72 hrs of exposure to 2000 lux bright light) and 72h BL+16h dark 
(72 hrs of exposure to 2000 lux bright light followed by dark-adaptation for 16 hrs). C. IMPDH1 normalized 
to the loading control did not show noticeable changes in protein expression. Quantification from three 




Taken together our results show that IMPDH1 assembles into aggregates at the outer segment layer 
of the retina (where phototransduction takes place) during bright light exposure, accumulating over 
time. These aggregates are reverted in subsequent dark-adaptation periods. Therefore we reasoned 
that the activity of this enzyme appears to be required to sustain the light response in these conditions.  
3.3.9 Constant bright light exposure substantially increases the flux towards 
de novo GTP and ATP synthesis 
 
As already mentioned, the picture from structural studies is emerging that the cellular aggregates from 
IMPDH proteins are bundles of filaments that serve to increase GTP synthesis under conditions of 
increased GTP demand. 
 
In order to assess whether the bright light conditions that induced IMPDH1 aggregation at the outer 
segment layer correlated with an increase in IMPDH1 activity, we determined nucleotide levels both 
by HPLC (Fig 40) and by mass spectrometry in living mice after 4 hrs of bright light exposure (Fig 
41). 
 
Figure 40: Nucleotide levels in whole murine retinas from dark-adapted mice, or mice that were 
exposed to bright light for 4h.  Retinal GMP, GDP and GTP levels were determined by HPLC. Values 
represent the Mean + SEM of at least 4 biological replicates. Unpaired t-test for dark versus 4h bright light: 
GMP (P=0.0205*), GDP (P=0.0161*) and GTP (P=0.8023, ns). 
Similarly to our in situ experiment (Fig 35), the HPLC analysis showed that GMP and GDP showed 
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We then repeated the exposure on living mice to bright light under the same conditions and 
determined the nucleotides by mass spectrometry. LC-MS/MS allowed us to determine the levels of 
IMP in dark and light conditions for the first time, revealing a substantial increase in IMP levels in the 
bright light condition (Fig 41). Interestingly the mass spectrometry analysis detected the decrease in 
cGMP that follows any adaptation to a light steady-state (Barbehenn et al. 1986), as well as an increase 
in the GMP and AMP levels.  
 
These data pointed to an increase in the flux towards de novo ATP and GTP synthesis upon light 
exposure. 
 
Fig 41. Mass spectrometry (MS) determination of nucleotide levels in murine retinas from dark-
adapted mice or mice that were exposed to bright light for 4h.  Retinal cGMP, GMP, GTP, IMP, AMP 
and ATP levels are expressed in arbitrary units (peak integration at MS), normalized per µg of protein. Note 
that a direct comparison between dark and light levels is established for each nucleotide, but that no direct 
comparison can be established between different nucleotides. Points represent  individual retinas, n=12. 
Unpaired t-test of dark versus 4 hrs bright light: cGMP (p=0.024*), GMP (p=0.089), GTP (p=0.962), IMP 
(p=0.004**), AMP (p=0.002**) and ATP (p=0.176). D: dark; BL: bright light.  
 
To test whether the de novo biosynthesis of purines was enhanced upon continuous light exposure, we 
performed an in vivo fluxomic analysis by performing the same experiment following intravitreal 
injection of an stable-isotope of glycine (a precursor in de novo biosynthesis of IMP). 1 µl of 20 mM 
[13C2,15N]-Glycine was intravitreally injected to living mice immediately preceding the 4 hrs bright 
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light exposure (or 4 hrs maintenance in the dark).  Because the vitreous volume is 5 µl, the effective 
concentration of Gly* in contact with the retina was 4 mM.  Following 4 hrs of dark or bright light 
exposure, retinas were dissected and immediately frozen for mass spectrometry analysis. The levels of 
labeled Gly*, IMP*, AMP* and GMP* were then determined by MS, and expressed as a function of 
unlabeled nucleotides. The percentage of IMP*, GMP* and AMP* were then normalized by the 
percentage of Gly* (Fig 42). 
Our results showed that IMP, GMP and AMP were labeled to a substantially higher extent in the 
bright light condition that under dark-adaptation, which revealed that the flux to de novo ATP and 
GTP synthesis increased under light conditions (Fig 42).  
 
Fig 42. Incorporation of [13C2,15N]-Glycine into purine nucleotides by de novo biosynthesis in the 
retinas of mice in a period of 4 hrs in darkness (dark) or under 2000 lux light exposure (bright light). 
The levels of labelled glycine, IMP, AMP and GMP were assessed and expressed as a function of total 
nucleotide. Incorporation of [13C2,15N]-Glycine into IMP, AMP and GMP was compared in dark and light 
conditions by normalizing the percentage of labeled nucleotide to the percentage of Gly*.  Unpaired t-test of 
dark versus 4 hrs bright light: IMP (P=0.009**), GMP (P=0.0051**) and AMP (P=0.0053**).  
 
Taken together our results show that the flux to de novo synthesis of purine nucleotides increases in 
response to light. Therefore the role of IMPDH1 phosphorylation at the Bateman domain could 
be to promote and stabilize a conformation of the protein that is permissive to this increase 
in flux from IMP to GMP, GDP and GTP. Furthermore, its desensitization to GDP/GTP and 
concurrent increase in IMP levels would promote the formation of filaments (based on recent 
structural findings in vitro, (Johnson and Kollman 2020), that would further desensitize the enzyme to 
GDP/GTP inhibition. Thus, the ultimate role of GDP/GTP feedback inhibition and its release in 
light would be to adjust the enzyme conformation and activity to the overall flux of de novo purine 
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nucleotide biosynthesis in dark/light conditions. It follows that light conditions must require higher 
levels of ATP and GTP.  
To test whether de novo GTP synthesis is required to sustain the light response kinetics under 
physiological light conditions, we recorded dark-adapted responses by electroretinogram (ERG). 
3.3.10  Inhibition of IMPDH catalytic activity delays mass rod recovery in  
electroretinogram responses. 
 
Two processes that increase GTP consumption upon light exposure would be GTP hydrolysis by the 
GTPase transducin at the activation step, and GTP conversion to cGMP synthesis during recovery 
of the light response by RetGC (A Mendez et al. 2001; Burns et al. 2002b).  
 
To assess if IMPDH1 catalytic activity is required to sustain the light response (transducin activation) 
or rod mass response recovery (cGMP production by RetGC), we recorded electroretinogram (ERG) 
responses simultaneously from both eyes of mice that were injected intravitreally with an IMPDH1 
inhibitor mycophenolate mofetil (MMF) or benzamide ribose (BZM) in their right eye; or control 
physiological saline buffer in their left eye.  
 
The result of transiently inhibiting IMPDH1 on the rate of mass rod recovery after a saturating flash 
was tested using a paired-flash ERG paradigm (Lyubarsky and Pugh 1996) (Fig 43A-B). Briefly, a test 
flash was triggered [3 Cd·s/m2], and an identical probe flash [3 Cd·s/m2] was activated at different 
interstimulus times (IST) 400, 600, 800, 1200, 1500 or 2000 msec. An effect on transducin activation 
would result on a-wave diminution after the test flash, whereas an effect on RetGC activity would 
result on a-wave diminution after the probe flash.  
 
IMPDH1 inhibitors did not significantly affect the amplitude of the a-wave or b-wave of the test flash 
[3 Cd·s/m2] (Fig 43E), indicating no major effect on transducin activation.  However, a slightly effect 
on the recovery rate was detected in both BZM and MMF injected eyes (Fig 43A-B).  
 
The percentage of recovery of a- and b-wave amplitudes was plotted to interstimulus time (IST), (Fig 
43C-D).  Both BZM and MMF had a modest but statistically significant effect at delaying mass rod 
response recovery.  
 
No alterations were observed in pure cone responses (Fig 43F), and both drugs caused the 
characteristic SDS-PAGE mobility shift of the enzyme caused by drug binding (Y. Ji et al. 2006), when 
retinas were obtained 20 min after intravitreal injection (Fig 43G), which demonstrates direct binding 




Figure 43.  Effect of IMPDH inhibition on mass rod response recovery. (see figure legend in next page) 
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Figure 43.  Effect of IMPDH inhibition on mass rod response recovery. A. Simultaneous 
electroretinogram (ERG) recordings from both eyes of a mouse injected with benzamide or drug dilution buffer 
(mock), in response to a probe flash triggered at increasing interstimulus times (IST) after a test flash.  B.  
Representative raw traces from simultaneous electroretinogram (ERG) recordings from both eyes of a mouse 
injected with MMF or drug dilution buffer (mock), in response to a probe flash triggered at increasing 
interstimulus times (IST) after a test flash. C. Statistical analysis of mass rod response recovery (recovery rate 
plotted to interstimulus time, ERG paired flash paradigm) in BZM-injected eyes versus corresponding control 
eyes.  Overimposed black dashed lines are the curves obtained for control non-injected mice. Two-way 
ANOVA (mock vs benzamide injections and IST as factors) with uncorrected Fisher´s test for multiple 
comparisons, a-wave benzamide vs mock [1200 msec (P=0.0027**); 1500 msec (P=0.0004***); 2000 msec 
(P=0.0046**), 4 mice analyzed]. D.  Statistical analysis of mass rod response recovery in mycophenolate mofetyl 
MMF-injected eyes versus corresponding control eyes.  Two-way ANOVA with uncorrected fisher’s test for 
multiple comparisons, a-wave MMF vs mock [1200 msec (P=0.0002***); 1500 msec (P<0.0001***); 2000 msec 
(P=0.0132*), 7 mice analyzed]. E. Left panel: Statistical comparison of a- and b-wave amplitudes of the test 
flash in the mock-injected left eye versus the benzamide (BZM)-injected right eye in four mice.  Each mouse 
is shown in a different color.  Mean (+SD) for a-wave and b-wave of the test flash were: a-wave [MOCK: 
246.8+44.5 and BZM: 239.1+28.2]; and b-wave [MOCK: 405.0+58.5 and BZM: 395.0+73.1]. Right panel: 
Statistical comparison of a- and b-wave amplitudes of the test flash in the mock-injected left eye versus the 
mycophenolate mofetyl (MMF)-injected right eye in seven mice.  Each mouse represented in a different color.  
Mean (+SD) for a-wave and b-wave of the test flash were: a-wave [MOCK: 203.0+51.1 and MMF: 218.8+33.4]; 
and b-wave [MOCK: 318.3+58.9 and MMF: 318.2+47.3].F.  Superimposed pure-cone responses of the mouse 
in panel A. No effects on cone response were detected. G. IMPDH1 mobility by SDS-PAGE is shifted by 
both benzamide and MMF in retinal extracts from intravitreally injected eyes.  
 
Taken together our results suggest that IMPDH1 activity contributes to mass rod recovery by 
sustaining the GTP pool upon light exposure.  
3.3.11  T159 and S160 sites are phosphorylated by PKC in vitro   
 
In order to identify the kinase/s responsible for the phosphorylation of the described residues of 
IMPDH1, the human IMPDH1a (546 aa) isoform, and mutant forms with all of these 4 residues 
mutated to Gly (4KO, i.e. quadruple mutant T159G/S160G/S416G/S477G) or with individual 
phosphorylation sites restored in the 4KO (for instance, T159-only; T159T/S160G/S416G/S477G) 
were purified to perform in vitro phosphorylation assays with the kinases PKA, PKCa, CaMKII, CK 
II, PKB-Akt and AMPK. 
 
PKCa phosphorylated the wild-type but not the 4KO enzyme, and phosphorylation was only restored 
in the mutants T159-only and S160-only, showing PKCa specificity for the Thr159 and Ser160 residues 
(Fig 44A). Other kinases fail to selectively phosphorylate any of the “-only” mutants (data not shown). 
 
Given the proximity of Thr159 and Ser160 to residues that are most prevalently mutated in adRP10 and 
rare LCA at the Bateman domain, we analyzed whether Thr159/Ser160 phosphorylation was affected in 
blindness associated mutations. For this, we purified the recombinant human IMPDH1a (546 aa) 
isoform carrying individual mutations associated to RP10 (R224P, D226N, V268I and H372P) or 
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LCA (R105W, N198K), and used them as substrates for phosphorylation reactions with PKCa in vitro 
(Fig 44B). Following a 32P-densitometry analysis, our data showed that the mutations N198K and 
R224P significantly reduced phosphorylation of IMPDH1 by PKCa, whereas H372P increased the 
phosphorylation level (Fig 44C). Out of the few adRP10 mutations that do not affect GDP/GTP 
binding directly (Fernández-Justel et al. 2019), H372P enhances PKC phosphorylation, which means 
it would cause GDP/GTP desensitization also. 
 
 
Figure 44.  PKC phosphorylates Thr159 and Ser160 of hIMPDH1 in in vitro phosphorylation assays. A. 
In vitro phosphorylation assays with PKCa kinase of hIMPDH1a (546aa) ; T159G/S160G/ S416G/S477G-
hIMPDH1a (546 aa) (4KO); and forms of the protein with phosphorylation sites individually restored.  5 µg 
of each mutant were incubated with 4 µg/ml recombinant hPKCa with 1 µl of 32P-g-ATP (3000 Ci/mmol), 
for 30 min at 30oC. Samples were resolved by SDS-PAGE, exposed to an X-ray film (autoradiograph), and 
immunoblotted for IMPDH1. PKC phosphorylated hIMPDH1a (546 aa) selectively at Thr159 and Ser160.  
Results shown are representative of two independent experiments. BSA (bovine serum albumin) was used as a 
negative control. B.  In vitro PKC phosphorylation assay of hIMPDH1a (546 aa) disease mutants R105W; 
N198K; R224P; D226N; V268I and H372P. C. Average intensity of autoradiograph signal normalized by the 
immunoblot signal for blindness-associated mutations, expressed as a function of the wildtype levels. N198K 
and R224P mutations resulted in a decrease of phosphorylation [P=0.0001*** and P=0.004** versus the 
wildtype, n=3 independent experiments]; while H372P led to an statistically significant increase in 
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Therefore our results showed that sites Thr159/Ser160 at IMPDH1 are PKC substrates in vitro.  
 
To test whether PKC is the kinase responsible of IMPDH1 phosphorylation in vivo, we treated in 
situ retinas with Bisindolylmaleimide I (BM), a selective PKC inhibitor, immediately before dark- 
or light-adaptation. We reasoned that if PKC was the enzyme responsible for the light-dependent 
phosphorylation required to boost GTP synthesis during light exposure, then in the presence of 
the drug the GTP levels should drop substantially in the light condition.  
 
This is what we observed (Fig 45A). Retinas from dark-adapted mice were dissected in DMEM 
medium supplemented with glycine and serine in the dark. BM was then added to a final 
concentration of 50 nM to the “inhibitor-treated samples” and DMSO to the mock samples, and 
retinas were incubated at 37oC in a 5% CO2 incubator for 20 min in the dark. Retinas were then 
kept in the dark or exposed to 2000 lux light for 5 min, and immediately processed for nucleotide 
determination by HPLC (see methods). Whereas the GTP levels were maintained at their dark 
values in the mock retinas after light exposure; the addition of BM caused a substantial drop  in  
the GTP at the light condition (Fig 45A). Dark retinas treated with BM showed a slight but not 
significant decrease in the GTP levels also (Fig 45A).  
 
The effect of BM on the light response was tested in vivo as described above (Fig 43). Mice were  
injected intravitreally with an effective concentration of 200 nM of BM in their right eyes; or control 
physiological saline buffer in their left eyes. After 30 min of drug injection ERG responses were 
recorded using the paired-flash paradigm described above. The percentage of recovery of a- and b-
wave amplitudes was plotted to interstimulus time (IST), (Fig 45B). BM had a modest but statistically 
significant effect at delaying mass rod response recovery.  
 








































Figure 45.  In vivo effect of PKC inhibition on nucleotide levels and light response. A. Guanine 
nucleotide levels (GMP, GDP and GTP) in dark-adapted or light exposed retinas in either the presence or 
absence of a selective PKC inhibitor, Bisindolylmalemide I (BM). Each point represent the nucleotide pool 
obtained from three retinas. Unpaired t-test for GTP levels [light versus light+BM, p=0.0071**] and [dark 
versus dark+BM, p=0.0546, ns]. B. Statistical analysis of mass rod response recovery (recovery rate plotted to 
interstimulus time, ERG paired flash paradigm) in BM-injected eyes versus corresponding control eyes. 
Overimposed black dashed lines are the curves obtained for control non-injected mice. Two-way ANOVA 
(mock vs BM injections and IST as factors) with uncorrected Fisher´s test for multiple comparisons, a-wave 
BM vs mock [1.2 sec (P=0.0468*); 1.5 sec (P=0.0263*); 2 sec (P=0.0019**), 4 mice analyzed]. 
Taken together our results point to a light-dependent phosphorylation of IMPDH1 at the Bateman 
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3.3.12  Discussion 
 
In this study we report that retinal IMPDH1 is phosphorylated at up to three residues in vivo: 
Thr159/Ser160 at the Bateman domain; Ser416 at the mobile flap in the catalytic domain; and Ser477 at the 
COOH-terminus.  In the bovine system, in which calf eyes were dark-adapted in situ for 1 h and retinas 
were processed in darkness or after 5 min of bright light exposure, Thr159/Ser160 was preferentially 
phosphorylated in response to light, Ser477 in the dark-adapted state, and Ser416 indistinctly at both 
conditions (Fig 29A-B). 
Actually, isoelectrofocusing separation of retinal extracts from dark-adapted or light-adapted living 
mice revealed that > 60% of the protein is phosphorylated under physiological conditions; with the 
predominant monophosphorylated form corresponding to phosphorylated Thr159/Ser160 in the light 
state and Ser477 in the dark state (based on the mass spectrometry data); and di-phosphorylated forms 
likely reflecting slow dephosphorylation kinetics of the reciprocal site. 
 
The effect of these phosphorylation events on hIMPDH1 catalytic activity in vitro was determined in 
enzymatic assays with the corresponding phosphomimetic mutants. The S416D mutation  
significantly reduces retinal hIMPDH1 catalytic activity (Fig 33C). However, because Ser416 
phosphorylation does not appear to be regulated by light, we speculate that this phosphorylation event 
may respond to metabolic stress or nutrient deficiency (manifested in the phosphoproteomic analysis 
due to the 1 h maintenance of the retinas in Locke´s -lacking Ser/Gly- during dark adaptation), to 
direct IMP towards ATP synthesis.  In this respect, Ser416 maps at a region that resembles a consensus 
site for AMPK (Hardie 2011), although the AMPK (A2/B2/G1) recombinant human isoform did 
not recognize hIMPDH1-546aa as a substrate in in vitro phosphorylation assays in this study.  We 
believe that Ser416 phosphorylation would have a limited contribution to regulation of the enzyme by 
light in vivo under physiological conditions. 
 
S477D substitution did not have a direct effect on enzymatic activity neither on GTP allosteric 
regulation of the enzyme. Thereby, we speculate that Ser477 phosphorylation might be involved in 
other aspects of enzyme regulation in vivo: e.g. inducing filament disassembly. To this respect, a 
recently reported structure of  IMPDH2 polymers has revealed details of the interface that mediates 
cytoophidia assembly: the 12 amino-terminal residues of the canonical IMPDH2 isoform extend from 
the catalytic domain to bind into the adjacent molecule, in a shallow surface groove formed by a short 
helix (aminoacids 476-485), two beta strands (51-63), and two short loops (355-360, 379-380) 
(Johnson and Kollman 2020). Strikingly, Ser477 maps into the short helix at the IMPDH2 cytoophidia 
longitudinal contact interface, allowing us to speculate that phosphorylation of Ser477 in IMPDH1 
might disrupt cytoophidia assembly. 
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Additionally, Ser477 phosphorylation might also be implied in protein translocation from outer to 
proximal photoreceptor compartments during dark-adaptation after a period of bright light exposure, 
or regulating local IMPDH1 interactions with other proteins. Further experiments are needed to 
corroborate these hypotheses.	
 
We here demonstrate that the T159D and S160D (or T159E and S160E) substitutions increased about 
5-fold the K1/2 for GDP/GTP inhibitory allosteric regulation of the enzyme in vitro, and propose that 
light-dependent phosphorylation of these residues in vivo would effectively desensitize the enzyme to 
GDP/GTP allosteric control and increase de novo GTP synthesis.   
 
Light-dependent activation of IMPDH1 might seem at odds with the assumption in the field that 
GMP, generated from cGMP hydrolysis during light exposure, would act as a negative feedback 
regulator of purine nucleotide synthesis by inhibiting IMPDH1, 5-phosphoribosyl 1-pyrophosphate 
synthetase (PRS), and glutamine phosphoribosyl amidotransferase (GPA) (Du et al. 2016).  However, 
by performing an in vivo metabolic flux analysis of purine nucleotide synthesis in dark/light conditions 
following an intravitreal injection of a stable isotope of Glycine, we found that the de novo synthesis of 
purine nucleotides was substantially increased with light, with IMP levels nearly doubling in light 
conditions (Fig 41). We found that IMP, GMP and AMP levels all increased with light; as did Gly* 
incorporation into these nucleotides (Fig 41 and Fig 42). The overall de novo purine nucleotide 
synthesis increased in the retinas of living mice exposed to bright light. 
 
Considering these results, we believe that most of the GMP increase observed upon light exposure 
by HPLC actually reflects the light-driven overall increase in de novo purine nucleotide synthesis, rather 
than the GMP coming from cGMP hydrolysis alone. It is likely that the fraction of GMP coming 
from the hydrolysis of cGMP would be under detection by HPLC, given that cGMP itself is under 
detection by HPLC in retinal extracts (Fig 36). cGMP levels in retinal extracts have been classically 
determined by radioimmunoassay (Debora B. Farber and Lolley 1974).  
 
Eukaryotic IMPDH isoforms contain three allosteric nucleotide binding sites at the Bateman domain, 
numbered 1, 2 and 3, that can bind either adenine or guanine nucleotides.  Nucleotide binding at these 
sites promote the dimerization of tetramers, forming reversible IMPDH octamers.  Depending on 
which nucleotide binds at sites 1, 2 and 3 the dimerization results in octamers with an extended 
conformation that are active (ATP bound) or octamers in a compressed conformation that are 
inhibited (GDP/GTP-bound).  Thr159/Ser160 maps at the nucleotide binding site 1 of IMPDH1. In 
this way, Thr159/Ser160 phosphorylation by light would dramatically decrease the affinity for 
GDP/GTP for the canonical site 1 reducing IMPDH1 allosteric inhibition.  
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In most cell types the ratio of ATP:GTP is between 3:1 to 5:1 (Traut 1994).  In vitro structural studies 
predict that under homeostatic quiescent conditions -purines largely provided by the savage pathways- 
IMPDH would bind both nucleotides and remain mostly in inhibited free octamers (Johnson and 
Kollman 2020). It would be the decrease in intracellular GTP during proliferation that would allow 
the extension of the Bateman domain causing activation and transient assembly into enzymatically 
active filaments (Johnson and Kollman 2020). 
 
GTP levels in the retina are particularly high, with GTP being equimolar or higher than ATP (Fig 35 
and Table 7), consistent with previous reports in frog rod inner/outer segment suspensions 
(Biernbaum and Bownds 1979) and bovine rod outer segments (Ostroy, Svoboda, and Wilson 1990). 
 
Thereby, we propose that under dark-adapted conditions IMPDH1 would bind GDP/GTP and shift 
the equilibrium towards free octamers in compacted inhibited conformation (GDP/GTP imposing 
negative feedback on IMPDH1 activity).  Upon light exposure, phosphorylation at Thr159/Ser160 would 
dramatically decrease the affinity for GDP/GTP, allowing the extension of the Bateman domain and 
promoting activation of the enzyme.  The loss of GDP/GTP sensing capacity would also -based on 
structural models, (Johnson and Kollman 2020)- be expected to induce the assembly of extended 
octamers into enzymatically active filaments. The gradual accumulation of these filaments upon 
constant light exposure would yield the aggregate structures that we observe at the rod outer segment 
layer (Fig 38 and 39).   
 
IMPDH subcellular aggregates are a landmark of cells or tissues with increased GTP demand and/or 
circumstances of metabolic GTP deficiency that require stimulation of GTP biosynthesis  (Aughey 
and Liu 2016; Keppeke et al. 2018; Y. S. Ji et al. 2006; Chang et al. 2015).  A recent in vivo study has 
shown, for instance, that IMPDH1 formation of filaments is inherent to T cell activation and 
proliferation, triggered at a post-translational level by NFAT or mTOR signaling, and serves to 
increase guanine nucleotide levels (Duong-Ly et al. 2018). We therefore propose that the accumulation 
of IMPDH1 aggregates at the outer segment would serve to increase the GTP synthesis locally. 
 
Our determinations of Gly* incorporation into IMP*, GMP* and AMP* performed by fluxomic 
analysis revealed an increase in the flux towards the de novo synthesis of purine nucleotides in response 
to light. These results are consistent with a major demand of GTP by photoreceptor cells in light 
conditions.   
 
The fact that light-dependent IMPDH1 aggregates accumulate at the outer segment layer suggests 
that light increases GTP demand due to phototransduction. In light conditions GTP at the outer 
segment would be consumed in its conversion to GDP by transducin GTPase, and to cGMP by 
guanylate cyclase. Our electroretinogram recordings, performed simultaneously from both eyes of 
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mice injected with an IMPDH inhibitor or control saline buffer, showed no inhibitor effects on the 
size of the test flash responses (Fig 43E), discarding a noticeable effect of IMPDH inhibition on 
activation of the light response.  However, inhibiting IMPDH1 caused a delay in mass rod response 
recovery, that was modest but statistically significant (Fig 43A-D).   
Thereby, we conclude that de novo GTP biosynthesis contributes to cGMP replenishment during the 
recovery phase of the light response, even if cGMP can be substantially sustained by the salvage 
pathways. 
 
In this respect, retinal GTP levels upon light exposure were reported to be maintained when it was 
living mice that were exposed to light, or in situ retinas kept in supplemented tissue culture medium 
(with glycine and serine), like in Du et al. 2016 study (Du et al. 2016) and this study (Fig 35, Table 7, 
Fig 40 and Fig 41). In contrast, reports of light causing a large decrease in GTP come from 
determinations performed in isolated ROS/RIS preparations or retinas kept in Ringers, that cannot 
sustain one-carbon metabolism (Biernbaum and Bownds 1979; Salceda et al. 1982).  
 
According to this model it might seem surprising that Impdh1-/- mice display only a slowly 
progressive retinal degeneration.  However, despite maintenance of the retinal structure, these mice 
present gradually diminished ERG responses from normal at 5 months to nearly extinguished at 13 
months of age (Aherne et al. 2004). Furthermore, compensatory changes like upregulation of 
IMPDH2 cannot be excluded in this chronic scenario.      
 
We here demonstrate that the light-dependent phosphorylated residues Thr159 and Ser160 in retinal 
hIMPDH1 were selective in vitro substrates for PKCa kinase; but not for the other kinases tested 
[PKA, CamKII, CKII, PKB-Akt and AMPK].  We also show that treatment of in situ retinas with a 
PKC inhibitor (bisindolylmaleimide I (BM)) led to a noticeable decrease of GTP retinal levels upon 
light exposure (Fig 45A); and that in vivo PKC inhibtion had an effect on the rate of recovery responses 
(Fig 45B).  We know from our phosphoproteomic analysis that the phosphorylation events that prime 
PKCa occur in the retina in response to light (Thr500, Thr641 and Ser660 (Keranen et al. 1995)).  
Therefore, we propose a model in which light triggers a signaling pathway that activates PKCa, that 
in turn phosphorylates IMPDH1 at the Bateman domain, desensitizing the enzyme to GTP/GDP 
inhibition.  
 
Our proposed model that GDP/GTP allosteric regulation of IMPDH1 is controlled by 
phosphorylation in vivo to adapt GTP synthesis to the illumination conditions supports previous 
hypothesis that IMPDH1 mutations would cause the pathology by resulting in higher than normal 
IMPDH1 activity and/or by forming irreversible filaments.  Abnormally high IMPDH1 activity could 
conceivably result in abnormally high cGMP synthesis, which is one of the well-known causes of 
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photoreceptor cell damage (Olshevskaya et al. 2004; Woodruff et al. 2007; Paquet-Durand et al. 2009; 
Trifunović et al. 2010; Sothilingam et al. 2015). On the other hand, the formation of filaments –in 
moments of sporadic bright light exposure in the natural world- would be reversible in healthy 
individuals, but irreversible in adRP10 patients by their impaired capacity to sense GDP/GTP levels.  
 
This could result in the gradual accumulation of protein aggregates that would eventually turn toxic, 
in line with the reported compromised stability of IMPDH1 mutants when recombinantly expressed 
(Aherne et al. 2004) and their high tendency to aggregate in vivo (Tam et al. 2010). Most IMPDH1 
mutations in adRP10 and adLCA, including the mutations N198K, R224P and D226N analyzed in 
this study, desensitize the enzyme to GDP/GTP allosteric inhibition (Buey et al. 2015). 
 
Interestingly, we here show that out of the few IMPDH1 mutations that do not significantly reduce 
GDP/GTP allosteric inhibition directly, like R105W, V268I and H372P, mutant H372P resulted in 
abnormally high phosphorylation at Thr159/Ser160 by PKCa in vitro (Fig 44B-C).  This means that the 
H372P mutation would ultimately result in desensitization of the enzyme to GDP/GTP allosteric 
inhibition as well, even if H372P mutation would do it indirectly.  
 
This study provides key insights into the complex IMPDH1 regulation in the retina, and proposes 
that phosphorylation-controlled GDP/GTP allosteric regulation of the enzyme plays an important 
role in vivo by serving to adjust the rate of de novo GTP synthesis to illumination conditions.  We 
propose that IMPDH1 mutations lead to retinal dystrophies by disrupting this mechanism of control.  
This study calls for the development of adRP10 and rare adLCA animal models in which to test this 
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GLOBAL DISCUSSION AND FUTURE PERSPECTIVES 
4.1 Role of GCAPs as damage mediators in the rd3 mouse model of 
LCA12 
Our study on rd3 mice has established that the calcium sensor protein GCAPs mediate the 
physiopathology in LCA12.  It is the Ca2+-free conformational state of GCAPs that trigger a cell death 
signal, so we can state that GCAPs act as sensors of the chronic low [Ca2+]i that results from RD3 
deficiency. 
There are many other genes that when mutated lead to chronic low [Ca2+]i, the so-called “light-
equivalent” disorders (Table 4, introduction).  One of the future lines of study should be testing 
whether GCAPs are generic “light-damage mediators”, involved in the physiopathology of most of 
these disorders. These disorders could include:  i) mutations in rhodopsin kinase (GRK1) and arrestin 
(SAG) that impair termination of the light response; ii) mutations in RPE65 and LRAT that impair 
chromophore recycling therefore leaving photoreceptors with the apoprotein opsin which presents a 
low constitutive activity; iii) mutations in the alpha subunits of transducin (GNAT1) that lead to 
Nougaret disease; iv) null mutations in REEP6 that lower the expression of RetGCs… and likely 
others to be discovered.  If GCAPs were generically involved in these disorders, elucidation of the 
mechanism by which they trigger ER stress and identification of therapeutic targets in the pathway 
would be of the outmost importance.  
- How do GCAPs induce ER stress and cell death in a context of chronic low Ca2+?  As we point in 
our model, we envision two possibilities:  i) by triggering cGMP synthesis chronically at the inner 
segment where cGMP is toxic; or ii) by accumulating in a conformational state that is unstable and 
tend to form toxic oligomers and/or trigger the heat shock response. 
 
i) Could GCAPs mediate the physiopathology by inducing deregulated/unabated cGMP 
synthesis at photoreceptor cell somas? 
 
In this study we have localized RD3 at the inner segments of photoreceptors, which is consistent with 
Dizhoor et al. model in which RD3 acts as a potent inhibitor of RetGC during its trafficking to the 
outer segment (Dizhoor, Olshevskaya, and Peshenko 2019). Based on this model, Dizhoor et al. 
proposed that the calcium sensors, in the absence of RD3, may stimulate cGMP synthesis by RetGC 
at the inner segments (IS). 
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Abnormal production of cGMP in the IS may in turn activate PKG leading to aberrant 
phosphorylation of key targets governing the Ca2+ dynamics of the endoplasmic reticulum, ER 
malfunction and ER stress. The involvement of PKG  in the physiopathology of mouse models of 
achromatopsia that involve ER stress has been previously reported (Ma et al. 2015). In their studies 
Ma et al. treated mice lacking functional CNGA3 and CNGB3 (CNG-channels subunits) with PKG 
inhibitors. They showed morphological rescue of animals treated with either KT5823 (a selective PKG 
inhibitor) or (Rp)-8-Br-cGMPS (a cGMP analogue that blocks PKG in its inactive state) and palliated 
ER stress effects. Therefore one future direction to test the involvement of PKG in the 
physiopathology of rd3 mice would be to follow the protocols of the Ding lab based on PKG 
inhibitors. Alternatively, rd3 mice could be bred with the PKG knock out model, to assess 
morphological rescue. For this approach we would select the Prkg1-/- mice, because this is the 
prevalent form of PKG in the retina and has been immunolocalized to the inner segments of 
photoreceptors (Gamm et al. 2000) where abnormal synthesis of cGMP is predicted to occur. 
ii) Could GCAPs trigger deleterious effects simply by accumulating in their Ca2+-free unstable 
conformation? 
Early studies showed that although GCAPs are active in its Ca2+-free form, this conformation made 
these proteins susceptible to proteolysis (Rudnicka-Nawrot et al. 1998) and made them propense to 
aggregate (Ana Mendez and Chen 2002; Hoyo et al. 2014).  
 
These characteristics make GCAPs “unstable” in the conditions of prolonged low calcium 
characteristic of “light-equivalent” disorders.  We have observed that Ca2+-free GCAPs present high 
affinity for HSP90 in our pull down assays. This raises the possibility that Ca2+-free GCAPs under 
chronic low [Ca2+]i may trigger the heat shock response that would ultimately cause ER stress.  
 
To unequivocally establish a mechanism of toxicity mediated by Ca2+-free GCAPs that is independent 
of GCAPs activation of the cyclase, we could analyse the effect of GCAPs ablation in the 
RetGC1/RetGC2 dKO model (lacking both RetGC1 and RetGC2 isoforms). In the 
RetGC1/RetGC2 dKO animals cGMP production is impaired, Ca2+ is expected to be abnormally low 
and GCAPs are retained at the proximal compartment of cells (Baehr et al. 2007). These animals 
present a retinal degeneration that resembles the human LCA1 phenotype. If GCAPs contributed to 
photoreceptor cell toxicity simply by accumulating in an unstable conformation, then GCAPs ablation 
should ameliorate the retinas of RetGC1/RetGC2 dKO with time.  If GCAPs just act by inducing 
unabated cGMP synthesis in “light-equivalent” disorders, then GCAPs ablation should not improve 
RetGC1/RetGC2 dKO mice.  
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Finally, a particularly interesting model in which to test our hypothesis of GCAPs as damage mediators 
in “light-equivalent disorders” would be the Reep6-/- mice.  Mutations in REEP6 have been 
associated with adRP (Arno et al. 2016). Reep6 acts on a similar manner as RD3. Reep6-/- mice 
present a loss of RetGC1 and RetGC2 isozymes, and manifest a fast retinal degeneration (<40% 
photoreceptors remain at 4 months) (Agrawal et al. 2017). Thereby, Reep6 has been proposed to act 
in a similar way as RD3 by stabilizing and/or trafficking guanylate cyclase.  
 
Agrawal et al. found altered ER stress with upregulation of CHOP in these mice. It will be very 
interesting to test whether RD3 levels are altered in Reep6-/- mice, because if this is not the case, then 
the chronic low Ca2+ and GCAPs retention at the IS (GCAPs require RetGCs for its trafficking to the 
OS) in this scenario would be causing cell death even when RD3 is silencing the remaining RetGCs.  
 
- Other roles of RD3? 
 
Given that rd3 mice display one of the fastest retinal degeneration among mouse models of retinal 
dystrophies, we cannot discard that RD3 might have additional roles. Recently it has been shown that 
rdl-1 (RD3 homolog in C.elegans) and the retromer (Vps26, Vps29 and Vps35 subunits) work 
antagonistically on different endomembrane components to regulate rGC trafficking to BAG neuron 
cilia (rGC, specific guanylate cyclase in BAG neurons of C.elegans) (Martínez-Velázquez and Ringstad 
2018). Martínez-Velázquez et al. observed that in the absence of rdl-1, rGC failed to distribute to the 
chemosensory cilia in these specific neurons. However, if in the absence of rdl-1 they depleted Vps29 
and Vps35 (specific retromer components) they reconstituted rGC trafficking to the sensory cilia. 
Whether a similar relationship between RD3 and retromer exists in mammal photoreceptor cells 
requires investigation. However, blocking the retromer components in LCA12 patients would not be 
a therapeutic option because VPS35 loss of function mutations have been associated with Parkinson 
(Tang et al. 2015) and Alzheimer diseases (Muhammad et al. 2008), suggesting strong adverse effects 











4.2 In Vivo regulation of IMPDH1 in the retina, and effect of adRP10 
IMPDH1 mutations on retinal physiology 
We here report a novel mechanism of regulation of IMPDH1 in the retina in vivo. First, we have 
characterized a light-dependent phosphorylation event at the Bateman domain that desensitizes the 
enzyme to its allosteric inhibition by GDP/GTP. We have shown that IMPDH1 inhibition in vivo 
delays light response recovery, which depends on cGMP synthesis. Interestingly, by determining 
guanine and adenine nucleotide levels in dark/light we have observed that IMP levels nearly double 
during bright light exposure. Measurements of Gly* (stable isotope) incorporation to IMP, GMP and 
AMP allowed us to conclude that the whole de novo biosynthesis of purines is boosted under light 
exposure.  Therefore we propose that this phosphorylation is part of a physiological program triggered 
by light to enhance de novo ATP and GTP synthesis to keep with the phototransduction demand. In 
this context, the release from GDP/GTP inhibition keeps IMPDH1 in a permissive state in light, to 
keep up with the increased metabolic flux. 
 
We have observed that upon prolonged light exposure IMPDH1 forms aggregates at the outer 
segment compartment of photoreceptors,  where cGMP turn-over multiplies by 10-20 in response to 
light. cGMP synthesis requires GTP as a substrate, there the increase in GTP demand.  
 
IMPDH1 aggregates could result from the bundling of IMPDH1 filaments. Recent structural studies 
have shown that the conditions that promote IMPDH filament formation in vitro are the simultaneous 
depletion of GDP/GTP (marks an increase in GTP demand in cells: e.g. proliferation) and an increase 
in IMP (stabilizes filaments, precluding their disassembly) (Johnson and Kollman 2020). By 
establishing a parallelism of our results with structural studies we propose the model of IMPDH1 
regulation depicted in Fig 46. 
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Figure 46. Proposed model of regulation of IMPDH1 activity in photoreceptor cells by light-
dependent phosphorylation at Thr159/Ser160.  In the dark, GTP can bind to the nucleotide binding sites at 
the Bateman domain and shift IMPDH1 conformation towards GTP-bound IMPDH1 compacted octamers 
that are inactive (negative feedback regulation in red).  Upon light exposure, phosphorylation at Thr159/Ser160 
desensitizes the enzyme to GTP, coinciding with the increase in IMP levels. We propose that these concurring 
conditions would cause filamentation of the enzyme, leading to protein aggregation at the outer segment layer. 
In this way, light exposure would stabilize IMPDH1 in an active conformation permissive to the increased flux 
towards guanine and adenine nucleotide synthesis (thicker arrows in light).  This increased flux is likely required 
to compensate for ATP and GTP consumption in the phototransduction process, to sustain the pools of ATP 
and GTP. IMPDH1 localization at the outer segment layer in these macrostructures would be reverted by 
dephosphorylation and gradual decrease of IMP levels during dark-adaptation. IMPDH1 localization at 
different light conditions is depicted in grey.  
 
Two important aspects of the model await further experimentation/ reinforcement: 
 
i) Whether phosphorylation at the Bateman domain is required to trigger IMPDH1 aggregates 
in vivo can be easily tested by treating mice with an specific PKC inhibitor previous to bright 
light exposure.  Alternatively, phosphomimic and phosphoKO mutants of IMPDH1 could be 
transfected in living rod photoreceptors by in vivo DNA electroporation, to test whether the 
phosphomimic mutants trigger aggregate formation in dark conditions. Finally, generation of 
specific antibodies to the phosphorylated peptide would allow us to establish where 
phosphorylation is taking place. 
   
ii) More exhaustive metabolic flux analysis can be performed with a series of stable isotopes (Gly, 
glucose) by doing time course analysis upon exposure to light steps of increasing intensity. 







- How we can gain insight from this study for understanding the adRP10 and LCA11 pathologies? 
 
Beyond understanding the physiological role and regulation of IMPDH1 in the retina, there is an urge 
to understand how IMPDH1 mutations lead to the adRP10 and LCA11 forms of blindness. Based on 
ours and previous studies  (Buey et al. 2015; Fernández-Justel et al. 2019) we envision two  possible 
pathways of damage: 1) Blindness-associated mutations with impaired GDP/GTP regulation result 
in unabated IMPDH1 activity that yields abnormally high cGMP levels which is a well-known cause 
of cell death in photoreceptors (Olshevskaya et al. 2004; Woodruff et al. 2007; Paquet-Durand et al. 
2009; Trifunović et al. 2010; Sothilingam et al. 2015); and 2) Blindness-associated mutations result in 
formation of filaments -in moments of sporadic bright light exposure in the natural world- that are 
irreversible due to their GDP/GTP desensitization  (GDP/GTP cannot induce the disassembly of 
filaments), and toxic upon accumulation.   
 
To test the in vivo effect of the adRP10 and LCA11 mutations it would be necessary to develop knock-
in mouse models with selected mutations, i.e. N198K and R224P (the most prevalent). These animal 
models would serve to assess whether mutations result in increased IMPDH1 activity independent of 
the light conditions, and the formation and reversibility of IMPDH1 aggregates upon different light 
environments. These knock-in models would also serve to test novel therapies for adRP10 and LCA11 
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CONCLUSIONS 
 
1. GCAPs ablation in the rd3 mice largely delays retinal degeneration; providing substantial 
morphological rescue.  
 
2. GCAPs ablation in the rd3 mice does not improve visual function.  
 
3. GCAPs mediate the physiopathology in rd3 mice by sensing the chronic low [Ca2+]i and 
inducing ER stress and CHOP-mediated apoptosis at an early stage of the disease.  
 
4. IMPDH1 is phosphorylated in vivo at three residues: Thr159/Ser160 in response to light, Ser416 
indistinctly in dark/light conditions, and Ser477 preferentially in the dark. 
 
5. Phosphorylation of Ser416 at the mobile flap of IMPDH1 reduces enzymatic activity in in vitro 
assays.  
 
6. Phosphorylation at the Bateman domain (Thr159/Ser160) desensitizes IMPDH1 to inhibitory 
allosteric regulation by GDP/GTP in vitro, which indicates that in vivo IMPDH1 activity 
should increase with light.  
 
7. Bright light exposure causes the progressive and reversible accumulation of IMPDH1 
aggregates at the rod outer segment layer of the retina; that correlates with an increase in 
IMP, AMP and GMP levels in the retina. 
 
8. Light increases the flux through de novo synthesis of purine nucleotides in the retina, likely to 
sustain the ATP and GTP pools despite their increased consumption. 
 
9. IMPDH1 inhibition in the retina in vivo delays rod mass recovery, implying that de novo 
synthesis of cGMP contributes to sustain the recovery kinetics of the light response.  
 
10. IMPDH1 residues Thr159/Ser160 are substrates of PKC in vitro. 
 
11. adRP10 mutation H372P results in increased phosphorylation at Thr159/Ser160 by PKC in 
vitro, which points to its desensitization to GDP/GTP in vivo.   
 
12.  In vivo treatment with a selective PKC inhibitor reduces the GTP pool under light exposure 
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6.1. Materials and methods for Chapter 1 
6.1.1. Ethics statement 
Pertaining to animal research, this study was conducted in accordance with the ARVO statement for 
the use of animals in ophthalmic and vision research and in compliance with acts 5/1995 and 
214/1997 for the welfare of experimental animals of the autonomous community (Generalitat) of 
Catalonia; and approved by the ethics committee on animal experiments of the University of 
Barcelona (Generalitat Reference #9906, protocols Bell  216/17; 217/17 and 218/17).  
 
6.1.2 Generation and affinity purification of antibodies against RetGC1 and RD3 
The polyclonal antibodies against RetGC1 and RD3 were generated against a peptide corresponding 
to the last 21aa of murine RetGC1 (Cys: H2N-IPPERRKKLEKARPGQFTGKC-OH) and to the 
last 16aa of murine RD3 (Cys: H2N-PPRTWSMPEFRAPQAD -OH). Peptides were conjugated to 
keyhole limpet hemocyanin (KLH) carrier protein (#77666, Thermo Fisher Scientific) and inoculated 
in New Zealand White rabbits following a standard 70 day antigen delivery protocol (Fig 47A): initial 
injection of  antigen (0.25 mg) emulsified in Freund’s complete adjuvant (Sigma), and three boosts of 
antigen (0.1 mg) in Freund’s incomplete adjuvant (Sigma).  Serum from immunized rabbits was 
purified by affinity chromatography, by using the immunizing peptide covalently coupled to agarose 
columns by –SH chemistry (Sulfolink technology, Thermo Fisher Scientific) (Fig 47B). 
Immunoglobulins were eluted from columns in acidic conditions (0.5 M glycine pH 2.5), neutralized 
(Tris HCl pH 8.8), dialyzed against 1x PBS pH 7.2, and concentrated with 10 K Amicon devices 
(Merck Millipore).  
 
6.1.3 Generation and affinity purification of antibody against bIMPDH1 canonical protein 
Anti-IMPDH1 antibody was generated against purified bovine canonical IMPDH1 (bIMPDH1-514 
aa).  Bovine IMPDH1 cDNA was amplified from total RNA from fresh bovine retinas and cloned 
into pET15b bacterial expression plasmid (Novagen®) for expression in E. coli BL21 (DE3) cells.  
The expression of recombinant protein was induced in bacterial cultures at OD600=0.6 for 5 hrs at 
37oC.  Cells were then collected and bacterial inclusion bodies were obtained and solubilized in 6 M 
guanidinium hydrochloride buffer as previously described (Krishnaiah 1975).  
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bIMPDH1-514aa.His was purified by metal chelation using a HiTrap column (GE Healthcare) and 
dialyzed against dialysis buffer (1 M urea, 0.4 M L-arginine, 20 mM Hepes and 200 mM NaCl). 
 
Purified bIMPDH1-514aa was used to immunize two New Zealand White rabbits following a 
standard 70 day protocol as described above. At exsanguination, blood serum was affinity purified 
with bIMPDH1-crosslinked to Aminolink coupling resin (Thermo Fisher Scientific). Antibodies were 
eluted, dialyzed and concentrated as described above. 
 
6.1.4 Antibodies preservation 
Following dialysis and concentration in PBS pH 7.2, antibody concentrations were assessed by a BCA 
assay (#23225, Thermo Fischer Scientific). Batches of ~4-6 mg antibody/ml were properly aliquoted 
in fresh tubes and conserved in different preservatives. Purified antibodies were preserved in either 
0.4% BSA, 0.025% sodium azide; or in 40% glycerol and kept at -80ºC until use.  
 
A fraction of non-purified serum was precipitated in ammonium sulphate to avoid the use of BSA or 
glycerol that would interfere in future crosslinking/conjugating procedures. For this, a saturated 
solution of ammonium sulphate (100%) was added drop by drop to serums until 40% saturation. As 
addition of ammonium sulphate would acidify antibodies causing antibody denaturalization, a final 
concentration of 50 mM Trisma base pH=8 was added to the mix. Precipitation of antibodies was 
allowed to proceed in a rotating wheel for 1 h, at 4ºC. Antibodies were further centrifuged at 12,000×g 
(4ºC) for 20 min, and then supernatants were discarded and pellets containing the precipitated 
antibody were kept at -80ºC until use. To reconstitute the precipitated fractions, antibodies were 
resuspended in PBS pH 7.2 and centrifuged at 12,000×g (4ºC) for 20 min. Supernatants containing 
clarified antibodies were transferred to fresh tubes and stored at 4ºC until use.  
 
6.1.5 Testing of antibodies by Western Blot 
Murine and bovine retinas were homogenized in homogenization buffer [20 mM Hepes, 115 mM 
KCl, 10 mM NaCl, 10 mM MgCl2, 1 mM PMSF and a protease cocktail inhibitor (Complete mini 
EDTA-free, Roche)].  Extracts were clarified by centrifugation at 12,000×g  20 min at 4ºC. Samples 
were boiled for 5 min after addition of 4x Laemmli SDS buffer, and fractions corresponding to one 
tenth of a murine retina (20 µg) or one hundredth of a bovine retina (50 µg) were resolved by SDS-
PAGE in tris-glycine gels.  Proteins were transferred to nitrocellulose membranes (0.2 µm 
nitrocellulose, Bio-Rad). Membranes were blocked for 1 hr at room temperature with 5% dry milk 
and then were incubated with anti-RetGC1 (1:1000), anti-RD3 (1:2000) or anti-IMPDH1 (1:5000) 
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Abs. Secondary antibody was a goat anti-rabbit IgG (Heavy and Light chains, H&L) antibody 
Dylight™ 800 conjugated  (#611-145-002, Rockland) at 1:5000. Images were acquired at an Odyssey 
Scanner (LI-COR). 
 
6.1.6 Testing of antibodies in indirect immunofluorescence localization assays 
 
For immunolocalization assays, murine or bovine eyes were enucleated, the cornea was excised and 
eyecups were fixed (4% paraformaldehyde, 0.02% glutaraldehyde in PBS, pH 7.4) for 30 min at room 
temperature.  Then the lens was removed and eyecups were further fixed for 1.30 hrs at room 
temperature. Eyecups were washed in PBS prior to being infiltrated in acrylamide (8.4% acrylamide, 
0.014% bisacrylamide in PBS pH 7.4) overnight at 4oC.  Following overnight infiltration, acrylamide 
polymerization was induced by addition of ammonium persulphate and TEMED.  Eyecups in 
acrylamide blocks were submerged in molds with O.C.T. compound (Tissue-Tek, Electron 
microscopy Sciences) and immediately frozen in liquid nitrogen. Cryosections were obtained at 20 
µm-thickness using a CM15105 Leica Cryostat (Leica Microsystems).  
 
RetGC1 and RD3 antibodies did not required antigen retrieval protocols.  The antibody against 
IMPDH1 worked optimally when applying a brief antigen retrieval protocol that consisted on 
incubation of the retinal sections with proteinase K in PBS (0.05 mg/ml) for 2 min, followed by a 
heat shock at 70ºC for 10 sec. Sections were extensively washed in PBS and incubated with blocking 
solution (3% normal goat serum, 1% BSA, 0.1% Triton-X100 in PBS pH 7.4) for 1 hr at room 
temperature. First antibodies were incubated over night at 4ºC in blocking solution without Triton-
X100 (RetGC1; 1:200); (RD3; 1:500) and (IMPDH1; 1:250). Secondary antibody was goat anti rabbit 
Alexa-488 (Thermo Fisher Scientific) incubated for 1.5 hrs at room temperature. Then retinas were 





Figure 47. Scheme of antibody generation, purification and testing. A. A standard 70 day (three boost) antigen 
delivery was followed to inject two rabbits per antigen. At day 0 animals were pre-bleed (1ml) to obtain control serum; 
and were injected with 0.25 mg antigen (RetGC-KLH; RD3-KLH or IMPDH1) in Complete Freund’s Adjuvant (CFA) at 
four subcutaneous sites. At days 14, 42 and 56 animals were boosted with 0.1 mg antigen in Incomplete Freund’s Adjuvant 
(IFA) at four subcutaneous sites. At days 28 and 56 a pre-bleed (1 ml) was collected to test antibody title and specificity. 
At day 70 animals were euthanized and bled (~70 ml blood/animal). Blood was centrifuged at 2500 rpm to obtain the 
serum fraction. B. Antibody purification consisted in crosslinking the antigen (RetGC and RD3 peptides; or whole 
recombinant IMPDH1) to agarose, using —SH or Aminolink chemistry (1). Serum was incubated in agarose columns for 
15 min (2), extensively washed in PBS pH 7.2, and bound antibodies were eluted in acidic conditions (0.5 M glycine pH 
2.5) further neutralized (Tris HCl pH 8.8) and dialyzed against PBS pH 7.2 (3). Antibodies were aliquoted and preserved 
in 0.4% BSA, 0.025% azide; in 40% glycerol and were kept at -80ºC until use. Antibody specificity was tested by western 
blot (4), immunofluorescence on fixed retinas (5) and in immunoprecipitation assays (6).   
 
6.1.7 Titration of bIMPDH1 antibody in Immunoprecipitation 
 
To perform immunoprecipitation assays, increasing amounts of IMPDH1 antibody (0.5 µg, 1 µg and 
3 µg) were incubated with a fixed amount of magnetic beads-protein G (Dynabeads, Life 
Technologies) for 15 min at room temperature. After three washes with 1x PBS, the beads-antibody 
complex was incubated with a fixed amount of bovine retinal extract (0.5 mg protein, corresponding 
to 1/10 of a bovine retina) for 1 h at room temperature in a rotating wheel. Flow through fractions 
were collected and beads were extensively washed. Elutions were performed by adding 20 µl of 1x 
SDS loading buffer to the antigen-antibody-beads complexes. Input, flow through and elution 
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fractions were run on a 12% SDS-PAGE, transferred to a nitrocellulose membrane and incubated 
with anti-IMPDH1 Ab. Instead of a secondary antibody, protein G-800 [protein G conjugated to 800 
fluorophore, (#PG00-32, Rockland, 1:200)] was used for the detection, to avoid detecting the 
immunoglobulin chains of the IMPDH1 Ab used in the immunoprecipitation reaction).  
 
The antibody against IMPDH1 was also cross-linked to magnetic beads using the pierce BS3 
crosslinker (Thermo Fisher Scientific) following manufacturer instructions. For that, 10 µg of the 
antibody were crosslinked to 50 µl of Dynabeads protein-G (Thermo Fisher Scientific) for 30 min at 
room temperature. The reaction was stopped and beads were extensively washed before proceeding 
with the immunoprecipitation. IP was performed in parallel with non- crosslinked antibody as 

















6.2 Materials and methods for Chapter 2 
6.2.1 Mice 
 
The B6.Cg-Rd3rd3/Boc strain of rd3 mice used in this study were obtained from the Jackson’s 
Laboratories (JAX Stock #8627 Maine, USA) as heterozygous wt/rd3 mice(B. Chang et al. 
1993). These mice present a point mutation after residue 106 (C→T) that results in a premature 
stop codon after residue 106. The rd3 mutation results in expression of a truncated form of 
the RD3 protein that is rapidly degraded (Friedman et al. 2006). Heterozygous animals were 
bred in order to obtain homozygous rd3/rd3 mice. Mice were genotyped by real-time 
polymerase chain reaction (RT-PCR) by making use of the TaqMan® SNP genotyping assay 
(Life Technologies, Carlsbad, USA). For that purpose, forward and reverse primers were 
designed to amplify a fragment of 68 bp from the Rd3 locus of genomic DNA that 
encompasses the rd3 mutation (Fw: 5′-CTGGAGACGCTCATGATGGA-3′; and Rv: 5′-
CGACGCTCCCTCTGTTGT-3′) and primer probes were designed to hybridize with either 
the amplified wild-type allele (VIC-5′-CTCTCTCATCTGCCCAGCC-3′) or knock-out allele 
(FAM-5′-CTCTCTCATCTACCCAGCC-3′). RT-PCR was performed in 25 µl reactions 
containing 12.5 µl TaqMan universal master Mix (Life Technologies); 300 nM each 
forward/reverse primer; 250 nM of each primer probe, and 20 ng of genomic DNA obtained 
from digested mouse tails (Nucleospin® Tissue, Macherey-Nagel, Düren, Germany). After 
10 min incubation at 95 °C, thermal cycling was performed on the StepOne Real-time PCR 
System (Thermo Fisher Scientific, Waltham, Massachusetts) and consisted of 40 cycles (95 °C 
for 15 s; 60 °C for 1 min). End-point allelic discrimination genotyping was assessed by 
inspecting the fluorescence plots for the wild type versus mutated probe (Fig 48B). 
 
To obtain mice expressing the rd3 mutation to homozygosis in the 
GCAPs−/− background, rd3/rd3 mice were bred to GCAPs−/− mice (Fig 48A).  
 
GCAPs−/− mice lack GCAP1 and GCAP2 expression, and their phenotype and genotyping 
protocols have been described (A Mendez et al. 2001) (Fig 48C-D).  
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Figure 48. Establishing the rd3/rd3 GCAPs-/- line. A. rd3/rd3 mice were bred to GCAPs-/- mice (1). The 
progeny was heterozygous for both rd3 and GCAPs null allele, and were subsequently crossed (2) to fix the rd3 
mutation (rd3/rd3). Selected progeny (3) that were GCAPs+/- and rd3/rd3 were then crossed in order to 
obtain rd3/rd3 GCAPs+/- and rd3/rd3 GCAPs-/- mice (4). B. Representative allelic discrimination plot in rd3 
genotyping: blue dots, rd3/rd3; green dots, wt/rd3; red dot wt/wt. C. Representative GCAPs genotyping result. 
The pair of primers used yield a PCR band of ~800bp band from the wt allele (green boxes) (Ana Mendez et 
al., 2001) [note that 172, 174 and 182 samples amplify in a higher Kb band (>800bp), this band also appears in 
negative GCAPs-/- control (2)]; whereas the KO allele yields a ~400bp band (blue boxes). D. Example of 




Anti-GCAP1 and anti-GCAP2 polyclonal antibodies have been previously described (López-Begines, 
Plana-Bonamaisó, and Méndez 2018).  The polyclonal antibodies against RetGC1 and RD3 were 
generated in rabbit against C-terminal peptides corresponding to the last 21 aa of murine RetGC1 and 
the last 16 aa of murine RD3 (see methods Chapter 1).  
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6.2.3 Specimen preparation for light and electron microscopy 
Mice of the indicated genotypes were reared under standard cyclic light (12 h dark:12 h light) and 
sacrificed by cervical dislocation. The vertical meridian of the eye was marked at the top for orientation 
purposes. The eye was enucleated, punctured, and immediately submerged in 2% paraformaldehyde, 
and 2.5% glutaraldehyde in 0.1 M cacodylate buffer pH 7.2 for 5 min. The cornea was excised and 
fixation was allowed to proceed for 1 h, before removal of the lense and further fixation of the eye 
cup for 12 h at 4 °C. Eye cups were washed with 0.1 M cacodylate buffer and fixed with 1% osmium 
tetroxide in 0.1 M cacodylate buffer for 2 h at room temperature. Specimens were dehydrated in 
ethanol (30–100%) or acetone, infiltrated with propylene oxide, and embedded in Epoxi embedding 
medium (Fluka Analytical, Munich, Germany). Retinal sections for histological analysis by light 
microscopy morphometry measurements were obtained with a Reichert Ultracut S ultramicrotome 
(Leica, Wetzlar, Germany) at 1-µm thickness and contrasted with Richardson’s stain (0.5% methylene 
blue, 0.5% Azine II, and 0.5% borax in dH2O). For transmission electron microscopy analysis, 
ultrathin sections were obtained (see below). 
 
6.2.4 Retinal morphometry analysis 
For morphometrical analysis, measurements of ONL thickness were taken on 1-µm sections at the 
vertical meridian of the eye that encompassed the optic nerve. Overlapping frames at 20x 
magnification were acquired covering the whole section with a Zeiss Axio Zoom.V16 stereo 
microscope (Zeiss, Oberkochen, Germany). An integrated image of the whole retinal section was 
assembled with the HUGIN fusion software. Measurements of ONL thickness were taken at 200-µm 
intervals from the optic nerve (12 divisions in the superior retina, and 10 divisions in the inferior 
retina) (Fig 49). For each morphometry analysis a minimum of four mice per genotype were used at 
indicated ages. Error bars represent the standard error of the mean (SEM). 
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Figure 49. Retinal morphometric analysis on retinal sections from the vertical meridian of the eye that 
traverse the optic nerve. A. Identification of photoreceptor nuclei on murine retinas. ONL, Outer nuclear 
layer; INL, Inner nuclear layer; GCL, Ganglion cell layer. B. 20x images are acquired by bright field microscopy 
covering the whole retina. Images of entire retinas are reconstructed using the Hugin application. Scale is set 
with Fiji (Image J) software, and retinas are divided at 12 equal divisions (+ numbering, superior retina) and 10 
equal divisions (- numbering, inferior retina) at 200 µm intervals. Fiji is then used to measure ONL thickness 
(µm) and a “Spider graph” is generated by plotting ONL width to optic nerve distance using Graph Pad Prism.   
 
6.2.5 Ultrathin sectioning and image acquisition at the transmission electron microscope 
Ultrathin sections (70–90 nm) were obtained with a Reichert Ultracut S ultramicrotome (Leica), 
collected on 200 mesh copper grids, counterstained by heavy metal staining (2% uranyl acetate in 50% 
ethanol for 30 min), and contrasted with 2% lead citrate for 10 min. Ultrathin sections were analyzed 
in a JEOL 1010 transmission electron microscope and images acquired with a Bioscan Gatan wide 
angle slow scan CCD camera. 
 
6.2.6 Immunofluorescence analysis in fixed tissue 
For immunofluorescence analysis, eye cups were fixed in 4% paraformaldehyde, 0.02% glutaraldehyde 
in phosphate-buffered saline (PBS), pH = 7.4 for 2 h at room temperature. Eye cups were infiltrated 
in acrylamide (8.4% acrylamide, 0.014% bisacrylamide in PBS pH 7.4) overnight at 4 °C. Acrylamide 
polymerization was induced and eye cup acrylamide blocks immediately frozen in O.C.T. compound 
(Tissue-Tek, Electron microscopy Sciences, Hatfield, PA) using liquid nitrogen. Cryosections were 
obtained at 18-µm thickness with a CM15105 Leica Cryostat (Leica Microsystems, Wetzlar, Germany). 














Immunolocalization of GCAP1 and GCAP2 required an antigen retrieval protocol, consistent on 
incubation with proteinase K (0.05 mg/ml in PBS) for 2 min, followed by a 10 s heating shock at 
70 °C. Sections were incubated with blocking solution (3% normal goat serum, 1% bovine serum 
albumin (BSA), 0.3% Triton-X100 in PBS pH7.4) for 1 h; first antibody in dilution buffer (3% normal 
goat serum, 0.4% BSA, 0.1% Triton-X100 in PBS pH 7.4) for 16 h at 4 °C; and secondary antibody 
(1.5 h at room temperature), and fixed with 4% paraformaldehyde prior to being mounted with 
Mowiol (Calbiochem #475904, San Diego, CA, USA). Antibodies used were anti-RetGC1 pAb; anti-
GCAP1 pAb; anti-GCAP2 pAb; anti-rhodopsin mAb 1D4; anti-PNA-647 (# L32460, Thermo Fisher 
Scientific); anti-rabbit Alexa Fluor 488 (#A-11034, Thermo Fisher Scientific, Walthman, MA, USA); 
and anti-mouse Alexa Fluor 555 (#A-32727, Thermo Fisher Scientific). Samples were mounted on 
0.13–0.16 mm thick cover glasses. 
 
6.2.7 Confocal microscopy and data analysis 
Confocal microscopy images were acquired at a confocal laser scanning microscope Zeiss LSM 880 
equipped with one GaAsP detector, with a 63×/1.4 NA oil objective. For localization of RetGC and 
GCAPs in Fig 19 and Fig 20 spectral bands were set to 493–550 nm for the 488 channel, 566–638 nm 
for the 555 channel, and to 638–755 nm for the 647 channel. The Z-stacks covered 16 µm of tissue 
with a 368 nm step size (~40 planes/stack). The image acquisition settings provided a pixel size of 
about 0.132 × 0.132 µm in 1024 × 1024 images. 
 
6.2.8 Western blot 
Retinas (at least n = 3 per condition) were homogenized in Laemmli sodium dodecyl sulfate (SDS) 
buffer with 1 mM phenylmethylsulfonyl fluoride (PMSF), and protease cocktail inhibitor (Complete 
mini EDTA-free, Roche). Samples were boiled for 10 min at 95 °C, and fractions corresponding to 
one tenth of a retina were resolved by 12 or 16% SDS–polyacrylamide gel electrophoresis. Proteins 
were transferred to nitrocellulose membranes (0.2 µm nitrocellulose, Bio-Rad, Hercules, CA, USA). 
Membranes were blocked for 1 h at room temperature with 5% non-fat dry milk in TBST and then 
were incubated overnight at 4 °C with custom polyclonal antibodies to RetGC1, RD3, GCAP1, and 
GCAP2, and antibodies anti-CHOP (#L63F7, Cell Signaling); anti-Caspase 3 (#9662, Cell Signaling); 
anti-PARP1 (#9542, Cell Signaling); goat anti-rabbit IgG (Heavy and Light chains, H&L) antibody 
Dylight™ 800 conjugated (#611-145-002, Rockland, Pottstown, PA, USA); goat anti-mouse IgG 
(H&L) antibody Dylight™ 680 conjugated (#610-144-002-0.5, Rockland); and donkey anti-goat 
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conjugated to Horseradish Peroxidase (HRP) was from Thermo Fisher (#86326). Detection was 
performed in an Odyssey Scanner (LI-COR Biosciences, Lincoln, Nebraska) or ImageQuant™ 
LAS500 (Ge Healthcare, Chicago, Illinois) image acquisition system. Band densitometric analysis was 
performed using the Fiji (Image J) software, and band intensity analysis presented in histograms always 
reflect band intensity of the protein of interest normalized by the intensity of tubulin in the loading 
control. 
 
6.2.9 Isoelectric focusing separation of murine retinal homogenates 
 
Retinas from wt and rd3/rd3 mice were dissected at p21, at an early onset of retinal degeneration 
of rd3 mice. Retinas were homogenized in homogenization buffer with phosphatase inhibitors 
[20 mM Hepes, 115 mM KCl, 10 mM NaCl, 10 mM MgCl2, 50 mM NaF, 5 mM β-glycerophosphate, 
1 mM PMSF, and a protease cocktail inhibitor (Complete mini EDTA-free, Roche, Basel, 
Switzerland); pH 7.4]. Samples were centrifuged at 13,200 rpm, 4 °C for 30 min, and supernatant 
fractions were kept. An aliquot was taken at this point for protein determination (BCA kit, Thermo 
Fisher Scientific). Protein material in supernatant fractions was precipitated by addition of three 
volumes of ice-chilled trichloroacetic acid (TCA)-acetone (13.3% w/v trichloroacetic acid in acetone, 
with dithiothreitol (DTT) to 20 mM final concentration); equilibration of samples to −20 °C for 72 h; 
and centrifugation at 13,000×g for 1 h at 4 °C. Protein pellets were washed twice with cold 20 mM 
DTT in acetone; and allowed to air-dry for 10 min. Samples were dissolved in 
urea/thiourea/CHAPS/DTT (7 M urea, 2 M thiourea, 40 mM DTT, 4% CHAPS, and 2% IPG buffer 
pH 3–10) to ensure complete reduction, denaturing, and solubilization of proteins in the samples. 
 
Samples were kept at −80 °C until use. For isoelectric focusing (IEF) separation, gel strips with a 
preformed linear pH gradient of pH 3–10 (prehydrated IPG Immobiline (TM) DryStrips pH 3–10, 
18 cm, GE Healthcare) were used. Threefold more sample was loaded for rd3/rd3 retinas than wt 
retinas in order to equilibrate the GCAP2 signal. IEF separation was conducted on an Ettan 
IPGphor3 system (GE Healthcare), following a 500 V step for 1 h, a gradient to 1000 V for 1 h, a 
gradient to 10,000 V for 3 h, and a 10,000 V step for 3 h. Gel strips were incubated in transfer buffer 
for 15 min, and proteins were transferred to nitrocellulose membranes by capillary action. GCAP2 
was immunoblotted with anti-GCAP2 pAb and goat anti-rabbit IgG (Heavy and Light chains) 
antibody Dylight™ 800. Bands were visualized at an Odyssey scanner (LI-COR), and densitometry 




6.2.10   Expression, purification, and in vitro phosphorylation of myristoylated GCAP2 for 
pull-down assays 
Myristoylated GCAP2 expression was induced in Escherichia coli BL21(DE3) cells transformed with 
pET-15b-bGCAP2 and the pBB131 plasmid encoding N-myristoyl transferase (a gift from Dr. J. 
Gordon, Washington University School of Medicine, Missouri, USA). Free myristic acid was added 
to 50 µg/ml to the cell culture and expression was induced for 4 h at 37 °C. bGCAP2 protein, was 
recovered from solubilized inclusion bodies and purified by on-column refolding using immobilized 
metal affinity chromatography (IMAC) on a Nickel-NTA [Nickel bound to agarose beads by chelation 
using nitrilotriacetic acid] as previously described (Hoyo et al. 2014).  
To obtain phosphorylated bGCAP2 for pull-down assays, in vitro phosphorylation reactions were 
performed with protein kinase G (PKGIα, Calbiochem, Billerica, MA, USA). Each 50 µl reaction 
contained 30 mM Tris-HCl pH 7.5, 5 mM MgCl2, 5 mM sodium phosphate buffer pH 7.5, 6 mM DTT, 
2 mM EGTA, 10 µM ATP, and 500 µM cGMP, with 10 µg of bGCAP2 in the presence or absence of 
purified PKGIα (100 units) to obtain phosphorylated GCAP2 (GCAP2-P) and the mock-control 
(GCAP2). Phosphorylation reactions were allowed to proceed for 2 h at 30 °C, and GCAP2 and 
GCAP2-P were covalently linked to Epoxi-magnetic beads (Life Technologies, Carlsbad, CA, USA). 
GCAP2- or GCAP2-P-beads were then incubated with bovine retinal homogenates obtained by 
homogenization of fresh bovine retinas in binding buffer (10 mM HEPES, 135 mM NaCl, 5 mM KCl, 
1 mM PMSF, 1 mM NaF, 1 mM β-mercaptoethanol, 1% Triton X-100, 4 mM EGTA, 2 mM EDTA, 
and Complete Mini protease inhibitors, pH 7.4). After 1 h incubation at room temperature, beads 
were washed and bound proteins were eluted under acidic conditions. Magnetic beads were 
extensively washed, and bound material was eluted in 0.2 M glycine pH 2.5 and immediately 
neutralized. Proteins in the bound fraction were identified by LC-MS/MS. The experiment included 
three biological replicates. 
 
6.2.11   LC-MS/MS 
Samples were reduced with 10 mM DTT at 60 °C for 30 min, and alkylated with 55 mM iodoacetamide 
for 30 min at room temperature. Samples were precipitated with 10% TCA. Pellets were dissolved in 
2 µl of 8 M urea and brought to a final volume of 10 µl with 25 mM ammonium bicarbonate. Samples 
were digested with sequencing grade trypsin in 25 mM ammonium bicarbonate for 12 h. For LC-
MS/MS, samples were resuspended in 0.1% formic acid and injected into a series Proxeon LC 
nanoEASY system (Thermo Fisher Scientific) coupled to a LTQ-Velos Orbitrap (Thermo Fisher 
Scientific). The resulting mass spectral peak lists were searched with the Sequest search engine 
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(v.2.1.04, Matrix Sciences, London, UK) against the merged BOVIN-MOUSE UP SP r 2011-1.fasta 
sequence library. For database searching, raw mass spectrometry files were submitted to the in-house 
MOUSE-BOVIN_UP_SP_r_2014-5.fasta Swiss-Prot database (released February 2014; 22460 
protein entries) using SEQUEST version 28.0 (Thermo Fisher Scientific). The criteria used to accept 
identification included a minimum of two peptides matched per protein, with a false discovery rate of 
1%. All proteins were treated as ungrouped. 
 
6.2.12   Characterizing differential protein interactions of GCAP2-P and GCAP2 
For label-free quantitative proteomic analysis of proteins identified with GCAP2-P versus GCAP2, 
we first filtered the protein lists to remove any duplications resulting from the use of bovine and 
mouse fasta sequence libraries. Only those proteins unequivocally assigned by at least a unique peptide 








where NSAFk is the Normalized Spectral Abundance Factor (Zybailov et al. 2006) for a given protein 
k; SpCk is the Spectral Count for protein k, Lk is the length of the protein in number of amino acids; 
and the denominator is the summation of the NSAFs of all identified proteins in that sample. This 
expression corrects for differences in sampling depth between both conditions assayed, and avoids 
the discontinuity seen in simple count ratios when a protein shows spectral count = 0 in one of the 
samples. 
Mean NSAF values were then calculated from triplicate biological samples, followed by a t-test 
comparison (two tails, unequal variance). To obtain the Volcano-plot, the logA
BCD;E
BCD;FE
	 was plotted 
in the X axis; and the −10 log(𝑝	𝑣𝑎𝑙𝑢𝑒) from the t-test was plotted in the Y axis, with MeanP 
referring to Mean NSAFGCAP2-P, and MeanNP referring to Mean NSAFGCAP2. Threshold curves for the 
volcano plot were obtained by fitting values to 𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛	2:	𝑓(𝑥) = O
PQR;




	 ratio threshold and m is the -10log(p-value) threshold.  m and n values were fixed 
to 5 and 1.35 respectively.  (Notes: taking 𝑎 ≡ logA U
V
WV
X and	𝑏 ≡ −10 log(𝑝 − 𝑣𝑎𝑙𝑢𝑒), the proteins 
passing the thresholds are those proteins that: 𝑎 < −√𝑛 and 𝑏 > 𝑓(𝑥),	for the negative side; and  
𝑎 > √𝑛 and 𝑏 > 𝑓(𝑥), for the positive side. 
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6.2.13   Electroretinography 
A total of 4–7 mice were tested for each animal group. Dark-adapted (>12 h) animals were 
anesthetized with an intraperitoneal injection of ketamine (70 mg/kg; Ketalar, Parke-Davis, 
Wellington, New Zealand) and xylazine (7 mg/kg; Rompun, Bayer, Leverkusen, Germany) in saline 
solution (NaCl 0.9%) and pupils were dilated with one drop of 1% tropicamide. A corneal electrode 
was used to record ERGs from right eyes (Burian-Allen, Hansen Ophthalmic Development Lab, 
Coralville, IA). Electrode was placed in the visual axis 1–2 mm from the cornea and a drop of 2% 
methyl-cellulose (Methocel, Ciba Vision, Hetlingen, Switzerland) was dropped between cornea and 
electrode. Mice were maintained for >5 min in absolute darkness before the recordings. Mouse 
temperature during the recording was maintained at 37 °C with a liquid heating pad. Full-field flash 
ERG responses were recorded with the retina illuminated with a LED-driven Ganzfeld dome. A series 
of light flashes of increasing intensity (from 0.001 to 10 cd/s/m2) were averaged both in scotopic and 
photopic conditions. Photopic cone responses were recorded following 5 min of light adaptation with 
a background white light (50 cd/m2). Light intensity was controlled for each animal group (Mavo-
Monitor USB, Gossen, Germany). Recorded electrophysiological responses were amplified, filtered 
(CP511 AC amplifier; Grass Instruments, Quincy, MA), and digitalized (ADInstruments Ltd, 
Oxfordshire, UK). The recording process was controlled with Scope version 3.8.1 software (Power 
Lab, ADInstruments Ltd). The stimulation protocols were designed according to the International 
Society for Clinical Electrophysiology of Vision. 
 
6.2.14   Generation of pRho-mRd3.V5-dsRed expression vector and in vivo DNA  
electroporation 
The expression vector used for in vivo DNA electroporation was based on the plasmid pRho-DsRed. 
pRho-DsRed was a gift from Connie Cepko (Addgene plasmid#11156; (Matsuda and Cepko 2004)). 
This plasmid contains the 2.2 kb-version of the rod opsin promoter from Bos Taurus (Zack et al. 
1991); a multicloning site; a Kozak sequence; the DsRed2 reporter gene; and the β-globin poly(A) 
signal (Matsuda and Cepko 2004). To make pRho-mRD3.V5-DsRed, murine rd3 cDNA was 
amplified by PCR with a forward primer that introduced an XbaI restriction site and the reverse 
primer introducing the V5 epitope in frame with RD3 COOH-terminal sequence, followed by an 
EcoRI restriction site. The mRD3.V5 DNA was inserted in the XbaI and EcoRI sites of pRho-DsRed, 
and the resulting expression vector was verified by sequencing. For in vivo electroporation, pRho-
mRd3.V5-dsRed vector was amplified with the pureLinkTM Expi Endotoxin-Free Mega Plasmid 
Purification Kit (Invitrogen, Carlsbad, California). 
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In vivo DNA electroporation in the retina following DNA injection in the subretinal space was 
performed as originally described (Matsuda and Cepko 2004) with minor modifications. A DNA 
solution (6 µg/µl) was prepared by mixing pRho-DsRed and pRho-mRD3.V5-DsRed at a molar ratio 
of 1:4 in phosphate saline buffer with 0.1% v-v fast green. Even though pRho-mRD3.V5-DsRed 
expressed dsRed, we found the levels of expression too low for detection of the eye injected area at 
the fluorescence dissection scope. Therefore pRho-DsRed was coinjected with pRho-mRD3.V5-
DsRed. Pups were injected the day they were born at the subretinal space, with 0.2–0.5 µl of DNA by 
using a Hamilton syringe with a blunt 30-gauge needle under a dissecting microscope (Zeiss 
KL1500LCD. Stemi2000, Germany). Tweezer-type electrodes were placed softly holding the head of 
the pup, and five 80 V square pulses of 50 ms duration with 950 ms intervals were applied using a 
CUY21 electroporator (Nepagene, Chiba, Japan). Electroporated eyes were processed at p20–p25 for 
immunofluorescence localization analysis as described above. Antibodies were anti-RetGC1 pAb and 
the anti-V5 mAb (#2F11F7, Invitrogen) by secondary antibodies α-rabbit Alexa Fluor 488 (Life 
Technologies) and α-mouse Alexa Fluor 647 (Life Technologies) both at 1:500 for 1.5 h at room 
temperature.  
Images were acquired with a LEICA SP5 microscope using a 63 × 1.4 NA oil objective. The pixel and 
step sizes are 100 nm and 198 nm respectively providing an effective image volume of 
131 µm × 131 µm × 9.5 µm. Two Hybrid detectors in photon counting mode and a photomultiplier 
tube (PMT) were used to acquire the different channels. The spectral configuration for the channel 1 
used a 488 nm laser line and an emission window from 498 to 535 nm. The channel 2 used the 633 nm 
laser line and an emission window between 642 and 722 nm. Finally, the channel 3 used the 543 nm 













6.3 Materials and methods for chapter 3 
6.3.1 Label-free quantitative proteomic analysis of enriched phosphopeptides from dark- 
and light-adapted bovine retinas 
Fresh calf eyes were obtained immediately postmortem and processed at the slaughterhouse premises.  
Upon collection, eyes were processed in a dark room by excising the cornea and submerging eyecups 
in chilled oxygenated Locke’s buffer (10 mM Hepes, 20 mM NaHCO3, 112.5 mM NaCl, 3.6 mM KCl, 
2.4 mM MgCl2, 1.2 mM CaCl2, 0.1 mM EDTA and 10 mM glucose, pH 7.4) for 1 hr of dark-
adaptation.  Retinas were then excised under dim red light.  Three retinas were kept for 5 min at room 
temperature in the dark; while three retinas were exposed to light of 2000 lux for 5 min.  Following 
dark/light exposure retinas were homogenized in homogenization buffer (HB) (20 mM Hepes, 115 
mM KCl, 10 mM NaCl, 10 mM MgCl2, 50 mM NaF, 5 mM ß-glycerophosphate, 1 mM PMSF and 
complete protease inhibitor cocktail [Complete mini EDTA-free, Roche], pH 7.4). Retinal 
homogenates were kept at -80ºC until further analysis. Subsequently, a basic fractionation protocol 
was performed to obtain fractions corresponding to soluble, peripheral and membrane proteins from 
each sample. Sample preparation for mass spectrometry analysis involved in solution digestion 
(peripheral and supernatant samples) or Filter Aided Sample Prep (FASP) digestion (membrane 
samples) (Wiśniewski et al. 2009). For in soluble digestion, samples were reduced with dithiothreitol 
(1 hr, 37°C) and alkylated in the dark with iodoacetamide (30 min, 25ºC).  Resulting protein extracts 
were diluted 1/3 with 200 mM NH4HCO3 and digested with LysC (#129-02541, Wako) overnight 
at 37ºC; and then diluted 1/2 and digested with trypsin (# V5113, Promega) for 8 hrs at 37˚C. The 
peptide mix was acidified with formic acid and desalted with a MacroSpin C18 column (The Nest 
Group, Inc).  For FASP digestion, samples were treated as previously described (Wiśniewski et al. 
2009). Samples were reduced with dithiothreitol (5 min, 95°C); alkylated in the dark with 
iodoacetamide (30 min, 25 ºC) and digested with LysC (# 129-02541, Wako) overnight at 37ºC and 
with trypsin (# V5113, Promega) for 8 hrs at 37˚C, as previously reported.  Phosphopeptide 
enrichment was performed in each sample with the Pierce TiO2 Phosphopeptide Enrichment kit (# 
88301,Thermo Fisher Scientific).  
Phosphopeptide mixes were analyzed in an Orbitrap Fusion Lumos mass spectrometer (Thermo 
Scientific, San Jose, CA, USA) coupled to an EasyLC (Thermo Scientific (Proxeon), Odense, 
Denmark).  Peptides were directly loaded onto the analytical column and separated by reversed-phase 
chromatography using a 50-cm column with an inner diameter of 75 µm, packed with 2 µm C18 
particles spectrometer (Thermo Scientific, San Jose, CA, USA).  Chromatographic gradients started at 
95% buffer A and 5% buffer B with a flow rate of 300 nl/min and gradually increased to 22% buffer 
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B in 79 min and then to 35% buffer B in 11 min.  After each analysis, the column was washed for 10 
min with 5% buffer A and 95% buffer B.  Buffer A: 0.1% formic acid in water.  Buffer B: 0.1% formic 
acid in acetonitrile. 
The mass spectrometer was operated in DDA mode and full MS scans with 1 micro scans at resolution 
of 120.000 were used over a mass range of m/z 350-1500 with detection in the Orbitrap. Auto gain 
control (AGC) was set to 2E5 and dynamic exclusion to 60 sec.  In each cycle of DDA analysis, 
following each survey scan Top Speed ions with charged 2 to 7 above a threshold ion count of 1e4 
were selected for fragmentation at normalized collision energy of 28%.  Fragment ion spectra 
produced via high-energy collision dissociation (HCD) were acquired in the Ion Trap, AGC was set 
to 3e4, isolation window of 1.6 m/z and a maximum injection time of 40 msec was used. All data were 
acquired with Xcalibur software v3.0.63.  
 
6.3.2 Data Analysis 
Proteome Discoverer software suite (v2.2, Thermo Fisher Scientific) and the Mascot search engine 
(v2.5, Matrix Science (2)) were used for peptide identification and quantification (Perkins et al. 1999). 
Samples were searched against the Uniprot proteome database corresponding to Bos Taurus 
(UP000009136), and a list of common contaminants (total entries 24,097), plus all the corresponding 
decoy entries.  Trypsin was chosen as enzyme and a maximum of three miscleavages were allowed.  
Carbamidomethylation (C) was set as a fixed modification, whereas oxidation (M), phosphorylation 
(STY) and acetylation (N-terminal) were used as variable modifications.  Searches were performed 
using a peptide tolerance of 7 ppm and a product ion tolerance of 0.5 Da, and identified 
phosphopeptides were filtered for FDR < 5 %. Phosphopeptides were quantified by extraction of its 
precursor areas using Skyline (version 4.2.0.19009).  Light/dark fold change and p values were 
calculated for phosphopeptides present in two or more replicates of each condition. 
 
6.3.3 In situ metabolic labeling 
Eight six-week-old C57BL6 mice were dark-adapted overnight.  Retinas were dissected under dim red 
light using a night vision dissecting scope, and placed in individual wells of  two 12-well dishes –eight 
retinas per dish- in 600 µl of Locke’s buffer (10mM Hepes, 20mM NaHCO3, 112.5mM NaCl, 3.6mM 
KCl, 2.4mM MgCl2, 1.2mM CaCl2, 0.1mM EDTA, 10mM glucose, sodium succinate, sodium 
glutamate, vitamin and amino acid supplement, pH 7.4) containing 1 mCi/ml 32P-orthophosphoric 
acid (9.000 Ci/mmol, NEX053010 Perkin Elmer, Waltham, MA, USA).  Retinas were incubated for 
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90 min at 37oC in a 5% CO2 incubator in the dark, to allow incorporation of the 32P radionuclide into 
the ATP pool of retinal cells.   
One multiwell dish was then placed over the bench at room temperature for 5 min in darkness (dark 
retinas); and the other was exposed to 2000 lux white light (light retinas) for 5 min.  Pools of two 
retinas were homogenized in HB.  Samples were then centrifuged at 14.000 rpm for 20 min, 4oC, to 
obtain supernatant and pellet fractions. Pellets were resuspended in HB with 1% TritonX100.  
Immunoprecipitation of IMPDH1 was carried out with 3 µg of anti-IMPDH1 pAb and 50 µl of 
Dynabeads-protein G (Thermo Scientific, Waltham, MA, USA).  Samples were resolved by SDS-
PAGE and transferred to nitrocellulose membranes, that were directly exposed to an X-ray film 
(AGFA Healthcare NV, Mortsel, Belgium) and subsequently immunoblotted for IMPDH1 using anti-
IMPDH1 pAb 1:5000 followed by goat-anti Rabbit IREDye 800 (LI-COR, Lincoln, NE, USA) 
1:5000. Bands visualized using an Odyssey Scan System (LI-COR).  An immunoprecipitation control 
was carried with an anti-IgG isotype control (#02-6102, Thermo Fisher Scientific). 
 
6.3.4 Isolectrofocusing separation of IMPDH1 
32P-labeled immunoprecipitated IMPDH1 from an in situ metabolic labeling procedure as described 
above was separated by isoelectrofocusing (IEF) to discern the differentially phosphorylated forms of 
the protein.  For that, IMPDH1 immunoprecipitated samples were dissolved in IEF loading buffer 
(7M urea, 2M thiourea, 4% CHAPs, 40mM DTT, 2% IPG buffer).  Samples were loaded into 
prehydrated pH-gradient IEF gel strips (18 cm linear gradient pH 3-10 DryStrips from GE Healthcare, 
Chicago, IL, USA), and run in an Ettan IPGphor3 IEF system (GE Healthcare, Chicago, IL, USA).  
Gel strips were incubated for 10m in transfer buffer (25 mM Tris base pH 8.3, 190 mM glycine, 0.2% 
SDS, 20% methanol) and proteins transferred to nitrocellulose membranes by capillary action.  
Membranes were first exposed to an X-ray film and subsequently immunoblotted for IMPDH1 as 
indicated above. 
For isoelectric focusing analysis of IMPDH1 from retinas of living mice after dark/light adaptation, 
mice were dark-adapted for 16 hrs and exposed to 2000 lux bright light after pupil dilation for 5, 20 
or 60 min.  Retinas were dissected and homogenized in HB.  Retinal homogenates were centrifuged 
at 13000 rpm for 20 min 4oC and supernatant fractions were kept.  Protein was precipitated with 3 
volumes of ice-chilled TCA-acetone buffer (13.3% w/v trichloroacetic acid in acetone, 20mM DTT), 
and samples were cooled at -20ºC for 16 hrs, and centrifuged at 13200 rpm for 1 hr at 4oC.  Protein 
pellets were washed in acetone, air-dried, resuspended in IEF buffer and resolved by IEF as described. 
  
 
   167 
 
6.3.5 Cloning of HsIMPDH1 different spliced forms into pETEV and site-directed 
mutagenesis 
 
Human IMPDH1 (1-514) ORF was obtained from a cDNA library and cloned into an in house 
modified pET15b expression vector (Alonso-García et al. 2009). A PCR-based strategy was used 
to insert NH2- and COOH- extra sequences to the ORF of the canonical protein, to generate the 
hIMPDH1 spliced retinal isoforms (1-546 and 1-595).  All DNA constructs were corroborated by 
DNA sequencing. 
 
Phosphomimetic mutants for enzymatic analysis were obtained by introducing mutations that 
created individual substitutions T159D, S160D, S416D, S477D into the 
pETEV15b_HsIMPDH1(546) vector; or in the pETEV15b_HsIMPDH1(514), using the 
QuickChange II Site-directed mutagenesis Kit (Agilent Technologies).   
 
Phospho-knockout mutants for in vitro phosphorylation assays were obtained by introducing 
mutations that created triple substitutions that left only one phosphorylation site 
S160G/S416G/S477G (T159 only); T159G/S416G/S477G (S160 only); T159G/S160G/S477G 
(S416 only) and T159G/S160G/S416G (S477 only) into the pETEV15b_HsIMPDH1(546). A 
mutant was also generated with the 4 phosphorylation sites mutated to Gly (4KO mutant).   
 
Blindness associated mutations R105W, N198K, R224P, D226N, V268I and H372P were 
introduced by site-directed mutagenesis in the pETEV15b_HsIMPDH1(546) vector. 
 
Primers used for site-directed mutagenesis are listed (Table 8).  
 


















Mutant Fw/Rv Sequence primer 
S160D Fw 5’-GGTGGGCATCGTCACCGACCGAGACATCGACTTT-3’ 
 Rv 5’-AAAGTCGATGTCTCGGTCGGTGACGATGCCCACC-3’ 
T159D/S160D Fw 5’-GCAAGCTGGTGGGCATCGTCGACGACCGAGACATCGACTTTCTTG-3’ 
 Rv 5’-CAAGAAAGTCGATGTCTCGGTCGTCGACGATGCCCACCAGCTTGC-3’ 
S416D Fw 5’-TACCGGGGCATGGGCGATCTGGATG-3’ 
 Rv 5’-CATCCAGATCGCCCATGCCCCGGTA-3’ 
S477D Fw 5’-GGCCCGCAGCCTGGATGTCCTTCGGTCC-3’ 
 Rv 5’-GGACCGAAGGACATCCAGGCTGCGGGCC-3’ 
T159G Fw 5’-TGGTGGGCATCGTCGGCTCCCGAGACATCG-3’ 
 Rv 5’-CGATGTCTCGGGAGCCGACGATGCCCACCA-3’ 
S160G Fw 5’-GTGGGCATCGTCACCGGCCGAGACATCGACTT-3’ 
 Rv 5’-AAGTCGATGTCTCGGCCGGTGACGATGCCCAC-3’ 
T159G/S160G Fw 5’-AGCTGGTGGGCATCGTCGGCGGCCGAGACATCGACTTTC-3’ 
 Rv 5’-GAAAGTCGATGTCTCGGCCGCCGACGATGCCCACCAGCT-3’ 
S416G Fw 5’-CGGGGCATGGGCGGACTGGATGCCATGGAG-3’ 
 Rv 5’-CTCCATGGCATCCAGTCCGCCCATGCCCCG-3’ 
S477G Fw 5’-GGCCCGCAGCCTGGGTGTCCTTCGGTCC-3’ 
 Rv 5’-GGACCGAAGGACACCCAGGCTGCGGGCC-3’ 
R105W Fw 5’-CAGGCCAACGAGGTGTGGAAGGTCAAGAAGT-3’ 
 Rv 5’-ACTTCTTGACCTTCCACACCTCGTTGGCCTG-3’ 
N198K Fw 5’-GTGACGTTGAAAGAGGCAAAGGAGATCCTGCAGCGTAGCA-3’ 
 Rv 5’-TGCTACGCTGCAGGATCTCCTTTGCCTCTTTCAACGTCAC-3’ 
R224P Fw 5’-GCCATCATCGCCCCCACCGACCTGAAG-3’ 
 Rv 5’-CTTCAGGTCGGTGGGGGCGATGATGGC-3’ 
D226N Fw 5’-ATCATCGCCCGCACCAACCTGAAGAAGAACC-3’ 
 Rv 5’-GGTTCTTCTTCAGGTTGGTGCGGGCGATGAT-3’ 
V268I Fw 5’-CACCCAGGCGGGCATCGACGTCATAGT-3’ 
 Rv 5’-ACTATGACGTCGATGCCCGCCTGGGTG-3’ 
H372P Fw 5’-CAGACCGTGGGACCCGTGGTCAAGGCC-3’ 
 Rv 5’-GGCCTTGACCACGGGTCCCACGGTCTG-3’ 
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6.3.6 Purification of IMPDH1 enzymes 
  
Human IMPDH1 enzymes were expressed in Escherichia coli strain BL21 (DE3) and purified by nickel-
chelating affinity chromatography as described before (Krishnaiah 1975), and as described in methods 
for Chapter 1. His-tag was removed from the recombinant proteins for the GDP/GTP assays.   
 
6.3.7 Enzymatic assays 
IMPDH activity was studied by monitoring the increase in absorbance at 340nm upon reduction of 
NAD+ at 32ºC, using 96-well microtiter plates. The reaction buffer was 100 mM Tris-HCl, 100 mM 
KCl, 2 mM DTT, pH 8.0. Final enzyme concentrations were set to 100 µgmL-1, NAD+ concentration 
was fixed at 0.5 mM and IMP concentration varied from 0.04 to 5 mM. Purine nucleotides were 
assayed at concentrations ranging from 0.09 to 6 mM. Free Mg2+ concentration was kept constant at 
1 mM, as previously described (Buey et al. 2017). The experimental data were non-linearly fitted to 
the Michaelis-Menten equation of enzyme kinetics using the GraphPad Prism program (GraphPad 
software) in order to obtain the maximum apparent initial velocity (Vmaxapp) as a function of the 
nucleotide concentration. Normalized Vmax values were calculated by dividing the Vmaxapp value in the 
presence of GTP/GDP nucleotides by Vmax in the absence of nucleotides. 
 
6.3.8 In vitro phosphorylation with PKC 
For in vitro phosphorylation assays with PKC, 5 µg of recombinant protein HsIMPDH1(546) or its 
mutants were diluted in 12 µl of dilution buffer (TrisHCl pH 8, 500 mM KCl and 2 mM DTT),  mixed 
with an equal volume of 2x kinase buffer (20 mM TrisHCl pH 7; 20 mM MgCl2; 0.05 mM phorbol 
12-myristate 13-acetate (PMA); 0.2 mM CaCl2; 0.2 mM ATP); 1 µl of 32P-ATP γ 3000 Ci/mmol (Perkin 
Elmer, Boston, Masachusetts, USA) and 1 µl of recombinant hPKC α (100ng/µl, Enzo Life Sciences, 
Farmingdale, NY, USA).  Samples were incubated for 15 min at 30oC, and reactions were stopped by 
addition of 4x SDS loading buffer.  Sample fractions corresponding to 2.5 µg of HsIMPDH1(546) 
were resolved by 12% SDS-PAGE, and proteins were transferred to 0.2 µm nitrocellulose membranes 
(Bio-rad). The membranes were first exposed to X-ray films (AGFA Healthcare NV, Mortsel, 
Belgium) for 2 hrs; and subsequently immunoblotted for IMPDH1. Membranes were scanned at an 





6.3.9   Nucleotide determination in retinal extracts by HPLC 
 
GMP, GDP, GTP, AMP and ATP levels were analytically measured in perchloric acid murine retinal 
extracts by ion-pairing high-performance liquid chromatography (HPLC).  For in situ experiments, 6-
8 week old C57Bl mice were dark-adapted for 16 hrs and their retinas were dissected under dim red 
light.  Retinas were placed in DMEM high glucose and either kept in the dark for 5 min at room 
temperature, or exposed to 2000 lux white light.  Immediately after the 5 min dark/light exposure 
retinas were washed with ice-cold PBS and pools of four retinas were homogenized in 120 µl of 1.2 
M perchloric acid in PBS.  Samples were centrifuged at 16000 rpm for 40 min at 4oC.  Deproteinized 
supernatants were transferred to new tubes, extracted with 1 vol of HPLC-grade chloroform, 
neutralized, clarified and filtered through 0.22 µm filters (Nanosep MF 0.22 µm, Pall, Westborough, 
Massachusetts, USA).  Samples were kept at -80oC until HPLC analysis.  For the in situ experiment to 
test the effect of PKC inhibition on the dark/light levels of guanine nucleotides, bisindolylmaleimide 
I (BM) was added to the medium at 50 nM concentration, and the dark-adapted retinas were incubated 
in a 5% CO2 incubator for 30 min, protected from light.  Retinas were then kept in the dark for 5 min, 
or exposed to 2000 lux white light for 5 min and processed as above.  For the in vivo experiment, 
retinas were obtained from 16 hrs dark-adapted mice or from mice exposed to 2000 lux white light 
for 4 hrs with pupils dilated, and processed the same way. 
HPLC analysis was performed as previously described (Di Pierro et al. 1995), with minor 
modifications.  A BRISA LC2 C18, 250 x 4.6mm, 5 µm particle size column (Teknokroma, Sant Cugat 
del Vallés, Spain) was equilibrated with mobile phase eluent A (10 mM tetrabuthylammonium 
hydroxide, 10 mM KH2PO4 , 0.25% v:v methanol, adjusted to pH 7.00 with HCl).  A linear gradient 
was formed with eluent B (2.8 mM tetrabuthylammonium hydroxide, 100 mM KH2PO4, 30% v:v 
methanol, adjusted to pH 5.5 with HCl) as follows: 5 min 100% eluent A; 5 min 90% eluent A; 5 min 
70% eluent A; 10 min 63% eluent A; 5 min 55% eluent A; 10 min 45% eluent A; 20 min 25% eluent 
A; 20 min 0% eluent A (100% eluent B).  A Waters Acquity HPLC with a 210nm-380nm diode array 
detector was used, at a flow rate of 0.8 ml/min and constant temperature of 40oC.  Injector 
temperature was 10oC.  Standard stock solutions (GMP, GDP, GTP, AMP, ATP) were diluted in 0.1 
M KH2PO4.  Nucleotide concentrations in each sample were determined by measuring the area of the 
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6.3.10   In vivo metabolic flux analysis by injection of a stable isotope of Gly 
 
A group of 6 week-old C57Bl mice was dark-adapted overnight.  They were anesthesized with an 
intraperitoneal injection of ketamine (70 mg/kg; Ketalar, Parke-Davis, Wellington, New Zealand) and 
xylazine (7 mg/kg; Rompun, Bayer, Leverkusen, Germany) in saline solution (NaCl 0.9%), and 
injected intravitreally with 1 µl of a 20 mM solution of 13C2,15N-Glycine (#CNLM-1673-H-0.5, 
Cambridge Isotope Laboratories) in phosphate saline buffer. The injection was performed under dim 
red light.  Mice were kept in darkness, or immediately transferred to a bright light setting (2000 lux 
white light) for 4 hrs.  Mouse recovery from anesthesia in the dark or light setting was promoted by 
keeping the mouse body temperature with a heating pad.  After 4 hrs, retinas were collected, frozen 
in dry ice and kept at -80oC until mass spectrometry analysis. Mass spectrometry analysis was 
performed as previously described (Roig et al. 2017).  
 
6.3.11   Electroretinogram analysis 
 
A group of four mice was used for benzamide (BZM) injection, a group of seven mice for 
mycophenolate mofetyl (MMF) injection, and a group of four mice for bisindolylmaleimide I (BM) 
injection. Dark-adapted (>12 hrs) animals were anaesthetized with an intraperitoneal injection as 
described above. For each mouse the right eye was injected with the inhibitor (BZM, MMF or BM), 
and the left eye with the physiological saline buffer used for drug dilution.  MMF was injected 
intravitreously to an effective concentration of 200 nM (1 µl injection of 1 µM stock); BZM was 
injected to an effective concentration of 80 µM (1 µl injection of 400 µM stock); and BM was injected 
to an effective concentration of 200 nM (1 µl injection of 1 µM stock).  Two corneal electrodes were 
used to record simultaneous ERGs from both eyes (Burian-Allen, Hansen Ophthalmic Development 
Lab, Coralville, IA).  Electrodes were placed in the visual axis 2-3 mm from the cornea, with a drop 
of 2% methyl-cellulose (Methocel, Ciba Vision, Hetlingen, Switzerland) between corneas and 
electrodes.  Mice were maintained for >10 min in absolute darkness before the recordings, initiated 
20 min after drug injection (30 min for BM treated mice).  Mouse temperature during the recording 
was maintained at 37 °C with a heating pad (Hot-Cold, Pelton Shepherd Industries, Stockton, CA).  
Full-field flash ERG was performed, with the retina illuminated with a Ganzfeld dome.  To test the 
effect of IMPDH inhibitors on rod mass recovery after a saturating light flash, we applied the paired-
flash paradigm (Lyubarsky and Pugh 1996), by triggering a test flash (3 Cd·s/m2) followed by a probe 
flash of identical intensity at increasing inter-stimulus (IST) intervals: 400, 600, 800, 1200, 1500 and 
2000 ms (double flash).  The rate of recovery for the a- and b-waves at each IST was obtained by 
calculating the ratio of a- or b-wave of the probe flash to the a- or b-wave of the test flash.  Cone 
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responses were recorded following 5 min of light-adaptation with background white light (50 Cd/m2) 
to a flash light of 3 Cd·s/m2.  Recorded electrophysiological responses were amplified; filtered (CP511 
AC amplifier; Grass Instruments, Quincy, MA), and digitalized (ADInstruments Ltd, Oxfordshire, 
UK). The recording process was controlled with Scope version 3.8.1 software (Power Lab, 
ADInstruments Ltd). The stimulation protocols were designed according to the International Society 
for Clinical Electrophysiology of Vision.  
 
 
6.3.12   IMPDH1 immunofluorescence localization in retinal sections 
 
For the analysis of spicula formation in response to mycophenolic acid (MPA) treatment, retinas 
from 16 hrs dark-adapted mice were dissected under dim red light and placed in DMEM-high 
glucose in the presence or absence of 10 µM MPA, protected from light in a 5% CO2 incubator 
for 1 or 2 hrs.  For analysis of the effect of living mice exposure to constant bright light, 16 hrs 
dark-adapted mice were exposed to 2000 lux bright light for 20 min, 2 hrs or 4 hrs after pupil 
dilation with a drop of phenylephrine and tropicamide.   
 
For 15 d constant-dark or 15 d constant-light rearing, mice were either housed in a dark cabinet 
or in a set of constant bright light exposure (2000lux) for 15 days. 
 
For studying the reversibility of IMPDH1 aggregates, mice were exposed to bright light (2000 lux) 
for 72h and then divided in two groups; first group was processed immediately after 72h bright 
light exposure; and the second group was kept in dark for 16 hr before processing.  
 
The obtention of retinal sections for immunofluorescence experiments and antigen retrieval 
protocols have been described in methods for chapter 1. For IMPDH1 localization primary 
antibodies were anti IMPDH1 (1:250), anti-Rhodopsin 1D4 (1:15000) and PNA-647 (1:40) 
(# L32460, Thermo Fisher Scientific) incubated over night at 4ºC. Secondary antibodies were anti-
rabbit Alexa Fluor 488 (#A-11034, Thermo Fisher Scientific) 1:500 and anti-mouse Alexa Fluor 
555 (#A-32727, Thermo Fisher Scientific) 1:500 incubated for 2h at room temperature.  Sections 
were mounted with Mowiol (Calbiochem). 
 
Confocal microscopy images were acquired with a confocal laser scanning microscope Leica SP5 
equipped with two HyD detectors. The spectral bands were set to 491-546 nm and 566-663 nm 
for 488 nm and 555 nm, respectively. The used objective was a HC PL APO 100x/1.4NA Oil and 
the samples were mounted on type 1.5 coverglasses (170 mm thick).  The stacks covered 
approximately 2 µm in the z-axis with a 0.13 µm step size. The settings of the image acquisition 
provided a pixel size of about 74.8 nm x 74.8 nm. 
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The image analysis of the immunofluorescence data was performed using Fiji (ImageJ).  In order 
to maximize the signal to noise ratio, we used the average projection of groups of 3 planes from 
large z-stacks.  For the particle quantification, we selected a region of interest (e.g. magnified 
frames of rod outer segment layer) and we applied a light Gaussian filter (radius of one pixel).  To 
determine the size of the areas with concentration of fluorescence we selected the pixels from the 
image that had a signal beyond a certain value. This value was determined from the statistics of 
intensity, taking only the 8% of the brighter pixels. Then, the areas of the spots were analyzed by 
using the plugin “analyze particles” from Fiji.  Counted spots were plotted according to its size 
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8.1 Cover  
Shown in the cover is a wild-type murine retina stained with acetylated-γ-tubulin (green signal) and 
IMPDH1 (red signal). Cover wants to show how specific is the expression of IMPDH1 in 
photoreceptor cells.  
In standard cyclic light conditions, IMPDH1 signal is restricted to photoreceptor cells staining inner 








































   
 
   205 
AGRAÏMENTS 
 
A part de totes les persones que m’han ajudat per tal de realitzar la tesis, a qui m’he anat dirigint durant 
els diferents capítols en els apartats de contribucions, m’agradaria fer uns agraïments més personals 
dirigits a aquelles persones que han estat al meu costat durant aquesta etapa.  
 
Primer de tot voldria agrair a la meva directora de tesis Ana Méndez deixar-me formar part del seu 
laboratori. Durant aquests anys he tingut la oportunitat de rebre una formació extensa, de la que 
m’enduc moltes coses. Per una banda totes les tècniques que he après, i per altra banda el marc 
intel·lectual que l’Ana ha anat inculcant en mi (sobretot allò de... Anna, tenemos que ir a por la 
“pregunta de calado” J). Ana, he après moltíssim; també que la ciència no és un camí de roses... (pero 
hay que ser más resiliente). Gràcies per tots aquests aprenentatges professionals i també personals, 
que m’emporto!  
  
A en Santi moltes gràcies per introduir-me en el mon del laboratori, per totes les idees que han acabat 
repercutint en aquest treball i totes les tècniques que va posar a punt. Va esser un plaer tenir-te com a 
mentor i company!!! 
 
A tots aquells que han passat pel laboratori, espero no deixar-me a ningú: Anna, Sergi, Ari, Francesc, 
Alex, Nerea, Marta, Alba, Laia, Paula i “Nerea pequeña”. Alguns heu passat temporades més 
curtes que d’altres, però recordo moments molt especials amb tots vosaltres. Tots heu estat de gran 
ajuda gràcies al vostre esforç i dedicació. Martona, a tu et deixo el relleu del laboratori (i en breus et 
faré entrega de la clau de la càmera fosca :D) desitjo que aprenguis moltes coses en aquesta nova etapa 
i que siguis un boost d’energia i coneixement pel laboratori. Moltíssima sort!! 
 
Als companys amb qui compartim laboratori, els diferents, variats, d’aquí i d’allà, els fotoswitches: 
heu estat el meu gran suport durant aquesta etapa. A part de ser grans científics sou tots persones 
increïbles i m’emporto uns grans amics. Ros et trobaré tantíssim a faltar, gràcies per donar-me suport 
sempre, fer que els dinars hagin estat tan entretinguts i per les tardes fins les tantes donant-nos ànims 
“forza Anita” J. Núria, ets fantàstica! Gràcies per ser-hi sempre i per ser l’alegria del laboratori! 
També per escoltar-me i guiar-me i “tranquil·litzar-me” també jeje :D Alex i Ricardo, us poso en el 
mateix pack ja que em sembla que heu estat els meus dos grans psicòlegs sobretot aquest últim any 
(deveu tenir unes ganes que marxi...) moltes gràcies per la vostra serenitat i paciència; us desitjo molta 
sort i espero que no perdem mai el contacte (Alex espero que recordis la meva cara d’aquí a dos mesos, 
gràcies). Aideta, la meva lleidatana, he rigut molt amb aquest idioma que parles i les coses que et 
passen, estic molt orgullosa del treball que has fet i malgrat m’has acabat avançant en la finalització de 
la tesis, jo no recordo haver fet mai cap aposta ;) A en Miquel vull agrair-li la seva proximitat i 
 
 206 
amabilitat (i els seus acudits dolents...bé potser això no tant ;)). Galyna, la nova incorporació, m’ho 
he passat molt bé amb tu, gràcies per la teva simpatia i consells J Nois, de veritat, ha estat un plaer 
compartir aquests anys al vostre costat! Ens veiem a plaça Osca, oi? ♡ 
 
Voldria agrair també als membres del departament de Fisiologia tot el suport que m’han donat 
sempre que ho he necessitat. Gràcies per ajudar-me en diferents tècniques i fins i tot per deixar-nos 
certs reactius en moments que ho hem necessitat. Gràcies a la Carla Pérez per ajudar-me amb el SNP 
genotyping, tots els “tips” que em vas donar van ser essencials per a desenvolupar aquesta tècnica. 
Gràcies al grup de Jose Luis Rosa per les mil i una vegades que ens han ajudat ja sigui aportant idees 
per avançar en el nostre treball, deixant-nos reactius, etc. I a tots aquells que d’una manera o altra heu 
ajudat a que aquest treball sigui possible. A l’Ana Manzano voldria agrair-li les paraules amables i de 
suport que sempre m’ha donat i per haver estat l’alegria del despatx :D   
 
No podria deixar-me els membres del grup de Biologia Cel·lular moltíssimes gràcies per tot. Gràcies 
per deixar-me utilitzar tota la bateria d’aparells sofisticats i moderns que teniu. Gràcies també a la 
Vanessa i la Marta pel seu suport durant els últims mesos quan em van ajudar a encarrilar els últims 
experiments. I a en Pep, gràcies per l’ajuda i “tips” que m’ha donat.  
 
A la Rocio del laboratori de Microbiologia moltes gràcies per ser sempre allà per escoltar-me i 
aconsellar-me en els moments més difícils. I molts ànims que ben aviat serà el teu moment :) 
 
Voldria fer un especial agraïment a l’Andreu, per tota la paciència que ha tingut aquests anys. Encara 
que no entrava dintre els nostres plans que la tesis s’allargués més de l’esperat, has aguantat al meu 
costat, donant-me suport i cuidant-me. Per això et dedico aquesta tesis, per compensar una mica 
aquesta espera que sé que se t’ha acabat fent pesada.♡ 
 
Gràcies també a la Clara, amb qui compartim aventures des de que vam començar la carrera. Sempre 
m’has donat bons consells en moments complicats i ens hem donat suport mútuament. Ara que és el 
moment en què et poses a escriure la tesis, veurem com reacciones a les teves pròpies frases ;)   
 
Finalment voldria fer un agraïment a la meva família per a tot el suport que m’han donat, per 
respectar sempre les meves decisions i creure en mi. I a les meves nenes: Isa, Sandra, Pilar i Neu 
que sabeu que us poso en el pack de la família, perquè és com si ho fóssiu. Gràcies per ser-hi des de 
petites i no deixar que aquesta amistat es trenqui, heu estat sempre fonamentals i també en aquesta 
etapa.   
 
 

























Plana-Bonamaisó et al. Cell Death and Disease           (2020) 11:62 
https://doi.org/10.1038/s41419-020-2255-0 Cell Death & Disease
ART ICLE Open Ac ce s s
GCAP neuronal calcium sensor proteins mediate
photoreceptor cell death in the rd3 mouse model
of LCA12 congenital blindness by involving
endoplasmic reticulum stress
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Abstract
Loss-of-function mutations in the retinal degeneration 3 (RD3) gene cause inherited retinopathy with impaired rod
and cone function and fast retinal degeneration in patients and in the natural strain of rd3 mice. The underlying
physiopathology mechanisms are not well understood. We previously proposed that guanylate cyclase-activating
proteins (GCAPs) might be key Ca2+-sensors mediating the physiopathology of this disorder, based on the
demonstrated toxicity of GCAP2 when blocked in its Ca2+-free form at photoreceptor inner segments. We here show
that the retinal degeneration in rd3 mice is substantially delayed by GCAPs ablation. While the number of retinal
photoreceptor cells is halved in 6 weeks in rd3 mice, it takes 8 months to halve in rd3/rd3 GCAPs−/− mice. Although
this substantial morphological rescue does not correlate with recovery of visual function due to very diminished
guanylate cyclase activity in rd3 mice, it is very informative of the mechanisms underlying photoreceptor cell death. By
showing that GCAP2 is mostly in its Ca2+-free-phosphorylated state in rd3 mice, we infer that the [Ca2+]i at rod inner
segments is permanently low. GCAPs are therefore retained at the inner segment in their Ca2+-free, guanylate cyclase
activator state. We show that in this conformational state GCAPs induce endoplasmic reticulum (ER) stress,
mitochondrial swelling, and cell death. ER stress and mitochondrial swelling are early hallmarks of rd3 retinas
preceding photoreceptor cell death, that are substantially rescued by GCAPs ablation. By revealing the involvement of
GCAPs-induced ER stress in the physiopathology of Leber’s congenital amaurosis 12 (LCA12), this work will aid to
guide novel therapies to preserve retinal integrity in LCA12 patients to expand the window for gene therapy
intervention to restore vision.
Introduction
Synthesis of cyclic GMP (cGMP) is an essential process
in photoreceptor cells of the retina, as cGMP is the signal-
transducing molecule in the light response1,2. Mutations
in a number of genes that impair or alter cGMP synthesis
in rods and cones have been associated to different forms
of blindness3–12. Loss-of-function mutations in the RD3
gene (name from the natural strain of “retinal degenera-
tion 3” mice, rd3 locus mutated) cause Leber’s congenital
amaurosis 12 (LCA12)13,14. LCA12 is characterized by rod
and cone impaired function and severe vision loss from an
early age, as well as rapid retinal degeneration.
The RD3 protein is required for the stability and ciliary
trafficking of guanylate cyclases RetGC1 and RetGC2,
responsible for cGMP synthesis15. In rd3 mice the levels
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of RetGC1 and RetGC2 are dramatically decreased, and
proteins are retained at the cell soma15. GCAPs (guanylate
cyclase-activating proteins), that are proteins that confer
Ca2+ sensitivity to RetGCs16–20 and depend on their
binding to RetGCs for their stability and distribution to
the outer segment, are also decreased in rd3 mice15,21,22.
As a consequence, there is reduced cGMP synthesis that
results in closure of cyclic nucleotide-gated channels
(CNG-channels) and presumed chronic hyperpolarization
of rd3 photoreceptors, concomitant to loss of visual
function. This phenotype mimics that of LCA1 caused by
null mutations in GUCY2D (RetGC1) in humans23, or by
retinal guanylate cyclase deficiency in mice (RetGC1/
RetGC2 double knockout mice21). However, while mice
deficient in RetGC1/RetGC2 show a progressive retinal
degeneration, in rd3 mice the loss of photoreceptor cells
progresses fast24.
RD3 was also reported to be a potent inhibitor of RetGC
catalytic activity in vitro25, diminishing RetGC basal
activity and competing with GCAP1 for RetGC binding. It
was proposed that one role of RD3 would be to prevent
RetGC activation while RetGCs traffic through the inner
segment25.
Little is known about the molecular mechanisms that
link the lack of RD3 with photoreceptor cell death in rd3
mice. We previously proposed that the GCAP proteins
could contribute to the physiopathology of retinal dys-
trophies characterized by rod/cone chronic hyperpolar-
ization. This hypothesis was based on the fact that when a
form of GCAP2 impaired to bind Ca2+ (with all functional
EF-hands mutated, EF−GCAP2) was expressed in living
photoreceptors, it was retained at the cell soma by
phosphorylation and 14-3-3 binding, resulting in severe
toxicity and fast retinal degeneration26. In rd3 mice,
GCAPs are retained at the cell soma in a presumed
context of chronic low [Ca2+]i. In addition, GUCA1B
(GCAP2) has been reported as a modifier gene of the rd3
mouse phenotype27. We hypothesized that Ca2+-free
GCAPs could be critically involved in the physiopathology
of LCA12.
We here tested that hypothesis by breeding rd3 mice to
GCAPs−/− mice. We show that the retinal degeneration
of rd3 mice was drastically delayed by GCAPs ablation.
While in rd3 mice the number of photoreceptors was
halved in 6 weeks, in rd3/rd3 GCAPs−/− it was halved in
8 months. By assessing the extent of GCAP2 phosphor-
ylation in rd3 mice, we infer that the GCAP proteins are
mostly in their Ca2+-free cyclase activator state in rd3 cell
somas. By expressing RD3.V5 as a transient transgene in
the rods of rd3 mice, we confirm that RD3 localizes
mostly to the inner segment compartment of rods, which
is consistent with the proposed role of RD3 as a RetGC
inhibitor. We show prominent induction of endoplasmic
reticulum (ER) stress and mitochondrial swelling in rd3
mice, that are substantially prevented by GCAPs ablation.
We conclude that GCAPs mediate the physiopathology of
LCA12 by triggering ER stress, and discuss the putative
mechanisms by which they might do so, ultimately
causing mitochondrial swelling, energy failure, and
cell death.
Results
Retinal degeneration due to RD3 deficiency is substantially
rescued by GCAPs ablation
To test the hypothesis that the GCAP proteins con-
tribute to the physiopathology of blindness associated to
the lack of functional RD3, we bred rd3 mice to GCAP1/
GCAP2 double knockout mice (GCAPs−/− mice), to
assess whether the retinal degeneration was delayed.
We first characterized the rate of retinal degeneration in
the specific rd3 strain used in this study (B6.Cg-Rd3rd3/
Boc), hereinafter referred to as rd3 mice, as rates of
degeneration vary in different rd3 strains24. As early as at
postnatal day 20 (p20), rd3mice presented a thinner outer
nuclear layer (ONL) than wild-type mice (10 rows versus
12 rows of nuclei, Fig. 1a). An statistical analysis of ONL
thickness performed on morphometric measurements
from wt/rd3 and rd3/rd3 littermate mouse retinas at p20,
p26, and p44 revealed that in rd3 mice the number of
photoreceptor cells was halved in ~6 weeks (Fig. 1a, b).
This is consistent with the reported rate of degeneration
of rd3 pigmented mouse strains24.
We confirmed that RetGC1 expression was severely
reduced in rd3 mice15. RetGC1 levels were reduced to
~12% of the expression in control mice at p20, Fig. 1c.
The expression levels of GCAP1 and GCAP2 were
reduced to 37 and 42% of the levels in control mice, Fig.
1c. A novel observation was that RetGC1 was detected by
immunofluorescence analysis on retinal sections of rd3
mice at the inner segment layer and perinuclear region of
photoreceptors, showing a characteristic punctated
staining, Fig. 1d. GCAP1 and GCAP2 were largely
retained to proximal photoreceptor compartments in rd3
mice, as previously described15, Fig. 1d. Specificity of the
antibodies to RetGC1 and RD3 used in Fig. 1c, d is shown
in Supplementary Fig. 1.
To assess whether ablation of GCAPs affected the time
course of retinal degeneration in the rd3 mice, we bred
rd3mice to GCAPs−/− mice. To minimize strain variation
effects, the breeding was established between rd3/rd3
GCAPs+/− mice, and homozygous rd3/rd3mice that were
either GCAPs+/− or GCAPs−/− littermates were com-
pared, Fig. 2. The ONL width of rd3/rd3 mice at p44 from
Fig. 1 is plotted as a reference. Compared to rd3/rd3 mice
at p44 (ONL thickness of 20 μm, 5 nuclei), rd3/rd3
GCAPs+/− showed a very minor improvement at this age
(22–24 μm, 5–6 nuclei, n= 4); while rd3/rd3 GCAPs−/−
mice showed a striking improvement (30–32 μm, 7–8
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Fig. 1 Time course and molecular alterations that characterize the retinal degeneration in rd3 mice strain B6.Cg-Rd3rd3/Boc. a Retinal
micrographs of wild type and rd3/rd3mice at p20, p26, and p44 show the progressive retinal degeneration in rd3/rd3mice, that halves the number of
photoreceptor cells at p44. Scale bar 20 μm. b Retinal morphometric analysis of wt/rd3 and rd3/rd3mice at the indicated ages, showing outer nuclear
layer (ONL) length (μm) at 200 μm intervals from the optic nerve in the vertical meridian of the eye, superior retina to the right. Each trace represents
the average measurements of four mice analyzed, with error bars indicating the standard error of the mean (SEM). (n= 2 biological replicas at p20,
and n= 2 biological replicas at p26 for wt/rd3 and rd3/rd3; n= 4 biological replicas at p44 for rd3/rd3). c Expression levels of RetGC1, GCAP1, and
GCAP2 in rd3/rd3mice compared to wt/rd3mice at p30. Histograms indicate the percentage of expression of each protein in rd3/rd3mice versus wt/
rd3 mice, after normalization with α-tubulin. No RD3 protein is detected in rd3/rd3 mice with an antibody generated against the RD3 C-terminus. For
the determination of protein levels, three independent experiments were performed: RetGC1 (wt/rd3 versus rd3; P < 0.0001***); GCAP1 (wt/rd3 versus
rd3; P < 0.032*); and GCAP2 (wt/rd3 versus rd3; P= 0.0017**). d Immunofluorescence localization of RetGC1, GCAP1, and GCAP2 in wt/rd3 and rd3/rd3
mice at p24. RetGC1, GCAP1, and GCAP2 signals are greatly reduced in rd3/rd3mice, and mostly restricted to the photoreceptor inner layer. Cones are
labeled with peanut agglutinin (PNA) in red; the rod outer segment layer with anti-Rhodopsin mAb 1D4 (1 cm overlay in cyan), and nuclei are labeled
with DAPI (blue). Scale bar 20 μm. OS, outer segment; IS, inner segment; ONL, outer nuclear layer; ST, synaptic terminals.
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nuclei, n= 4), Fig. 2a, b. This substantial rescue effect of
GCAPs ablation was preserved at p60 (Fig. 2c, d), when
four biological replicas per genotype were analyzed. In the
absence of GCAPs, the rd3 mice preserved 75% of their
photoreceptors at p60; while in the presence of GCAPs
they preserved <50%.
This substantial preservation of photoreceptors in the
absence of GCAPs correlated with an increase in RetGC1
levels in rd3/rd3 GCAPs−/− retinas (Fig. 2e, f). Quite
surprisingly, RetGC1 in rd3/rd3 GCAPs−/− mice was
distributed to rod outer segments (ROSs) to a higher
extent than in rd3/rd3 mice (Fig. 2g, i).
At 8 months of age, rd3/rd3 mice did not retain any
photoreceptor cells, while rd3/rd3 GCAPs−/− mice pre-
served five rows of photoreceptors with visible outer
segments, Fig. 2j, k.
We conclude that GCAPs ablation markedly slows
down photoreceptor cell death in the rd3 mice, implying
that GCAP proteins are involved in the physiopathology
of LCA12.
Morphological rescue of rd3 retinas by GCAPs ablation
does not correlate with an amelioration of visual function
To test whether the substantial morphological rescue of
rd3mice that resulted from GCAPs ablation correlated with
an amelioration of visual function, light-elicited electro-
retinogram (ERG) responses were recorded from wt, rd3/
rd3, GCAPs−/−, and rd3/rd3 GCAPs−/− mice at p40.
Rd3 mice showed substantially reduced scotopic and
photopic responses (Fig. 3), as expected based on the
drastically reduced RetGC levels in these mice, as pre-
viously reported28. Despite this substantially reduced
sensitivity to light, rd3 mice elicited diminished but reli-
able responses to flashes in the scotopic and photopic
range (Fig. 3), indicating that at p40 they retained some
rod and cone visual function.
GCAPs−/− mice presented reduced visual responses in
the scotopic and photopic range due to the lack of GCAPs
stimulation of guanylate cyclase activity, but they largely
retained visual function (Fig. 3).
Strikingly, rd3/rd3 GCAPs−/− mice at p40 yielded
barely noticeable responses to flashes at either the sco-
topic or photopic range, despite maintaining 25% more
photoreceptor cells than rd3/rd3mice and higher levels of
RetGC at their retinas. A possible explanation for these
results is that rd3/rd3 GCAPs−/− responses reflect the
lack of stimulation of RetGC activity by the GCAP pro-
teins; whereas rd3/rd3 mice retain GCAP stimulation of
the remaining RetGC proteins.
Taken together our results show that GCAPs ablation in
the rd3 mice substantially prevented retinal degeneration
but at the cost of impairing rather than ameliorating
visual function.
Subcellular localization of RD3 in retinal sections
RD3 was described as a potent inhibitor of RetGC activity
in vitro, and was predicted to localize to the inner segment
layer where it could silence the cyclase during its transport
to the cilium25. However, RD3 was immunolocalized to the
outer segment layer of the retina in wt mice by specific
antibodies against the COOH-terminus of the protein15.
To determine RD3 subcellular localization by avoiding
the use of anti-RD3 antibodies, we generated transient
transgenic mice that expressed RD3 fused to a short tag
(RD3.V5) in rod photoreceptors. To express RD3.V5 in
rods, we made use of in vivo DNA electroporation after
subretinal injection in newborn rd3/rd3 mice with the
construct pRho-RD3.V5-dsRed. RD3 was then immuno-
localized at p20 using well-established anti-V5 antibodies
(Methods section).
RD3.V5 showed the mosaic pattern of expression that
characterizes in vivo DNA electroporation transgenesis, in
(see figure on previous page)
Fig. 2 Retinal degeneration in rd3 mice is substantially prevented by GCAPs ablation. a Retinal morphology of rd3/rd3; rd3/rd3 GCAPs+/− and
rd3/rd3 GCAPs−/− mice at p44. Photoreceptor cell loss is substantially prevented in the GCAPs−/− background. Scale bar 20 μm. b Retinal
morphometry analysis of the indicated genotypes at p44 showing ONL length (μm) along the vertical meridian of the eye. Each trace shows the
average from measurements taken from four mice, with error bars showing the standard error of the mean (SEM). GCAPs removal results in
preservation of 25% more photoreceptors at p44. c Morphology of the retina in rd3/rd3 GCAPs+/− and rd3/rd3 GCAPs−/− at p60. The protective effect
of GCAPs ablation persists at this age. Scale bar 20 μm. d Statistical analysis of ONL length in rd3/rd3 GCAPs+/− and rd3/rd3 GCAPs−/− retinas at p60.
Results are mean ± SEM of four biological replicas. e Level of expression of RetGC1 in rd3/rd3 GCAPs+/− and rd3/rd3 GCAPs−/− retinas at p30, p40,
and p60. RetGC1 expression levels correlate with the fraction of photoreceptors preserved. f Statistical analysis of RetGC1 expression levels, mean ±
SEM of three biological replicas per genotype. RetGC1 levels are not altered by the presence or absence of GCAPs at p30, consistent with rd3/rd3 and
rd3/rd3 GCAPs−/− mice having a similar ONL thickness at this age. RetGC1 levels are significantly increased in the GCAPs−/− background at p40 and
p60, reflecting the extent to which photoreceptor cells are preserved at these ages. Unpaired t-test (rd3/rd3 versus rd3/rd3 GCAPs−/− at p40, P=
0,0023**); (rd3/rd3 versus rd3/rd3 GCAPs−/− at p60, P= 0,0043**). g–i In the absence of GCAPs, more RetGC1 distributes to the rod outer segment
(ROS) layer in rd3 mice i, than in the presence of GCAPs h. Scale bar 20 μm. OS, outer segment; IS, inner segment; ONL, outer nuclear layer; ST,
synaptic terminals. j, k The protective effect of GCAPs ablation persists at 8 months. A representative retinal section of rd3/rd3 mice at 8 months, with
nuclei stained with DAPI (blue), shows a complete loss of the photoreceptor cell layer j. A retinal section of rd3/rd3 GCAPs−/− mice at 8 months
shows an outer nuclear layer with five rows of nuclei that preserve their outer segments (note the ROS layer stained with anti-rhodopsin antibody).
Retinal sections are representative of three mice per genotype. Scale bar 20 μm.
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which only transfected cells express the transgene. The
expression of RD3.V5 in rd3/rd3-transfected rods
restored RetGC1 expression and its localization to the
outer segment, which indicated that the RD3.V5 protein
was active (Fig. 4). RD3.V5 localized to the inner and
outer segments of transfected cells, giving a much
stronger signal at the inner segments. Particularly, there
appears to be a membrane domain, probably at the con-
necting cilium, where the RetGC1 and RD3.V5 signals
strongly colocalize (see the white signal from the merged
green and magenta channels with “staple” shape, Fig. 4).
Therefore our results are in line with the results
obtained by Dizhoor et al.29 that localize RD3 mainly at
the inner segment, although we observe some signal at the
outer segment as well. The mosaic expression excludes
that this signal is unspecific, as electroporated cells are
surrounded by negative control cells. Anti-V5 antibodies
unspecifically stain synaptic ribbons. This signal is clearly
unspecific because it is detected in transfected and
untransfected cells (Fig. 4).
GCAP2 in rd3mice is mostly in its phosphorylated Ca2+-free
form, a target for 14-3-3 binding
We have previously reported that an accumulation of
Ca2+-free GCAP2 at the inner segment is highly dele-
terious for rod cells26. In rd3 photoreceptor cells, GCAP2
Fig. 3 Light responses are drastically reduced in rd3/rd3 GCAPs−/− mice. Electroretinographic recordings from 40-d-old wt, rd3/rd3, GCAPs−/−,
and rd3/rd3 GCAPs−/− mice in response to light stimuli of increasing intensity at scotopic or photopic conditions. Representative recordings are
shown from one mouse of each genotype, evoked by light pulses of increasing intensity (indicated in cd/s/m2). Scotopic a-wave and b-wave
amplitudes (mean ± SD) and photopic b-wave amplitudes are plotted at different light intensities from a total of four wt mice, seven rd3/rd3 mice,
five GCAPs−/−, and five rd3/rd3 GCAPs−/− mice. Both GCAPs−/− and rd3/rd3 mice showed substantially reduced responses when compared to wild-
type responses. GCAPs ablation in rd3/rd3 mice resulted in nearly abolished responses at the scotopic or photopic range.
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is retained at the inner segment (Fig. 1d). To test whether
GCAP2 is in its Ca2+-free “deleterious” conformation in
rd3 mice, we analyzed GCAP2 levels of phosphorylation.
In vitro and in vivo studies have shown that GCAP2 is
phosphorylated at Ser201 preferentially in its Ca2+-free
form26,30. In wt mice, ~50% of GCAP2 is phosphorylated
when mice are reared under standard cyclic light, inde-
pendently of their sacrifice in the dark or light period26.
However, a GCAP2 mutant locked in its Ca2+-free form
(EF−GCAP2) transgenically expressed in rods showed a
much higher extent of GCAP2 phosphorylation. This
indicates that the extent of GCAP2 phosphorylation
in vivo reflects the fraction of GCAP2 molecules in the
Ca2+-free conformation26.
The extent of GCAP2 phosphorylation in rd3/rd3 ver-
sus wt mice was analyzed by resolving retinal homo-
genates at p21 in isoelectrofocusing gel strips that covered
a linear pH gradient of 3–10 (Fig. 5a). Threefold more
rd3/rd3 protein sample (100 μg) than wt sample (25 μg)
was loaded, in order to equilibrate the GCAP2 signal.
Unphosphorylated GCAP2 presented an isoelectric point
(IP) of 4.92, whereas phosphorylated GCAP2 an IP of
4.85. In wt mice, GCAP2 and GCAP2-P were present at a
1:1 ratio as originally reported. In contrast, GCAP2 and
GCAP2-P were observed at a 1:3 ratio in rd3mice (Fig. 5b).
This ratio of GCAP2 to GCAP2-P was very similar to the
ratio reported for EF−GCAP2 mice26, and indicates that
GCAP2 in rd3 mice is mostly in its phosphorylated Ca2+
-free state.
To gain insight into the mechanism by which Ca2+-free
GCAP2 could contribute to the physiopathology of rd3
mice, we searched for molecular targets of Ca2+-free
GCAP2 in the retina. We performed pull-down assays
with purified myristoylated recombinant bGCAP2 that
was in vitro phosphorylated—or with its mock control—
on Triton-X100 solubilized bovine retinas, under EGTA
conditions (Methods section). Experiments were per-
formed in triplicate. Bound proteins were identified by
liquid chromatography and mass spectrometry (LC-MS/
MS) and subjected to label-free quantitative statistical
analysis. For each identified protein (776 total proteins,
Supplementary Table 1), the equation detailed in Methods
section was used to determine its normalized spectral
abundance factor (NSAF) in the GCAP2-P and the
GCAP2 sample. The scatter plot in Fig. 5c presents the
Log2 (Mean NSAFGCAP2-P/Mean NSAFGCAP2) on the x-
axis, versus the −10Log(P value) in the y-axis, considering
threshold values of 1,35 and 5 for the x- and y-axis,
respectively. Proteins that showed an statistically sig-
nificant preference for GCAP2-P are shown as red dots,
while those with preference for unphosphorylated GCAP2
as blue dots (Fig. 5c).
The 14-3-3 proteins, known to interact with GCAP2-
P26, were identified with robust statistics as GCAP2-P
binding proteins; as were proteins NDUFS5 (NADH
dehydrogenase(ubiquinone) iron-sulfur protein 5), Ndel1
(nuclear distribution protein nude-like1), and RPL31 (60S
ribosomal protein L31). On the other side, among the
proteins with preference for unphosphorylated Ca2+-free
GCAP2, were HSP90(α,β) and HspB8, chaperones that
may be required to stabilize this unstable form of the
protein, and superoxide dismutase 1 and peroxiredoxin-6,
involved in maintaining the redox state of the cell.
RetGC1 was only identified in two out of three experi-
ments, with ≤6 spectral counts, and showed a slight pre-
ference for the unphosphorylated form of GCAP2
Fig. 4 Subcellular localization of RD3 protein in murine retinas. Immunolocalization of RD3.V5 protein in retinal sections from rd3/rd3 mice
electroporated with pRho-mRD3.V5-dsRed. RD3.V5 distributes between the inner and outer segment compartments of transfected photoreceptor
cells, with a stronger signal at inner segments. Note that the expression of RD3.V5 in transfected cells restores RetGC1 expression levels and its
transport to the outer segment. The red channel shows the dsRed signal from pRho-dsRed, a plasmid coelectroporated with pRho-mRD3.V5-dsRed to
serve as a reporter in the identification of the eye injected area (Methods section). Anti-V5 antibody staining of the synaptic ribbons is observed in
transfected and untransfected cells, and is an unspecific signal. Scale bar 20 μm.
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(Supplementary Table 1). However, it is well established
that the RetGC–GCAPs interaction is very sensitive to
detergents, and virtually impossible to detect in pull-down
assays.
ER stress and mitochondrial swelling are prominent early
signs of retinal degeneration in the rd3 mice that are
substantially rescued by GCAPs ablation
One early alteration that we observed in rd3 retinas at
p20 was rhodopsin mislocalization. Although rhodopsin
transport is not affected by the lack of RD3 and rhodopsin
antibodies largely stain the outer segment layer in rd3
mice (e.g., Fig. 1), a number of photoreceptor cells showed
rhodopsin perinuclear staining in any taken frame of the
rd3 outer retina at p20 (Fig. 6a). This was not observed in
age-matching wt or rd3/rd3 GCAPs−/− mice (Fig. 6a).
The number of cells per unit area that showed mis-
localized rhodopsin in rd3 mice was highest at p20 and
diminished with age (Fig. 6b, c).
Because this signal could be reflecting rhodopsin
retention at the ER due to ER dysfunction, we assessed ER
stress by comparing the levels of ER stress marker C/EBP
homologous protein (CHOP) in wt, rd3/rd3 and rd3/rd3
GCAPs−/− mice. CHOP is a transcription factor that links
severe ER impairment with the induction of apoptosis31.
We observed a clear induction of CHOP expression in rd3
mice at p20 (Fig. 6d, e), that was substantially prevented
by GCAPs ablation (Fig. 6d, e).
Apoptotic cell death was assessed by evaluating caspase
3 activation (detection of the p17 large fragment from
caspase 3 cleavage) and the cleavage of poly (ADP-ribose)
polymerase PARP, a main target of caspases. Figure 6d, e
shows activated p17 fragment of caspase 3 at a much
higher level in rd3 mice than in wt or rd3/rd3 GCAPs−/−
mice, with statistical significance (experiment performed
in triplicate). The extent of PARP1 cleavage in rd3 mice
versus wt and rd3/rd3 GCAPs−/− mice confirms the
induction of apoptotic cell death in rd3 mice at p20, that
is partially rescued by GCAPs ablation.
Actually, one of the most prominent alterations in rd3
mice at p20–p26 revealed by ultrastructural analysis was
mitochondrial swelling, indicative of apoptosis. Figure 7
shows representative electron micrographs of rd3/rd3
mice at p20–p26 (Fig. 7b, d), opposed to rd3/wt hetero-
zygous littermate controls (Fig. 7a, c). Retinas from rd3/
rd3 mice showed distinctive features like emerging ver-
tical outer segment membrane discs (black arrows in Fig.
7b, d, and enlarged area in Fig. 7e); as well as disc
structures that have been internalized at the inner seg-
ment (black arrowheads in Fig. 7f, g, h, k). The most
prominent morphological alteration in rd3/rd3 mice was
mitochondrial swelling at the inner segment, noticeable at
p20 at a fraction of cells (Fig. 7f, magnified at Fig. 7g), and
at p26 at the majority of cells (Fig. 7i, j). This mitochon-
drial swelling preceded cell death.
Interestingly, the striking mitochondrial swelling in rd3
photoreceptor cells (Fig. 7l) was greatly diminished in
rd3/rd3 GCAPs−/− mice (Fig. 7m) when four animals of
each genotype were compared (Fig. 7n).
Taken together, our results show that GCAPs induce the
ER stress response in rd3 mice, inducing CHOP expres-
sion and triggering apoptosis at a very early stage of the
disease, and that GCAPs ablation substantially suppresses
this induction and prevents photoreceptor cell death.
Discussion
We here show that the GCAP proteins play a central role
in the physiopathology of blinding diseases associated to
loss of functional RD3 (LCA12), by showing that GCAPs
ablation substantially delays retinal degeneration in the rd3
mouse model. While preservation of the retinal morphology
is not accompanied by restoration of visual function, it is
very revealing of the molecular mechanisms that link the
lack of functional RD3 with photoreceptor cell death, and
may assist at designing therapies to expand the window for
gene therapy intervention in LCA12 patients.
We first confirmed all the previously reported mani-
festations of the phenotype of the rd3 mice15, with further
attention to meaningful details. RetGC1 levels are dras-
tically reduced in rd3 retinas as reported, but can still be
detected, and are estimated at ~12% of the wild-type
levels in rd3 mice at p20 (Fig. 1). RetGC1 is retained at
(see figure on previous page)
Fig. 5 GCAP2 in rd3/rd3 retinas is largely in its Ca2+-free-phosphorylated state, which is a target for 14-3-3 binding. a Isoelectric focusing
(IEF) separation of retinal homogenates from wt and rd3/rd3mice at p30 in linear pH 3–10 gradient gel strips. Following IEF, proteins were transferred
to a nitrocellulose membrane and immunoblotted with anti-GCAP2 pAb. b The GCAP2-P to GCAP2 ratio was determined by densitometric analysis
(mean ± SEM) of three independent isoelectrofocusing experiments. Unpaired t-test (GCAP2 versus GCAP2-P in wt mice, P= 0.72) and (GCAP2 versus
GCAP2-P in rd3 mice, P= 0.0082**). c Label-free quantitative proteomic analysis to identify putative protein interactions of Ca2+-free GCAP2-P and
GCAP2. Pull-down assays were performed on bovine retinal homogenates with purified myristoylated GCAP2 that was phosphorylated in vitro or a
MOCK-phosphorylation control, under EGTA conditions. The volcano plot represents the statistical analysis of three independent pull-down assays.
Log2 (P/NP) refers to Log2 (Mean NSAFGCAP2-P/Mean NSAFGCAP2), with NSAF being the normalized spectral abundance factor, see Methods section.
The already reported 14-3-3 phosphobinding proteins (different isoforms) were clearly revealed as Ca2+-free GCAP2-P interactors, validating the
assay. Other putative interactors identified with statistical significance are marked in red (GCAP2-P) and blue (GCAP2). The whole list of identified
proteins is provided in Supplementary Table 1.
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proximal cell compartments, mostly at the inner segment
and perinuclear regions (Figs. 1d and 4). GCAP1 and
GCAP2 levels are reduced in rd3 mice to ~37 and ~42%
of wild-type levels. Although mostly retained at the inner
segment as previously reported15, traces of RetGC1,
GCAP1, and GCAP2 are also observed at the outer
Fig. 6 (See legend on next page.)
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segment layer (Fig. 1d), explaining why rd3mice elicit bigger
ERG responses than rd3/rd3 GCAPs−/− mice (Fig. 3).
The rd3 strain of mice showed a fast rate of retinal
degeneration, going from approximately ten rows of
photoreceptor nuclei at p20 to approximately five rows at
p44. GCAPs ablation substantially slowed down retinal
degeneration, so that at 8 months of age rd3/rd3
GCAPs−/− mice still retained five rows of photoreceptor
nuclei. Therefore, the loss of RD3 still caused cell death in
the absence of GCAPs, but at a substantially slower rate.
We infer that: (i) the loss of RD3 causes an initial insult,
with its origin in the closure of CNG-channels and the
ensuing chronic decrease in [Ca2+]i; and (ii) the GCAP
proteins mediate/amplify the response to this initial
insult.
At a molecular level we show that >75% of GCAP2 in
rd3 mice is phosphorylated and therefore in its Ca2+-free
state, which is indicative of low [Ca2+]i at rd3 photo-
receptor cell somas. Both GCAPs would therefore be in
their Ca2+-free, guanylate cyclase activator state at pho-
toreceptor cell somas of rd3 mice, where they result in
cellular damage. How would GCAPs induce damage in
this context?
We envision two possible pathways, sketched in our
proposed model in Fig. 8.
First, as proposed by Dizhoor et al.29 Ca2+-free GCAPs
could, in the absence of RD3, stimulate RetGCs and
promote constitutive cGMP synthesis at the inner seg-
ment, where it would result in toxicity. Dizhoor’s
demonstration that RD3.GFP expressed as a transgene in
rods localizes to the inner segment compartment29 sup-
ports RD3 proposed role of silencing RetGCs while at the
inner segment25. Dizhoor et al. also bred the rd3 mice to
GCAPs−/− mice and reported the retinal morphological
rescue, interpreting the outcome as a demonstration of
the importance of cyclase silencing at the inner segment
for photoreceptor viability. While we believe that other
scenarios cannot be discarded at this point, we consider
our data to be consistent with Dizhoor’s interpretation.
We here show that the levels of RetGC in rd3 mice are
~12% of the wild-type levels, that are present at the inner
segment layer. By showing that GCAP2 is mostly phos-
phorylated, we can infer that GCAPs are in their Ca2
+-free form. Although 75% of the GCAP2 present in rd3
mice (reduced to 42% of GCAP2 wild-type levels) is
phosphorylated and bound to 14-3-3 and therefore not
free to bind the cyclase, there is still ~10% of GCAP2
(referred to wild-type GCAP2 levels) that could bind the
cyclase and activate it in a constitutive manner. Con-
stitutive synthesis of cGMP would therefore rely on ~12%
of the wild type levels of RetGC and ~10% of GCAP2,
which is apparently low. However, constitutive synthesis
of cGMP at the inner segment compartment of cones has
been shown to be very toxic and the basis of the physio-
pathology in mouse models of achromatopsia caused by
null mutations in cone CNG-channel subunits CNGA3
and CNGB3. In these models, activation of cGMP-
dependent protein kinase (PKG) alters ER ionic home-
ostasis causing ER stress32–34. Actually, we here show that
GCAPs mediate damage by activating ER stress-mediated
apoptosis, by demonstrating CHOP induction as well as
caspase 3 and PARP1 cleavage in rd3 mice that are pre-
vented in rd3/rd3 GCAPs−/− mice (Fig. 6). Nevertheless,
evidence of cGMP synthesis specifically at the inner seg-
ment compartment and/or PKG involvement is still
missing in the rd3 model and will require further inves-
tigation. An intriguing thought, assuming that preventing
RetGC activity at the inner segment is critical for pho-
toreceptor’s viability, is that GCAP2 phosphorylation and
14-3-3 binding might serve as an additional mechanism to
prevent cyclase activation in this compartment. Whether
GCAP1 is phosphorylated is not known, and will require
further investigation. However, it is GUCA1B gene
encoding GCAP2 that was identified as a modifier gene of
the rd3 mouse phenotype27, and GCAP2 expression that
was downregulated in rd3 mice35.
A second putative pathway of damage involves the
conformational instability of Ca2+-free GCAP2,
(see figure on previous page)
Fig. 6 Rhodopsin mislocalization, ER stress, and apoptosis are early signs of retinal degeneration in rd3 mice that are palliated by GCAPs
ablation. a Retinal sections from wt, rd3/rd3, and rd3/rd3 GCAPs−/− mice at p20 stained with anti-rhodopsin antibody (green) and DAPI (blue).
Rhodopsin mislocalization at the perinuclear region and proximal compartments is observed in a number of photoreceptor cells at any given frame
of the outer retina in rd3/rd3 mice at p20, but not in wt or rd3/rd3 GCAPs−/− mice this age. Scale bar 20 μm. b, c Representative images and
quantification of cells that present rhodopsin mislocalization at p20 versus p60 in rd3 mice, expressed per unit area (n= 5 rd3/rd3 mice at p20; n= 4
rd3/rd3 mice at p60]. Unpaired t-test p20 versus p60, P= 0.0058**). d Levels of CHOP; full length and p17 kDa fragment of cleaved caspase 3; and full
length and 89 kDa fragment of cleaved PARP1 proteins in retinal extracts from wt, rd3/rd3, and rd3/rd3 GCAPs−/− at p20. Note that the full-length
casp3 and c-casp3 signals were obtained from different exposure conditions of the same membrane, given that c-casp3 represents a small
percentage of full-length casp3. No RD3 protein was observed in rd3/rd3 or rd3/rd3 GCAPs−/− extracts. e Six independent experiments were
performed to determine CHOP expression levels (wt versus rd3/rd3, P= 0.0012**; and rd3/rd3 versus rd3/rd3 GCAPs−/−, P= 0.0001***). Three
independent experiments were performed to determine PARP1 and c-PARP1 levels (PARP1: wt versus rd3, P= 0.001***; and rd3/rd3 versus rd3/rd3
GCAPs−/−, P= 0.0018**); (c-PARP1: wt versus rd3, P= 0.026*; and rd3/rd3 versus rd3/rd3 GCAPs−/−, P= 0.37 NS). Three independent experiments
were performed to determine casp3 and c-casp3 levels (casp3: wt versus rd3, P= 0.035*; and rd3/rd3 versus rd3/rd3 GCAPs−/−, P= 0.05*); (c-casp3: wt
versus rd3, P= 0.026*; and rd3/rd3 versus rd3/rd3 GCAPs−/−, P= 0.031*).
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manifested by its high tendency to aggregate when
expressed in bacteria26. We have previously shown that
a form of GCAP2 locked in its Ca2+-free form expres-
sed as a transgene in rods is retained at the inner seg-
ment compartment by phosphorylation and 14-3-3
chaperone binding, leading to a fast retinal degenera-
tion26. EF−GCAP2 toxicity occurs in the presence of
RD3 silencing the cyclase. One possibility would be that
the Ca2+-free form of GCAP2 formed toxic protein
oligomers, with 14-3-3 binding serving a protective role
by preventing this formation. In this manner, GCAP2
could cause damage in a similar way as how α-synuclein
contributes to Parkinson’s disease36,37. The instability of
Ca2+-free GCAP2 is also reflected in its high affinity for
the HSP90 dimer observed in pull-down assays (Fig. 5),
that raises the possibility that Ca2+-free GCAP2 under
chronic low [Ca2+]i may trigger the heat shock response.
A few other proteins were selectively identified as
putative interactors of GCAP2-P, like the cytoskeletal
regulator Ndel1, nuclear-distribution gene E homolog
like-1 protein, a modulator of dynein that has been
involved in securing the selectivity of cargo delivered to
axons38, and at inhibiting primary cilia assembly in pro-
liferating cells39. Ndel1 would be a putative candidate to
mediate the morphological disc alterations observed in
rd3mice. Future experiments will test this hypothesis, and
aim at confirming other putative interactions.
Finally, by expressing RD3.V5 as a transgene in the rods
of rd3 mice, we report that RD3 localizes mainly to
photoreceptor inner segments, although it also distributes
to some extent to the outer segments (Fig. 4). The outer
segment RD3 signal might not have been so apparent in
the recent study of RD3.GFP localization in rods29 due to
the protein modification by the much bigger tag. RD3
main localization to the inner segment provides some
insight into the mechanisms underlying trafficking of the
cyclase to the cilium. The cyclase is probably transported
in two stages: a first stage, in which it is escorted and
silenced by RD3 to the base of the connecting cilium; and
a second, in which the GCAPs displace RD3 to bind the
cyclase, previous to RetGC/GCAPs complex entry into
(see figure on previous page)
Fig. 7 Mitochondrial swelling is an early sign of retinal degeneration in rd3/rd3 mice that is substantially prevented by GCAPs ablation.
a–e Comparison of rd3/rd3 retinas at p20 (b, d) versus rd3/wt littermate controls (a, c). Retinas from rd3/rd3 mice present distinctive features like
emerging vertical outer segment membrane discs (black arrows in b and d, and in the enlarged area in e); as well as swelling mitochondria
(arrowheads, b and e). f, g, i, j Mitochondrial swelling is a landmark ultrastructural alteration in rd3/rd3 mice at early stages of retinal degeneration, as
observed dramatically at a high number of photoreceptor cells at p26. h, k Other striking alterations are the internalization at the inner segment of
what appears to be stacks of outer segment disc membranes (black arrowheads). l, m, n Mitochondrial swelling is substantially prevented by GCAPs
ablation in the rd3 mice, as observed by comparing a representative electron micrograph of retinal sections from rd3/rd3 l and rd3/rd3 GCAPs−/−
mice m at p26. Images are the result of fusing four transmission electron microscopy fields obtained at 10,000× magnification. The number of
photoreceptor cells that present mitochondrial swelling is substantially reduced in rd3/rd3 GCAPs−/− mice versus rd3/rd3 mice. n Four independent
regions were analyzed per retina; and retinas were obtained from four mice of each genotype. Histograms represent the percentage of cells with
presence of vacuoles, from the total number of cells. Unpaired t-test (rd3/rd3 versus rd3/rd3 GCAPs−/−, P= 0.019*).
Fig. 8 Sketch summarizing the mechanisms that likely contribute
to the physiopathology of rd3 mice and LCA12 patients. The lack
of RD3 represents an immediate insult for photoreceptor cells by
causing chronic hyperpolarization and chronic low [Ca2+]i due to the
closure of CNG-channels by the severe drop in cGMP synthesis. This
chronic low [Ca2+]i likely represents the original insult causing
damage to the cell. Chronic low Ca2+ cause the GCAP proteins to
remain permanently in their Ca2+-free conformation. GCAPs in their
Ca2+-free guanylate cyclase activator state in the absence of RD3 may
stimulate cGMP synthesis at the inner segment, ultimately causing ER
stress and ER stress-mediated apoptosis. Ca2+-free GCAP2
conformational instability may also ultimately induce ER stress. GCAP2
phosphorylation and 14-3-3 binding might serve a protective role
from both pathways of damage.
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the outer segment compartment. Future studies will be




Pertaining to animal research, this study was conducted
in accordance with the Association for Research in Vision
and Ophthalmology (ARVO) statement for the use of
animals in ophthalmic and vision research and in com-
pliance with acts 5/1995 and 214/1997 for the welfare of
experimental animals of the autonomous community
(Generalitat) of Catalonia; ref. #9906, and approved by the
ethics committee on animal experiments of the University
of Barcelona, Bell 216/17, 217/17, and 218/17.
Mice
The B6.Cg-Rd3rd3/Boc strain of rd3 mice used in this
study were obtained from the Jackson’s Laboratories (JAX
Stock #8627 Maine, USA) as heterozygous wt/rd3 mice13.
These mice present a point mutation after residue 106
(C→T) that results in a premature stop codon after resi-
due 106. The rd3 mutation results in expression of a
truncated form of the RD3 protein that is rapidly degra-
ded14. Heterozygous animals were bred in order to obtain
homozygous rd3/rd3 mice. Mice were genotyped by real-
time polymerase chain reaction (RT-PCR) by making use
of the TaqMan® SNP genotyping assay (Life Technolo-
gies, Carlsbad, USA). For that purpose, forward and
reverse primers were designed to amplify a fragment of
68 bp from the Rd3 locus of genomic DNA that encom-
passes the rd3 mutation (Fw: 5′-CTGGAGACGC
TCATGATGGA-3′; and Rv: 5′-CGACGCTCCCTCTG
TTGT-3′) and primer probes were designed to hybridize
with either the amplified wild-type allele (VIC-5′-CT
CTCTCATCTGCCCAGCC-3′) or knock-out allele
(FAM-5′-CTCTCTCATCTACCCAGCC-3′). RT-PCR
was performed in 25 μl reactions containing 12.5 μl Taq-
Man universal master Mix (Life Technologies); 300 nM
each forward/reverse primer; 250 nM of each primer
probe, and 20 ng of genomic DNA obtained from digested
mouse tails (Nucleospin® Tissue, Macherey-Nagel, Düren,
Germany). After 10 min incubation at 95 °C, thermal
cycling was performed on the StepOne Real-time PCR
System (Thermo Fisher Scientific, Waltham, Massachu-
setts) and consisted of 40 cycles (95 °C for 15 s; 60 °C for
1 min). End-point allelic discrimination genotyping was
assessed by inspecting the fluorescence plots for the wild
type versus mutated probe.
To obtain mice expressing the rd3 mutation to homo-
zygosis in the GCAPs−/− background, rd3/rd3 mice were
bred to GCAPs−/− mice. GCAPs−/− mice lack GCAP1
and GCAP2 expression, and their phenotype has been
described40.
Antibodies
Anti-GCAP1 and anti-GCAP2 polyclonal antibodies
have been previously described22. The polyclonal anti-
bodies against RetGC1 and RD3 were generated in rabbit
against C-terminal peptides corresponding to the last
21aa of murine RetGC1 and the last 16aa of murine RD3.
Peptides were conjugated to keyhole limpet hemocyanin
carrier protein (Imject maleimide activated carrier protein
spin kit, Thermo Fisher Scientific) for inoculation in
rabbits. A 90-day, three antigen-injection protocol was
followed. Serum from immunized rabbits was purified by
affinity chromatography by using the immunizing peptide
covalently coupled to an agarose column by –SH chem-
istry (Sulfolink immobilization kit for peptides, Thermo
Fisher Scientific). The specificity of the antibodies is
shown by Western blot analysis of whole retinal extracts
in Supplementary Fig. 1.
Specimen preparation for light and electron microscopy
Mice of the indicated genotypes were reared under
standard cyclic light (12 h dark:12 h light) and sacrificed by
cervical dislocation. The vertical meridian of the eye was
marked at the top for orientation purposes. The eye was
enucleated, punctured, and immediately submerged in 2%
paraformaldehyde, and 2.5% glutaraldehyde in 0.1M
cacodylate buffer pH 7.2 for 5min. The cornea was excised
and fixation was allowed to proceed for 1 h, before
removal of the lense and further fixation of the eye cup for
12 h at 4 °C. Eye cups were washed with 0.1M cacodylate
buffer and fixed with 1% osmium tetroxide in 0.1M
cacodylate buffer for 2 h at room temperature. Specimens
were dehydrated in ethanol (30–100%) or acetone, infil-
trated with propylene oxide, and embedded in Epoxi
embedding medium (Fluka Analytical, Munich, Germany).
Retinal sections for histological analysis by light micro-
scopy morphometry measurements were obtained with a
Reichert Ultracut S ultramicrotome (Leica, Wetzlar, Ger-
many) at 1-μm thickness and contrasted with Richardson’s
stain (0.5% methylene blue, 0.5% Azine II, and 0.5% borax
in dH2O). For transmission electron microscopy analysis,
ultrathin sections were obtained (see below).
Retinal morphometry analysis
For morphometrical analysis, measurements of ONL
thickness were taken on 1-μm sections at the vertical
meridian of the eye that encompassed the optic nerve.
Overlapping frames at 20× magnification were acquired
covering the whole section with a Zeiss Axio Zoom.
V16 stereo microscope (Zeiss, Oberkochen, Germany).
An integrated image of the whole retinal section was
assembled with the HUGIN fusion software. Measure-
ments of ONL thickness were taken at 200-µm intervals
from the optic nerve (12 divisions in the superior retina,
and 10 divisions in the inferior retina). For each
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morphometry analysis a minimum of four mice per gen-
otype were used at indicated ages. Error bars represent the
standard error of the mean (SEM).
Ultrathin sectioning and image acquisition at the
transmission electron microscope
Ultrathin sections (70–90 nm) were obtained with a
Reichert Ultracut S ultramicrotome (Leica), collected on
200 mesh copper grids, counterstained by heavy metal
staining (2% uranyl acetate in 50% ethanol for 30min),
and contrasted with 2% lead citrate for 10min. Ultrathin
sections were analyzed in a JEOL 1010 transmission
electron microscope and images acquired with a Bioscan
Gatan wide angle slow scan CCD camera.
Immunofluorescence analysis in fixed tissue
For immunofluorescence analysis, eye cups were fixed
in 4% paraformaldehyde, 0.02% glutaraldehyde in
phosphate-buffered saline (PBS), pH= 7.4 for 2 h at room
temperature. Eye cups were infiltrated in acrylamide (8.4%
acrylamide, 0.014% bisacrylamide in PBS pH 7.4) over-
night at 4 °C. Acrylamide polymerization was induced and
eye cup acrylamide blocks immediately frozen in O.C.T.
compound (Tissue-Tek, Electron microscopy Sciences,
Hatfield, PA) using liquid nitrogen. Cryosections were
obtained at 18-µm thickness with a CM15105 Leica
Cryostat (Leica Microsystems, Wetzlar, Germany).
Immunolocalization of GCAP1 and GCAP2 required an
antigen retrieval protocol, consistent on incubation with
proteinase K (0.05 mg/ml in PBS) for 2 min, followed by a
10 s heating shock at 70 °C. Sections were incubated with
blocking solution (3% normal goat serum, 1% bovine
serum albumin (BSA), 0.3% Triton-X100 in PBS pH7.4)
for 1 h; first antibody in dilution buffer (3% normal goat
serum, 0.4% BSA, 0.1% Triton-X100 in PBS pH 7.4) for
16 h at 4 °C; and secondary antibody (1.5 h at room tem-
perature), and fixed with 4% paraformaldehyde prior to
being mounted with Mowiol (Calbiochem #475904, San
Diego, CA, USA). Antibodies used were anti-RetGC1
pAb; anti-GCAP1 pAb; anti-GCAP2 pAb; anti-rhodopsin
mAb 1D4; anti-PNA-647 (# L32460, Thermo Fisher Sci-
entific); anti-rabbit Alexa Fluor 488 (Thermo Fisher Sci-
entific A-11034, Walthman, MA, USA); and anti-mouse
Alexa Fluor 555 (Thermo Fisher Scientific #A-32727).
Samples were mounted on 0.13–0.16 mm thick cover
glasses.
Confocal microscopy and data analysis
Confocal microscopy images were acquired at a con-
focal laser scanning microscope Zeiss LSM 880 equipped
with one GaAsP detector, with a 63×/1.4 NA oil objective.
For localization of RetGC and GCAPs in Figs. 1 and 2,
spectral bands were set to 493–550 nm for the 488
channel, 566–638 nm for the 555 channel, and to
638–755 nm for the 647 channel. The Z-stacks covered
16 μm of tissue with a 368 nm step size (~40 planes/
stack). The image acquisition settings provided a pixel size
of about 0.132 × 0.132 μm in 1024 × 1024 images.
Western blot
Retinas (at least n= 3 per condition) were homogenized
in Laemmli sodium dodecyl sulfate (SDS) buffer with
1 mM phenylmethylsulfonyl fluoride (PMSF), and pro-
tease cocktail inhibitor (Complete mini EDTA-free,
Roche). Samples were boiled for 10 min at 95 °C, and
fractions corresponding to one tenth of a retina were
resolved by 12 or 16% SDS–polyacrylamide gel electro-
phoresis. Proteins were transferred to nitrocellulose
membranes (0.2 µm nitrocellulose, Bio-Rad, Hercules,
CA, USA). Membranes were blocked for 1 h at room
temperature with 5% non-fat dry milk in TBST and then
were incubated overnight at 4 °C with custom polyclonal
antibodies to RetGC1, RD3, GCAP1, and GCAP2, and
antibodies anti-CHOP (Cell Signaling L63F7); anti-
Caspase 3 (Cell Signaling 9662); anti-PARP1 (Cell Sig-
naling 9542); goat anti-rabbit IgG (Heavy and Light
chains) antibody Dylight™ 800 conjugated (Rockland
#611-145-002, Pottstown, PA, USA); goat anti-mouse IgG
(H&L) antibody Dylight™ 680 conjugated (Rockland
#610-144-002-0.5); and donkey anti-goat conjugated to
Horseradish Peroxidase (HRP) was from Thermo Fisher
(86326). Detection was performed in an Odyssey Scanner
(LI-COR Biosciences, Lincoln, Nebraska) or Image-
Quant™ LAS500 (Ge Healthcare, Chicago, Illinois) image
acquisition system. Band densitometric analysis was per-
formed using the Fiji (Image J) software, and band
intensity analysis presented in histograms always reflect
band intensity of the protein of interest normalized by the
intensity of tubulin in the loading control.
Isoelectric focusing separation of murine retinal
homogenates
Retinas from wt and rd3/rd3mice were dissected at p21,
at an early onset of retinal degeneration of rd3 mice.
Retinas were homogenized in homogenization buffer with
phosphatase inhibitors [20 mM Hepes, 115mM KCl,
10 mM NaCl, 10 mM MgCl2, 50 mM NaF, 5 mM
β-glycerophosphate, 1 mM PMSF, and a protease cocktail
inhibitor (Complete mini EDTA-free, Roche, Basel,
Switzerland); pH 7.4]. Samples were centrifuged at
13,200 rpm, 4 °C for 30min, and supernatant fractions
were kept. An aliquot was taken at this point for protein
determination (BCA kit, Thermo Fisher Scientific). Pro-
tein material in supernatant fractions was precipitated by
addition of three volumes of ice-chilled trichloroacetic
acid (TCA)-acetone (13.3% w/v trichloroacetic acid in
acetone, with dithiothreitol (DTT) to 20mM final con-
centration); equilibration of samples to −20 °C for 72 h;
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and centrifugation at 13,000×g for 1 h at 4 °C. Protein
pellets were washed twice with cold 20mM DTT in
acetone; and allowed to air-dry for 10min. Samples were
dissolved in urea/thiourea/CHAPS/DTT (7M urea, 2M
thiourea, 40 mM DTT, 4% CHAPS, and 2% IPG buffer pH
3–10) to ensure complete reduction, denaturing, and
solubilization of proteins in the samples.
Samples were kept at −80 °C until use. For isoelectric
focusing (IEF) separation, gel strips with a preformed
linear pH gradient of pH 3–10 (prehydrated IPG Immo-
biline (TM) DryStrips pH 3–10, 18 cm, GE Healthcare)
were used. Threefold more sample was loaded for rd3/rd3
retinas than wt retinas in order to equilibrate the
GCAP2 signal. IEF separation was conducted on an Ettan
IPGphor3 system (GE Healthcare), following a 500 V step
for 1 h, a gradient to 1000 V for 1 h, a gradient to 10,000 V
for 3 h, and a 10,000 V step for 3 h. Gel strips were
incubated in transfer buffer for 15min, and proteins were
transferred to nitrocellulose membranes by capillary
action. GCAP2 was immunoblotted with anti-GCAP2
pAb and goat anti-rabbit IgG (Heavy and Light chains)
antibody Dylight™ 800. Bands were visualized at an
Odyssey scanner (LI-COR), and densitometry analysis was
performed with the Fiji (ImageJ) software.
Expression, purification, and in vitro phosphorylation of
myristoylated GCAP2 for pull-down assays
Myristoylated GCAP2 expression was induced in
Escherichia coli BL21(DE3) cells transformed with pET-
15b-bGCAP2 and the pBB131 plasmid encoding N-
myristoyl transferase (a gift from Dr. J. Gordon,
Washington University School of Medicine, Missouri,
USA). Free myristic acid was added to 50 μg/ml to the cell
culture and expression was induced for 4 h at 37 °C.
bGCAP2 protein, was recovered from solubilized inclu-
sion bodies and purified by on-column refolding using
immobilized metal affinity chromatography (IMAC) on a
Nickel-NTA [Nickel bound to agarose beads by chelation
using nitrilotriacetic acid] as previously described26.
To obtain phosphorylated bGCAP2 for pull-down
assays, in vitro phosphorylation reactions were per-
formed with protein kinase G (PKGIα, Calbiochem, Bill-
erica, MA, USA). Each 50 µl reaction contained 30mM
Tris-HCl pH 7.5, 5 mM MgCl2, 5 mM sodium phosphate
buffer pH 7.5, 6 mM DTT, 2 mM EGTA, 10 µM ATP, and
500 µM cGMP, with 10 µg of bGCAP2 in the presence or
absence of purified PKGIα (100 units) to obtain phos-
phorylated GCAP2 (GCAP2-P) and the mock-control
(GCAP2). Phosphorylation reactions were allowed to
proceed for 2 h at 30 °C, and GCAP2 and GCAP2-P were
covalently linked to Epoxi-magnetic beads (Life Tech-
nologies, Carlsbad, CA, USA). GCAP2- or GCAP2-P-
beads were then incubated with bovine retinal homo-
genates obtained by homogenization of fresh bovine
retinas in binding buffer (10 mM HEPES, 135mM NaCl,
5 mM KCl, 1 mM PMSF, 1 mM NaF, 1 mM
β-mercaptoethanol, 1% Triton X-100, 4 mM EGTA,
2 mM EDTA, and Complete Mini protease inhibitors, pH
7.4). After 1 h incubation at room temperature, beads
were washed and bound proteins were eluted under acidic
conditions. Magnetic beads were extensively washed, and
bound material was eluted in 0.2M glycine pH 2.5 and
immediately neutralized. Proteins in the bound fraction
were identified by LC-MS/MS. The experiment included
three biological replicates.
LC-MS/MS
Samples were reduced with 10 mM DTT at 60 °C for
30min, and alkylated with 55mM iodoacetamide for
30min at room temperature. Samples were precipitated
with 10% TCA. Pellets were dissolved in 2 μl of 8M urea
and brought to a final volume of 10 μl with 25mM
ammonium bicarbonate. Samples were digested with
sequencing grade trypsin in 25mM ammonium bicarbo-
nate for 12 h. For LC-MS/MS, samples were resuspended
in 0.1% formic acid and injected into a series Proxeon LC
nanoEASY system (Thermo Fisher Scientific) coupled to a
LTQ-Velos Orbitrap (Thermo Fisher Scientific). The
resulting mass spectral peak lists were searched with the
Sequest search engine (v.2.1.04, Matrix Sciences, London,
UK) against the merged BOVIN-MOUSE UP SP r 2011-1.
fasta sequence library. For database searching, raw mass
spectrometry files were submitted to the in-house
MOUSE-BOVIN_UP_SP_r_2014-5.fasta Swiss-Prot data-
base (released February 2014; 22460 protein entries) using
SEQUEST version 28.0 (Thermo Fisher Scientific). The
criteria used to accept identification included a minimum
of two peptides matched per protein, with a false dis-
covery rate of 1%. All proteins were treated as ungrouped.
Characterizing differential protein interactions of GCAP2-P
and GCAP2
For label-free quantitative proteomic analysis of pro-
teins identified with GCAP2-P versus GCAP2, we first
filtered the protein lists to remove any duplications
resulting from the use of bovine and mouse fasta
sequence libraries. Only those proteins unequivocally
assigned by at least a unique peptide were retained. For
each protein identified the NSAF was calculated with the
following equation:
NSAFk ¼ ðSpCk þ 1Þ=LkPn
i¼0ðSpCi þ 1Þ=Li
ð1Þ
where NSAFk is the Normalized Spectral Abundance
Factor41 for a given protein k; SpCk is the Spectral Count
for protein k, Lk is the length of the protein in number of
amino acids; and the denominator is the summation of
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the NSAFs of all identified proteins in that sample. This
expression corrects for differences in sampling depth
between both conditions assayed, and avoids the dis-
continuity seen in simple count ratios when a protein
shows spectral count= 0 in one of the samples.
Mean NSAF values were then calculated from triplicate
biological samples, followed by a t-test comparison (two




was plotted in the x-axis; and the
10logðp valueÞ from the t-test was plotted in the y-axis,
with MeanP referring to Mean NSAFGCAP2-P, and MeanNP
referring to Mean NSAFGCAP2. Threshold curves for the
volcano plot were obtained by fitting values to
f xð Þ ¼ 1
x2  nþm ð2Þ




is the −10log(p value) threshold. m and n values were





and b  10logðp valueÞ , the proteins
passing the thresholds are those proteins that: a< ffiffiffinp




and b > f(x),
for the positive side.
Electroretinography
A total of 4–7 mice were tested for each animal group.
Dark-adapted (>12 h) animals were anesthetized with an
intraperitoneal injection of ketamine (70 mg/kg; Ketalar,
Parke-Davis, Wellington, New Zealand) and xylazine
(7 mg/kg; Rompun, Bayer, Leverkusen, Germany) in saline
solution (NaCl 0.9%) and pupils were dilated with one
drop of 1% tropicamide. A corneal electrode was used to
record ERGs from right eyes (Burian-Allen, Hansen
Ophthalmic Development Lab, Coralville, IA). Electrode
was placed in the visual axis 1–2mm from the cornea and
a drop of 2% methyl-cellulose (Methocel, Ciba Vision,
Hetlingen, Switzerland) was dropped between cornea and
electrode. Mice were maintained for >5 min in absolute
darkness before the recordings. Mouse temperature dur-
ing the recording was maintained at 37 °C with a liquid
heating pad. Full-field flash ERG responses were recorded
with the retina illuminated with a LED-driven Ganzfeld
dome. A series of light flashes of increasing intensity
(from 0.001 to 10 cd/s/m2) were averaged both in scotopic
and photopic conditions. Photopic cone responses were
recorded following 5min of light adaptation with a
background white light (50 cd/m2). Light intensity was
controlled for each animal group (Mavo-Monitor USB,
Gossen, Germany). Recorded electrophysiological
responses were amplified, filtered (CP511 AC amplifier;
Grass Instruments, Quincy, MA), and digitalized (ADIn-
struments Ltd, Oxfordshire, UK). The recording process
was controlled with Scope version 3.8.1 software (Power
Lab, ADInstruments Ltd). The stimulation protocols were
designed according to the International Society for Clin-
ical Electrophysiology of Vision.
Generation of pRho-mRd3.V5-dsRed expression vector and
in vivo DNA electroporation
The expression vector used for in vivo DNA electro-
poration was based on the plasmid pRho-DsRed. pRho-
DsRed was a gift from Connie Cepko (Addgene plas-
mid#11156; http://n2t.net/addgene:11156;RRID:
Addgene_11156)42. This plasmid contains the 2.2 kb-
version of the rod opsin promoter from Bos taurus43; a
multicloning site; a Kozak sequence; the DsRed2 reporter
gene; and the β-globin poly(A) signal42. To make pRho-
mRD3.V5-DsRed, murine rd3 cDNA was amplified by
PCR with a forward primer that introduced an XbaI
restriction site and the reverse primer introducing the V5
epitope in frame with RD3 COOH-terminal sequence,
followed by an EcoRI restriction site. The mRD3.V5 DNA
was inserted in the XbaI and EcoRI sites of pRho-DsRed,
and the resulting expression vector was verified by
sequencing. For in vivo electroporation, pRho-mRd3.V5-
dsRed vector was amplified with the pureLinkTM Expi
Endotoxin-Free Mega Plasmid Purification Kit (Invitro-
gen, Carlsbad, California).
In vivo DNA electroporation in the retina following
DNA injection in the subretinal space was performed as
originally described42 with minor modifications. A
DNA solution (6 μg/μl) was prepared by mixing pRho-
DsRed and pRho-mRD3.V5-DsRed at a molar ratio of
1:4 in phosphate saline buffer with 0.1% v-v fast green.
Even though pRho-mRD3.V5-DsRed expressed dsRed,
we found the levels of expression too low for detection
of the eye injected area at the fluorescence dissection
scope. Therefore pRho-DsRed was coinjected with
pRho-mRD3.V5-DsRed. Pups were injected the day
they were born at the subretinal space, with 0.2–0.5 µl
of DNA by using a Hamilton syringe with a blunt 30-
gauge needle under a dissecting microscope (Zeiss
KL1500LCD. Stemi2000, Germany). Tweezer-type
electrodes were placed softly holding the head of the
pup, and five 80 V square pulses of 50 ms duration with
950 ms intervals were applied using a CUY21 electro-
porator (Nepagene, Chiba, Japan). Electroporated eyes
were processed at p20–p25 for immunofluorescence
localization analysis as described above. Antibodies
were anti-RetGC1 pAb and the anti-V5 mAb (2F11F7,
Invitrogen) by secondary antibodies α-rabbit Alexa
Fluor 488 (Life Technologies) and α-mouse Alexa Fluor
647 (Life Technologies) both at 1:500 for 1.5 h at room
temperature. The image has been acquired with a
LEICA SP5 microscope using a 63 × 1.4 NA oil objec-
tive. The pixel and step sizes are 100 nm and 198 nm
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respectively providing an effective image volume of
131 μm × 131 μm × 9.5 μm. Two Hybrid detectors in
photon counting mode and a photomultiplier tube
(PMT) have been used to acquire the different channels.
The spectral configuration for the channel 1 used a
488 nm laser line and an emission window from 498 to
535 nm. The channel 2 used the 633 nm laser line and
an emission window between 642 and 722 nm. Finally,
the channel 3 used the 543 nm laser line with the
emission window set between 551 and 616 nm.
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